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INTRODUCTION 
This dissertation is presented in a series of three chapters. Each chapter is formatted 
as a stand-alone article following the formatting specifications of Environmental Science' and 
Technology. This approach facilitates a more streamlined method of preparing manuscripts 
for publication of the research without the necessity of re-writing the dissertation. 
Data collected from the bioavailability and biomethylation experiments are included 
in the following appendices: 
Appendix I - In-Vitro Data 
Appenidx II - In-Vivo Data 
Appendix III - Chemical Speciation Data 
Appendix IV - Biomethylation Data 
A quality assurance work plan was developed for this project and is included as 
Appendix V. Data were not collected until all control limits were met. 
Chapter 1 
An In-Vitro Gastro-Intestinal Method to Assess Bioavailable Arsenic in 
Contaminated Soils and Solid Media 
ABSTRACT 
2 
A method was developed to simulate the human gastro-intestinal environment to better 
evaluate the soil ingestion pathway and bioavailability of arsenic as a soil contaminant. The 
in-vitro gastro-intestinal (IVG) method parameters are based upon the medical and nutrition 
science literature in the concentrations of biochemicals, soil:solution volumes, and 
experimental conditions. The IVG method is presented with the appropriate conditions 
representing the two phases of digestion: the stomach phase and the intestinal phase. As an 
alternative method, and . to simulate the adsorption of chemicals across the intestinal 
membrane, an adsorbent of freshly prepared iron oxide gel was added to the intestinal phase 
solution (the IVG-AB method). The IVG and IVG-AB method results were compared to in-
vivo results from the conduct of soil feeding trials using the immature swine model. Results 
of the IVG stomach phase and intestinal phase were linearly correlated (r = 0.69 and 0.67, 
respectively) with in-vivo bioavailable arsenic (P < 0.01). The slope of the linear regression 
lines were 0.88 and 0. 76 for the IVG stomach phase and intestinal phase, respectively. This 
suggests that the IVG method measures nearly as much arsenic as the in-vivo method 
measured. Similar results were demonstrated for the IVG-AB stomach phase and intestinal 
phase; both phases were linearly correlated (r = 0.64 and 0.63, respectively) with in-vivo 
bioavailable arsenic (P<0.05). The slopes of the linear regression lines were similar at 0.87 
3 
and 0. 74 for the IVG-AB stomach phase and intestinal phase, respectively. Analysis of 
variance showed the IVG stomach phase and intestinal phase, as well as the IVG-AB stomach 
phase were not statistically different from the in-vivo method. 
Key Words: arsenic contamination, bioavailability, bioavailable arsenic, incidental soil 
ingestion, smelter wastes, in-vitro method, gastrointestinal simulation, immature swine model 
INTRODUCTION 
Arsenic is a naturally occurring element typically found in soil at background 
concentrations ranging from 0.1 to 40 mg kg-1 (Bowen, 1979). Arsenic contamination of soil 
may result from: mining, milling, and smelting of copper, lead, and zinc sulfide ores (Lindau, 
1977; Nelson, 1977); raw and spent oil shale (Shendrikar and Faudel, 1978); and coal fly ash 
(Hansen et al., 1984; Wadge and Hutton, 1987). Arsenic has been found at high levels 
(10,000 to 20,000 mg kg-1) in some contaminated areas such that the concentration results 
in unacceptable levels of risk to human health from the incidental ingestion of soil (Life 
Systems, 1992a, 1992b). · Chronic exposure to arsenic may result in skin and internal organ 
cancers, impaired nerve function, kidney and liver damage, and skin lesions (ATSDR, 1991). 
Incidental soil ingestion by children is an important pathway in assessing public health 
risks associated with exposure to arsenic-contaminated soils. Incidental ingestion of soil 
results from normal hand-to-mouth activities and represents the principal direct pathway for 
exposure to non-dietary sources of arsenic in contaminated areas. The importance of soil 
ingestion by children as a health issue has been reported by numerous researchers and fully 
illustrates the importance of this pathway in terms of subsequent chemical exposure (Binder 
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et al., 1986; Calabrese et al., 1989; Clausing et al., 1987; Davis et al., 1990; van Wijnen et al., 
1990). 
Most risk from arsenic is associated with the forms of arsenic that are biologically 
available for absorption, or "bioavailable" to humans. A bioavailable chemical is the portion 
of a chemical dose that enters the systemic circulation from an administered dose. Presently, 
methods are not available to quantify the amount (as a percentage) ofbioavailable arsenic in 
soils to accurately assess risk from incidental ingestion of arsenic contaminated materials. 
Hence, some baseline risk assessments developed for contaminated sites have used the 
conservative assumption that all (i.e. 100%) of the arsenic present in soils and wastes is 
bioavailable. However, arsenic may exist in many geochemical forms ( e.g. oxides, sulfides) 
and physical forms (e.g. flue dust, slag, tailings, calcine, waste ore) at hazardous waste sites 
contaminated by mining and smelter wastes. These waste forms vary in their solubilities and 
geochemical stabilities to the extent that many are not likely to be very bioavailable and 
therefore may pose only small risks to humans. 
The bioavailability of metals, especially lead and arsenic, in some mining wastes have been 
assessed by conducting expensive and lengthy feeding trials using animal models. The animal 
model of choice for investigating the enteric bioavailability of arsenic in children requires 
selection based on similar age and anatomical and physiological characteristics. Pigs are 
remarkably similar to humans with respect to their digestive tract, nutritional requirements, 
bone development, and mineral metabolism (Dodds, 1982). Also, pigs, like humans, tend to 
ingest food intermittently allowing the stomach to evacuate periodically. This physiology is 
consistent with the way children most likely ingest arsenic-contaminated materials, between 
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meals when the gastric pH is lowest. Immature pigs have therefore been used successfully as 
a model for gastrointestinal function of children (Miller and Ullrey, 1987; Weis and LaVelle, 
1991). 
In order to overcome some of the difficulties and expenses associated with the conduct 
of animal feeding trials to assess bioavailability of metals in soils, research effort has been 
directed toward the development of chemical methods which simulate the gastrointestinal 
environment. One such method is the physiologically-based extracted test (PBET) reported 
by Ruby et al. (1996). Results for the PBET method have been shown it to be good predictor 
of lead bioavailability, and the authors reported that their test may have potential for use in 
determining arsenic bioavailability. However, PBET research with arsenic contaminated 
materials has been limited to only a small number of materials and these results are 
inconclusive. 
The gastrointestinal digestive processes are quite complicated and difficult to simulate in-
vitro. Several studies in the area of human nutrition have reported in-vitro methods to assess 
bioavailable iron in foodstuffs (Rao et al.,1978; Miller et al., 1981; Schwartz et al., 1982; and 
Crews et al., 1983). Many of these procedural steps are based upon the medical and 
biochemical scientific literature to gain an understanding of the digestive process, especially 
in terms of digestive solution volumes produced in response to food intake volume, pH 
conditions during digestive phases, and quantities of digestive juices and enzymes produced 
such as pepsin, bile acids, pancreatin, etc. (Orten and Neuhaus, 1975; Malagelada et al., 
1976). 
There are two predominant mechanisms involved during digestion of metals contaminated 
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soil: the solubility of the metal from the soil matrix and the uptake (absorption) of the-metal 
across the intestinal membrane. Previous in-vitro type studies have looked at the solubility 
of metals under gastrointestinal conditions as an indicator of potential bioavailability (Davis 
et al., 1992; Ruby et al., 1993; Ruby et al., 1996), but in-vitro gastrointestinal methods which 
simulate the mechanism of absorption have not been reported. Arsenate, and the chemically 
similar phosphate, have been shown to have a high affinity for amorphous iron oxide gel 
(Pierce and Moore, 1982; Sharpley, 1991; Myers et al., 1995). Incorporation ofiron oxide . 
gel in an in-vitro procedure to simulate intestinal absorption is also evaluated in this study. 
The primary objective of our study is to develop a method to measure the bioavailable 
fraction of arsenic in soil and waste which correlates well with the bioavailable arsenic as 
measured in-vivo (per pig feeding trials). A second objective is to compare results from our 
in-vitro studies with those from another in-vitro method under development, the PBET (Ruby 
et al., 1996). An in-vitro gastrointestinal technique will provide a rapid, inexpensive testing 
method to obtain scientifically derived data to select appropriate remedies at contaminated 
sites which are cost-effective and protective of human health and the environment. A measure 
ofbioavailable arsenic will also serve to lower the uncertainty surrounding the quantification 
of potential risks arising from exposure to arsenic-contaminated media. 
EXPERIMENTAL METHODS 
Study Soils and Solid Media 
Two matrices were collected for this study from a typical mining/smelter site in the 
western U.S. where wastes were deposited between 20 and 50 years ago. These aged and 
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weathered wastes include a calcine material, a waste product which results from the roasting 
and smelting of arsenopyrite ore for the extraction of arsenic, and an iron slag material, a 
waste product which results from the smelting of ores for lead which is also high in iron. Five 
calcine (Cl through C5) and five iron slag (Sl through S5) samples were collected for this 
from the same site. In addition to the collected soils, five more contaminated solid materials 
( designated as E 1 through ES), which had been archived following previous studies involving 
chemical analyses and pig feeding trials, were included in the study to test the in-vitro method 
over a broader range of matrices. These materials consist of soils and slags. Chemical and 
physical properties for the study materials are presented in Table 1 and total arsenic 
concentrations (ranging from 233 to 17,456 mg kg -1) are presented in Table 2. 
Mineralogical composition of one representative calcine ( C4) and one representative slag 
(S4) was determined by microprobe analysis for the various iron and arsenic bearing 
compounds. The calcine was found to contain: 3 8% iron-manganese sulfate, 28% iron-
arsenic-oxide, and 3 5% iron-manganese oxide. The iron slag was found to contain: 17% 
iron-manganese sulfate, 49% iron-arsenic oxide, 4% iron-manganese oxide, 30% lead-
manganese oxide, and 2% slag. 
Approximately five gallons of each soil was collected, air dried under ambient conditions, 
and sieved to collect the particle size fraction< 250 µm. This fraction has been determined 
to be the size which adheres to fingers and is thus available for incidental ingestion. Soils 
were thoroughly homogenized/mixed prior to use and stored in secured, air-tight containers. 
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Immature Pig Feeding Trial 
Standard operating procedures developed by Dr. Stan Casteel of the University of 
Missouri-Columbia Veterinary Medicine Diagnostic Laboratory, approved by the U.S. 
Environmental Protection Agency (EPA) Region 8 (Casteel, 1995), were utilized in the 
immature pig feeding trials. Intact male pigs weighing 10 to 12 kg were randomly assigned 
to treatment groups, consisting of calcine dosing group, slag dosing group, negative control 
group (no soil), and positive control group (oral N~As04•7H20). Five pigs were used per 
treatment group, with the exception of three pigs per negative control group. All pigs were 
individually housed in arsenic-free cages and fed low-arsenic feed and water. After a three 
day acclimation period, the pigs were exposed to soil/treatment doses. Doses were delivered 
daily (half in morning and half in evening) via 5 g of a vehicle of low-arsenic/low lead diet 
material (Ziegler Bros., Inc., Gardners, PA), wetted slightly with distilled water to a cookie 
dough-like consistency. A depression was made in the center, the soil dose was placed into 
the depression, and the material folded to enclose the dose. The entire vehicle was hand fed 
to .the pigs on schedule. Every three days thereafter, for five collection periods, 24-hour 
urines were collected from each pig. The urines were filtered (Whatman 2), placed into 
plastic bottles, and preserved to pH 2 with concentrated HCI. Urine samples were packed 
securely in coolers on ice and shipped by overnight carrier under chain of custody procedures 
to Oklahoma State University (OSU) for arsenic analysis. Following an additional filtering 
through 0.45 µm filters, arsenic analysis was performed by a Thermo-Jarell Ash Inductively 
Coupled Plasma (ICP) (Maxim) utilizing Hydride Generation (HG). To prepare the urine 
sample for hydride generation, a 10.0 ml aliquot of urine was placed into a test tube and 
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mixed with 3.3 ml concentrated HCl and 4.0 ml of a solution containing 10% pota~sium 
iodide and 1 % ascorbic acid. After a reaction period of at least 1 hour, arsenic was 
determined by ICP-HG. 
In-Vitro Procedures 
All in-vitro work was conducted in the laboratories of OSU. A conceptual overview of 
the in-vitro study is presented in Figure 1. Bioavailable arsenic was measured in our study 
by two separate in-vitro methods and compared to the in-vivo study results. An additional 
comparison of our in-vitro results was made with another previously published in-vitro 
procedure (Ruby et al., 1996; Medlin, 1997). Quart-size canning jars were used as reactor 
vessels because of their wide-mouth and heavy glass composition. All in-vitro procedures 
were conducted in a water bath at body temperature (37 ° C), anaerobic conditions were 
maintained by constantly diffusing argon gas through the solution, and the pH of the in-vitro 
solutions was monitored constantly and adjusted as necessary throughout the procedure. 
Constant mixing was maintained throughout the procedures (to simulate gastric mixing) by 
use of individual paddle stirrers at a speed of approximately 100 rpm. A schematic diagram 
depicting the in-vitro reactor design is illustrated in Figure 2. · 
The in-vitro methods were conducted in two separate phases: 1) gastric phase, low pH 
by adjustment with concentrated HCl (Fisher Scientific, St. Louis, Mo., trace metal grade), 
followed by 2) intestinal phase, pH raised by adjustment with a saturated solution of NaHC03 . 
Throughout the gastric and intestinal phases, a small amount of surfactant was added ( e.g. 
decanol) to control excessive foaming due to constant argon gas diffusing through the 
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solutions. Each phase duration was I-hour, and at the end of each, a 40 ml sample was 
collected using a new Luer-lock syringe. Samples were centrifuged at 10,000 rpm for 15 
minutes, and the supernatant was filtered through a 0.45 µm filter, acidified to pH 2 with 
concentrated HCl, and analyzed for arsenic by ICP-HG (following preparation for hydride 
generation as described above for urine). All in-vitro tests were performed in triplicate 
(simultaneously) for all soils. The three in-vitro methods studied are presented below. 
Adequate blanks, duplicates, and matrix spikes were analyzed to meet quality assurance and 
quality control requirements. Table 3 presents the experimental parameters for each of the in-
vitro methods, for clarity, along with their respective literature references. 
1) In-vitro Gastrointestinal Method (IVG): Gastric phase solution was prepared by 
making a solution of0.15 M NaCl (Fisher Scientific, St. Louis, MO.) and 1 % porcine pepsin 
(Sigma Chemical Co., St. Louis, Mo., 146518). Soil (4 g) was added to 600 ml of gastric 
solutio~. To mimic the in-vivo procedure, an equivalent amount of the dosing vehicle was_ 
added to simulate the in-vivo dosing technique. Dosing of soil to pigs'in-vivo was 100 mg 
soil to 5 g of dough. Therefore, the in-vitro reactor included 200 g of dough in the 600 ml 
of gastric solution to maintain the same ratio (on a volume basis). The pH adjustment of the 
gastric solution was made following the addition of soil, to account for the various buffering 
capacities inherent in each soil. The gastric phase solution was modified to the intestinal 
phase solution by first adjusting the pH to 5.5 with a saturated solution ofNaHC03• Porcine 
bile extract (Sigma Chemical Co., St. Louis, Mo., Cat. No. B8631) and porcine pancreatin 
(Cat. No. P1500) were added following pH stabilization, 2.10 and 0.21 g, respectively. 
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2) In-Vitro Gastrointestinal Method with Absorption (IVG-AB): A second in-vitro 
procedure was performed to determine if an intestinal absorption step could be simulated. 
The procedure is the same as the IVG method described above with the exception of adding 
freshly prepared amorphous iron oxide gel during the intestinal phase as an adsorbent. Iron 
oxide gel is prepared (Myers et al., 1995) by making a 0.65 M FeCl3•6H20 solution, then 
slowly adding a solution of 2. 7 M NH40H until the pH is approximately 6. The amorphous 
iron oxide gel is then collected by centrifuging the solution at 10,000 rpm for 15 minutes, then 
carefully pouring off the supernatant. Teng ofiron oxide is placed onto a square (5" x 5") 
of nylon membrane macroporus filter, 8 µm pore size. Nylon string is then used to tie up the 
fabric similar to a tea bag which is then allowed to hang freely in the reactor vessel 
throughout the entire intestinal phase. At the end of the intestinal phase, the iron oxide bag 
is removed and placed into a 250 ml Erlenmeyer flask. Arsenate is desorbed by adding 200 
ml of0.2 MH2S04 to the flask and shaking on a reciprocal shaker for 1 hour. The resulting 
solution is filtered through a 0.45 µm pore size filter and analyzed for arsenic by ICP-HG. 
3) Physiologically Based Extraction Test (PBET): The PBET procedure was 
performed as described in Ruby et al., 1996 and Medlin, 1997, with the following exceptions. 
To maintain anaerobic conditions, argon gas was diffused through the in-vitro solutions 
continuously rather than utilizing closed reactor vessels, and the pH of the gastric solution 
was raised to 7.0 (to perform the intestinal phase step) by addition of a NaHC03 solution 
rather than using dialysis tubing packed with NaHC03 powder. The NaHC9 solution 
reacted much quicker (1.5 to 2 hours faster) and dialysis tubing was subject to breaking by 
inadvertent contact with the mixing blade. 
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In-Vivo Bioavailability Calculations 
The amount of arsenic which is absorbed through the gastrointestinal tract (bioavailable 
arsenic) may be described in absolute or relative terms (Casteel, 1995). Absolute 
bioavailability (ABA) is the ratio of the amount of arsenic absorbed compared to the amount 
ingested: 
ABA = Absorbed Dose 
Ingested Dose Equation (1) 
Relative bioavailability (RBA) is the ratio of the absolute bioavailability of arsenic present in 
some test material ( study soil) compared to the absolute bioavailability of arsenic in some 
appropriate reference material: 
ABA (study soil) RBA = ~~~---''---=---~-'-~-
ABA (reference material) Equation (2) 
In our study, the reference material was the control N3.zAs04•7H20 (a readily soluble form, 
therefore easily absorbed): Arsenic excretion in urine is found to be a linear function of the 
administered dose (Casteel, 1995), and is approximately independent of time after five days 
of exposure during feeding trials. Because of the rapid excretion of arsenic via the urine, the 
urinary excretion fraction (UEF), defined as the amount excreted in the urine divided by the 
amount dosed, may sometimes be a reasonable approximation of the oral absorption fraction 
or ABA. However, this ratio will underestimate total absorption, because some absorbed 
arsenic is excreted in the feces via the bile and some enters tissue compartments ( e.g. skin, 
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hair, etc.) from which it is cleared very slowly or not at all. Thus, the urinary excretion 
fraction is not equated with the ABA. The UEF can be used, however, to compute the RBA 
as follows: 
RBA (of soil As vs. reference As) = UEF (study soil) Equation (3) UEF (reference material) 
All in-vivo bioavailabilities in this study are reported as RBAs. 
In-Vitro Bioavailability Calculations 
The standard analysis for soil metal content, including arsenic, during the investigation of 
the nature and extent of contamination of CERCLA sites is by hot digestion with HN03 and 
H202, USEPA SW 846, Method 3050 (1986). The resulting total metal concentration is then 
used for estimating risks to human health. The realization that probably not all (100%) of the 
total metal measured by complete digestion is bioavailable has led risk assessors to use a 
fraction (percentage) of total metal which better represents the fraction which is bioavailable 
in the risk calculation. For our in-vitro results, bioavailable arsenic is calculated by dividing 
the arsenic concentration measured in the in-vitro stomach phase or the in-vitro intestinal 
phase solutions by that measured as total arsenic (all on a concentration in soil basis), as 
described by the following equation: 
In-vitro bioavailable As, % = [ in-vitro As, mg kg -I] * 100 
total As, mg kg -I Equation (4) 
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For the in-vitro method utilizing iron oxide adsorbing gel (IVG-AB), the intestinal phase 
solution arsenic and the arsenic dissolved from the iron oxide gel are summed to represent 
the total intestinal phase arsenic. 
RESULTS AND DISCUSSION 
The length of time to perform the stomach phase and intestinal phase (reaction time) was 
not clearly described in the literature. Hence, an experiment was conducted using the PBET 
method (Ruby et al., 1996; Medlin, 1997) (on one calcine and one slag sample) to determine 
the dissolution of arsenic over time for each of the phases. The soluble concentration of 
arsenic remained relatively constant during the stomach phase with samples collected every 
20 minutes; arsenic concentration results ranged from 1.1 to 1. 9 % of total for the calcine and 
from 13. 8 to 15. 6% of the total soil arsenic for the slag. Likewise, samples were collected 
every 60 minutes over a 3-hour intestinal phase and again, arsenic concentration in solution 
remained relatively constant; arsenic concentration results ranged from 2.0 to 2.3% of total 
for the calcine and from 10.1 to 10.6% of total for the slag. A I-hour duration was selected 
for reaction time of each phase. 
Other studies have shown the type of food incorporated into the in-vitro method can 
affect lead bioavailability (Medlin, 1997). In order to replicate conditions of the in-vivo 
experiment as closely as possible, an experiment was conducted to evaluate the condition of 
food (using the soil dosing vehicle) added versus no food (vehicle) added. An equivalent 
volume of soil dosing vehicle (which represented 200 g of vehicle) was added to the reactor 
vessel. One calcine sample and one slag sample were tested with and without food. For the 
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slag sample, there was no difference in the soluble arsenic measured in either the stomach or 
intestinal phases of the vessels with food as compared to the vessels without food (21.1 µg 
g·1 stomach phase and 24.4 µg g intestinal phase, no-food conditions versus 19.7 µg·g 
stomach phase and24.3 µg g·1 intestinal phase, with-food conditions). However, for the 
calcine sample, more arsenic was solubilized in the with food treatment as compared to the 
without food treatment (2.65 µg g·1 stomach phase and 6.92 µg g·1 intestinal phase, no-food 
conditions versus 7.86 µg g·1 stomach phase and 10.3 µg g intestinal phase, with-food 
conditions). Apparently, adding food would not inhibit arsenic solubilization, and in some 
cases, may increase arsenic solubilization. For the the IVG and the IVG-AB in-vitro 
experiments, 200 g of dough was added to represent the addition of food. 
To simulate absorption across the intestinal membrane, iron oxide gel was added to the 
IVG-AB intestinal phase solution. To determine the quantity of iron oxide gel to use, an 
experiment was conducted to determine the effectiveness of various amounts of gel in terms 
of the amount of arsenic adsorbed from the intestinal phase solution, thereby allowing for 
potentially more arsenic to become solubilized from the soil. First, iron oxide gel coated filter 
papers were utilized, prepared as described by Myers et al. (1995). The gel coated filter 
papers have approximately 80 mg of iron oxide coating on each. Only a small amount of 
arsenic (approximately 0.1 mg As per g of iron oxide) was adsorbed from a 100 mg L·1 
intestinal phase solution spiked with sodium arsenate (less than 1 % recovery). Greater 
quantities of iron oxide gel were required to enhance the amount of arsenic adsorbed from 
solution, and thus, another method was necessary to hold the iron oxide gel in the solution. 
Experiments were conducted using various mesh sizes of filter fabric to hold 10 g of iron 
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oxide gel. A mesh size of 8 µm pore size was found to be sufficient in that it allowed water 
to flow through the fabric, yet did not allow the iron oxide gel to diffuse into the intestinal 
solution. Using 10 g of freshly prepared iron oxide gel, approximately 1 mg of arsenic was 
adsorbed per 1 g of iron oxide from a 100 mg L-1 spiked intestinal phase solution (16.7% 
recovery). 
The results of all in-vitro tests are presented in Figure 3. Although fifteen soils were 
tested throughout all in-vitro experiments, only thirteen xy points are presented on each plot. 
Two of the slag samples had very low arsenic concentrations and were below in-vivo 
bioavailability detection limits. Results of the IVG stomach phase were linearly correlated 
(r= 0.69) with in-vivo bioavailable arsenic (P<0.01) (Figure 3a). The slope of 0.88 means 
the IVG method measures almost the same amount of arsenic as the in-vivo method. The 
IVG intestinal phase was also linearly correlated with in-vivo arsenic with a r2 of 0.67 
(P<0.05). 
Figure 3c presents the results of the IVG-AB stomach phase. Because the IVG-AB 
stomach phase is the same procedure as for the IVG stomach phase, we would not expect 
to see much difference between results ofFigures 3a and 3c, and in fact, the results are nearly 
. the same. Slight differences were found between the IVG and the IVG-AB intestinal phases 
(Figures 3b and 3d). Adding the adsorbing material to the in-vitro solution decreases the r2 
value of the linear regression line to 0.63 (as compared to 0.67 for IVG), statistically 
significant at (P < 0.05). The slope of the intestinal phase linear regression line of the IVG-
AB is nearly the same as the slope of the intestinal phase IVG linear regression line. 
The PBET stomach phase results are not linearly correlated with in-vivo arsenic, while 
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the intestinal phase is correlated with an r2 of 0.57 (P < 0.05). The slopes of the PBET 
regressions (Figures 3e and 3f) were lower than those obtained for the IVG and IVG-AB 
methods (Figures 3a through 3d). These results suggest the IVG and IVG-AB methods 
measure more bioavailable arsenic from the contaminated soils than the PBET method. 
In consideration the r2 values of the in-vitro tests, it appears that the largest differences 
are between the PBET test results as compared to the IVG and IVG-AB results. Generally, 
the PBET method (stomach phase) appears to solubilize approximately half of the arsenic 
solubilized in the IVG and IVG-AB methods. One important difference between these 
methods is the amount of pepsin used in the in-vitro solutions. The PBET solution contains 
one-tenth the pepsin concentration of the IVG solutions. We selected the IVG pepsin 
concentrations from the human nutrition and medical literature (Malagelada et al., 1976; 
Crews et al.,1983). Pepsin is one of the most important of the digestive enzymes, it 
hydrolyzes peptide bonds in proteins and polypeptides with a low degree of specificity. 
Another difference between the two methods is that the PBET method does not incorporate 
any type of food into the gastric solution. Food has been shown to have an affect on 
bioavailability (Medlin, 1997). 
While correlations represent a method of comparing the in-vitro methods with the in-vivo 
method, additional statistical techniques to determine if the in-vitro methods are significantly 
different from the in-vivo methods are necessary. An analysis of variance was conducted 
using the Duncan's Multiple Range Test (SAS, 1997) (Table 4). As shown in Table 4, for all 
media samples (calcine, iron slag, and miscellaneous soils and slags) only the IVG stomach 
phase method was equivalent with the in-vivo method (P<0.05). Evaluating the media 
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separately, the iron slag material tested by the IVG-stomach phase method was statistically 
equivalent to the in-vivo method, yet the calcine materials were different (at P<0.05). When 
only the slags and soils were evaluated (all media except the calcines), the IVG-stomach 
phase was still statistically equivalent with the in-vivo method at P<0.05. Similar results were 
demonstrated for the IVG-AB.,.intestinal phase method. When only the slags and soils were 
evaluated, the IVG-AB intestinal method was statistically equivalent with the in-vivo method 
(at P<0.05). The calcine samples, as analyzed by any of the in-vitro methods, were not 
statistically equivalent with the in-vivo method. For nearly all groups of materials tested, 
there are no statistical differences between the IVG stomach phase, IVG intestine phase, and 
IVG-AB intestine phase. In other words, extending the in-vitro method beyond the gastric 
phase did not improve the ability of the method to measure bioavailable arsenic. Also of note 
is that neither the PBET stomach phase nor PBET intestinal phase in-vitro methods were 
found to be statistically equivalent with the in-vivo method for any groups of contaminated 
materials tested. 
To evaluate and compare the variability of the test results for each of the different 
methods (in-vitro and in-vivo), the coefficients of variation (CV) were determined for each 
(Table 4). The CVs for the IVG and IVG-AB methods for all media were similar; ranging 
between 73.0 and 75.2%. The IVG and IVG-AB methods were less precise than the in-vivo 
method which demonstrates a CV of 65.6%. The PBET-stomach CV was quite high at 
95.2%, while the PBET for the intestinal phase was much lower, and more similar to the IVG 
methods, at 76.4%. When considering the calcine and slag materials as separate media, the 
precision results differ greatly. The CVs for the IVG and IVG-AB methods range from 74.0 
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to 77.2% and the in-vivo CV for the calcine media alone is 88.8% (Table 4). The CVs for 
IVG and IVG-AB methods range from 26.5 to 28.9% and the in-vivo CV for the slag media 
alone is 41.6% (Table 4). When all media is evaluated, except the calcine material, the CV 
values for all in-vitro methods compare well with the CV for the in-vivo method. The IVG 
and IVG-AB method CVs range from 38.7 to 42.4%, while the in-vivo CV is 49.1 % (Table 
4). 
It is not expected that any one in-vitro method can be developed which will result in an 
exact replication of in-vivo bioavailability. The human digestive system is too complex and 
dynamic to simulate in the laboratory. A more reasonable approach may be to develop in-
vitro methods which are based upon human gastro-physiology and correlate well with in-vivo 
method results. From this correlation, mathematical relationships can be developed which will 
be useful in making risk estimates. The discipline of soil science has used this very concept 
successfully when early work was performed to find suitable chemical extractants to measure 
plant available nutrients. Chemical extractants cannot extract plant nutrients in the same 
manner as a living plant under the conditions of the plant root environment. However, good 
correlations between soil extractants and plant uptake has allowed soil scientists to use that 
relationship to make reasonable predictions of plant available nutrients in soil and fertilizer 
recommendations (Amacher, 1996). Similar relationships between in-vitro and in-vivo 
methods may lead to the development of mathematical relationships from which predictions 
can be made to derive bioavailable arsenic concentrations in soils for risk estimates which 
have a lower degree of uncertainty and aid in the design and cost-effectiveness of remedial 
strategies at contaminated sites. 
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Table 1. Major element content and select Eroperties of study media. 
Study Media 
Properties Cl C2 C3 C4 C5 SI S2 S3 S4 S5 El E2 E3 E4 E5 
pftl) 2.6 2.6 3.1 3.1 5.7 7.4 7.7 7.1 7.4 7.4 3.9 4.6 7.5 7.3 7.6 
TOC(%i2) 0.36 0.22 0.58 0.41 0.61 0.89 3.13 1.58 3.38 3.22 0.81 1.52 2.28 0.23 4.58 
%< 2 um<3) 5.7 IO.I 13.4 9.8 7.4 6.5 18.4 8.4 7.3 7.5 
%< 50 um<3) 51.6 49.8 57.4 45.5 49.4 30.2 59.1 36.5 45.1 45.6 
Soluble Anions<4) 
mgkg·1 
Chloride 2545 2950 1237 1079 1711 944 1172 2198 976 1129 4224 9868 912 2446 14171 
Sulfate 158281 83119 23368 224253 219776 1308 3287 10509 2898 2529 221126 347176 2484 1360 9449 
Nitrate 102.5 159.9 100.3 49.4 297.3 146.9 941.7 507.0 552.2 628.2 323.9 2471.3 53.8 77.5 875.9 
Major Elements<5) 
% 
Si 17.39 17.02 18.00 18.04 22.67 16.83 21.27 23.00 20.05 20.47 22.60 28.83 16.66 12.78 26.54 
Al 1.19 1.17 1.60 1.80 3.02 2.43 3.62 3.20 2.64 2.74 7.56 4.64 L73 2.48 3.56 
Ca 1.20 0.68 0.41 2.90 2.86 12.15 9.64 8.57 7.50 6.07 2.43 3.98 12.07 13.99 8.43 
Mg 0.16 0.16 0.16 0.22 0.46 1.13 1.53 1.19 1.00 0.95 0.80 0.65 1.33 0.83 1.78 
Na 0.14 0.10 0.22 0.24 0.42 0.13 0.33 0.56 0.36 0.36 0.01 0.50 0.01 2.08 0.24 
K 0.57 0.53 0.68 0.66 1.15 0.70 1.28 1.01 0.81 0.85 2.99 1.54 0.41 0.66 1.15 
Fe 29.66 31.68 28.54 24.97 16.65 20.91 11.68 16.65 17.21 18.33 7.07 2.01 20.37 22.54 6.17 
Mn 0.06 0.07 0.06 0.05 0.07 0.21 0.12 0.09 0.12 0.12 1.58 0.28 0.36 0.88 0.11 
Ti 0.14 0.14 0.17 0.18 0.29 0.22 0.30 0.25 0.22 0.23 0.40 0.24 0.10 0.22 0.20 
Heavy Metals<6) 
mgkg·1 
Pb 11072 12105 10983 8431 5528 8736 6835 3512 12612 11526 9196 214 11844 12061 3675 
Cu 385 318 384 524 997 1807 1606 2208 4228 4009 975 8243 2212 2547 954 
Ni 39.1 35.9 31.4 32.2 37.4 24.5 24.4 31.9 35.3 34.0 14.8 17.3 36.7 24.5 24.3 
<1l1:l, soil:O.OIMCaCJ, (3lpipette Method (Gee and Bauder, 1986) <5Jx-Ray Fluor. (Karathanasis and Hajek, 1996) 
<2lTotal Organic Carbon (Nelson and Sommers, 1996) <4l1g soil:10 ml H20, Shake I-hr, Filter 0.45 um <6lsW 846, Method 3050 (USEPA, 1986) 
N 
\Jo 
Table 2. Chemical content of arsenic in study media. 
Study Media 
Arsenic Concentration Cl Cl C3 C4 C5 Sl S2 S3 
Total (mg kg·1t> 11294 17456 13472 11525 6245 405 450 1180 
TCLP (mg L·1i 2> 3.0 3.0 3.0 2.9 3.0 3.0 2.8 2.9 
TCLP (mg kg·1i 2> 59.4 60.3 60.5 58.8 60.0 59.2 55.6 58.1 
In-Vivo Bioavailable As(%) 2.7 3.3 8.3 22.1 30.1 -- -- 28.7 
(l>sw 846, Method 3050 (USEPA, 1986) 
<2>sw 846 Method 1311 (USEP A, 1986) 
S4 S5 El El E3 
5022 4650 331 233 799 
3.2 2.9 2.6 2.8 2.6 
63.4 58.6 53.0 55.1 52.2 
30.1 16.4 6.2 42.8 29.1 
E4 E5 
1463 401 
2.7 2.9 
54.5 59.0 
18.7 36.5 
N 
O'\ 
Table 3. In-vitro experimental parameters and literature references. 
Method and Reference 
Parameter IVG: Reference IVG-AB: Reference 
Gastric Solution 
pH 1.8 Malagelada et al., 197 6 1. 8 Malagelada et al., 197 6 
NaCl 0.15M Crews et al., 1983 0.15 M Crews et al., 1983 
Pepsin 1.0 % Crews et al., 1983 1.0 % Crews et al., 1983 
Citrate none -- none --
Malate none -- none --
Lactic Acid none -- none --
Acetic Acid none -- none --
Soil: Solution Ratio 1:150 Malagelada et al., 197 6 1: 15 0 Malagelada et al., 1976 
Food Added yes Casteel, 1995 yes Casteel, 1995 
· Intestinal Solution 
pH 5.5 Malagelada et al., 197 6 5. 5 Malagelada et al., 197 6 
Pancreatin 0.35 % Crews et al., 1983 0.35 % Crews et al., 1983 
Bile Extract 0.035 % Crews et al., 1983 0.035 % Crews et al., 1983 
Adsorbent (Iron Oxide) no -- yes none available 
PBET (Ruby et aJ., 1996) 
2 
none 
0.10% 
0.05 % 
0.05 % 
0.5% 
0.50% 
1:100 
no 
7.0 
0.018 % 
0.05 % 
no 
N 
-.....l 
Table 4. Analysis of variance using Duncan's Multiple Range Test (SAS, 1997). Values reported are means for that group. 
Mean values with the same letter designations indicate no difference between groups at P < 0.05. Bold values show no 
differences between in-vitro and in-vivo methods. 
Samples IVG-Stomach IVG-Intestinal IVG-AB-Intestinal PBET-Stomach PBET-Intestine In-Vivo 
All Media 16.7 ab 14.8 b 15.3 b 11.8 be 8.26 C 21.0 a 
(n=l3) 
CV**(%) 75.2 74.6 73.0 95.2 76.4 65.6 
Calcine Only 3.66 b 3.52 b 4.00b 1.44 b 1.47 b 13.5 a 
(n=5) 
CV**(%) 74.0 75.9 77.2 77.4 47.3 88.8 
Iron Slag Only 24.8 a 22.7 a 24.1 a 13.9b 12.0 b 25.4 a 
(n=3) 
CV**(%) 27.4 28.9 26.6 61.0 33.6 41.6 
All Media 24.8 a 21.9 ab 23.0 ab 18.3 be 12.5 C 25.9 a 
Except Calcine 
(n=8) 
CV**(%) 41.3 42.4 38.7 58.9 40.7 49.1 
*Quanititative difference between means necessary for methods to be significantly different at P<0.05. 
**CV= Coefficient of variation,%. 
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Figure 1. Conceptual approach to the in-vitro method evaluation. 
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Figure 2. In-vitro reactor flask. 
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Figure 3. Comparisons of in-vitro gastrointestinal stomach and intestinal phase 
extractable As with in-vivo bioavailable As. **Statistically significant, P < 0.01; 
*statistically significant, P < 0.05. 
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Chapter2 
Chemical Speciation Methods to Assess Bioavailable Anenic in 
Contaminated Soils and Solid Wastes 
ABSTRACT 
32 
The soil ingestion pathway has been shown to drive the risk at some hazardous waste sites 
contaminated with arsenic. Chemical extractants have been described in the literature which 
extract for various pools of arsenic in soils and solid media, yet none have been evaluated in 
their ability to measure bioavailable arsenic. A variety of extractants were evaluated in this 
study and compared to bioavailable arsenic as measured in-vivo by animal feeding trials 
(unmature swine model). Extractants such as deionized water, IM sodium acetate, and 0.1 
M N3iHPO/O. l M NaH2P04 all extract, to varying degrees, the non-occluded or surficial 
arsenic from soil particles. More aggressive extractants were evaluated which dissolve iron, 
manganese, and aluminum oxide fractions associated with arsenic in soils. These more 
aggressive extractants include hydroxylamine hydrochloride, ammonium oxalate, and sodium 
hydroxide. Individual extractant results were compared with total arsenic, as measured by hot 
acid digestion (USEPA SW-846, Method 3050), and a chemically extracted percent 
bioavailable arsenic was obtained. The chemically extracted bioavailability was compared 
with the in-vivo bioavailability to determine the degree of correlation. All extractants were 
positively correlated. The extractailts which measure non-occluded surficial arsenic were 
found to underestimate the true in-vivo bioavailable arsenic, and the more aggressive 
extractants which dissolve the oxide fractions were found to overestimate in-vivo bioavailable 
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arsenic. The hydroxylamine hydrochloride extractant was the only extractant found to be 
linearly correlated (r = 0.54) with in-vivo bioavailable arsenic (P < 0. IO). The sodium 
hydroxide extractant was found to come closer to the true value of bioavailable arsenic, yet 
not close enough to be statistically significant. It appears that the fraction of arsenic in 
contaminated soils and solid media which is bioavailable is comprised of arsenic fractions 
between the surficially complexed ( desorbable) arsenic and the arsenic associated with the 
iron/manganese/aluminum oxides. 
Key Words: incidental soil ingestion, arsenic contamination, bioavailability, bioavailable 
arsenic, chemical fractionation, extraction 
INTRODUCTION 
Arsenic is a naturally occurring element typically found in soil at background 
concentrations ranging from 0.1 to 40 mg kg·1 (Bowen, 1979). Arsenic contamination of soil 
may result from: mining, milling, and smelting of copper, lead, and zinc sulfide ores (Lindau, 
1977; Nelson, 1977); raw and spent oil shale (Shendrikar and Faudel, 1978); and coal fly ash 
(Turner, 1981; Hansen et al:, 1984; Wadge and Hutton, 1987). Arsenic has been found at 
high levels (10,000 to 20,000 mg kg"1) in some contaminated areas such that the 
concentration results in unacceptable levels of risk to human health from the incidental 
ingestion of soil (Life Systems, 1992a, 1992b). Chronic exposure to arsenic may result in skin 
and internal organ cancers, impaired nerve function, kidney and liver damage, and skin lesions 
(ATSDR, 1991). · 
Incidental soil ingestion by children is an important pathway in assessing public health 
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risks associated with exposure to arsenic-contaminated soils. Incidental ingestion of soil 
results from normal hand-to-mouth activities and represents the principal direct pathway for 
exposure to non-dietary sources of arsenic in contaminated areas. The importance of soil 
ingestion by children as a health issue has been reported by numerous researchers and fully 
illustrates the importance of this pathway in terms of subsequent chemical exposure (Binder 
et al., 1986; Calabrese et al., 1989; Clausing et al., 1987; Davis et al., 1990; van Wijnen et al., 
1990). 
Most risk from arsenic is associated with the forms of arsenic that are biologically 
available for absorption, or "bioavailable" to humans. A bioavailable chemical is the portion 
of a chemical dose that enters the systemic circulation from an administered dose. Presently, 
methods are not available to quantify the amount (as a percentage) ofbioavailable arsenic in 
soils to accurately assess risk from incidental ingestion of arsenic. contaminated materials. 
Hence, some baseline risk assessments developed for contaminated sites have used the 
conservative assumption that all (ie. 100%) of the arsenic present in soils and wastes is 
bioavailable. However, arsenic may exist in many geochemical forms ( eg. oxides, sulfides) 
and physical forms ( eg. flue dust, slag, tailings, calcine, waste ore) at hazardous waste sites 
contaminated by mining and smelter wastes. These waste forms vary in their solubilities and 
geochemical stabilities to the extent that many are not likely to be very bioavailable and 
therefore may pose only small risks to humans. 
The bioavailability of metals, especially lead and arsenic, in some mining wastes have been 
assessed by conducting expensive and lengthy feeding trials using animal models, The animal 
model of choice for investigating the enteric bioavailability of arsenic in children requires 
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selection based on similar age and anatomical and physiological characteristics. Pigs are 
remarkably similar to humans with respect to their digestive tract, nutritional requirements, 
bone development, and mineral metabolism (Dodds, 1982). Also, pigs, like humans, tend to 
ingest food intermittently allowing the stomach to evacuate periodically. This physiology is 
consistent with the way children most likely ingest arsenic-contaminated materials, between 
meals when the gastric pH is lowest. Immature pigs have therefore been used successfully as 
a model for gastrointestinal function of children (Miller and Ullrey, 1987; Weis and LaVelle, 
1991). 
The method routinely used to characterize arsenic in contaminated solid wastes at 
hazardous waste sites for remedial investigation and risk assessment purposes is by hot acid 
extraction using USEPA SW-846, Method 3050 (USEPA, 1986). However, total content 
may not be related to solubility or bioavailability. Therefore, it is unlikely that total arsenic 
content will provide an accurate assessment of risk from contaminated materials. 
One approach to evaluate solubility and availability of chemical elements in soils involves 
the use of selective chemical extractants. This approach has been historically used to evaluate 
plant nutrients in soil. Work performed as early as the 1930's by soil scientists ( eg. Bray, 
Hester, Morgan, Spurway, and Truog) has demonstrated the need to measure "labile" pools 
rather than total content of nutrients to evaluate conditions for optimum plant growth (Peck 
and Soltanpour, 1990). Soil test methods for a limited number of metal contaminants have 
been correlated with plant uptake (Iyengar et al., 1981; LeClaire et al.,1984; Sims, 1986; 
Soon and Bates, 1982; Xian, 1989), however, little information is available on arsenic. 
· Chemical speciation methods involving sequential extraction are used to determine the 
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amount of contaminant in specific chemical pools (Ure, 1990). This approach is dictated by 
chemical thermodynamics in that the "strongest adsorption sites fill first," which means 
bioavailability may be a function of contaminant concentration in soil systems. Bioavailability 
is inversely related to the matrix's ability to adsorb or precipitate the contaminant. Soils have 
a range of adsorption sites that vary in bonding energies and adsorption strength. Specific 
adsorption sites in soil strongly retain contaminants rendering them unavailable, whereas 
weaker adsorption sites will release contaminants making them bioavailable. Most chemical 
speciation methods have been used to measure heavy metals in ion-exchangeable, surficially 
adsorbed, precipitated, organic chelated, and occluded chemical pools in baseline soils 
(Shuman, 1985; Tessier et al., 1979), in sewage sludge-amended soils (Emmerich et al., 1982; 
Sposito eta/., 1982), and in contaminated soils (Gibson and Farmer, 1986; Gupta and Chen, 
1975; Hickey and Kittrick, 1984; Kuo et al., 1983; Ma and Rao, 1997; Soon and Bates, 
1982). Both heavy metal solubility and bioavailability decrease with each successive step of 
the sequential extraction. 
Because arsenic is chemically similar to phosphorus, it has been evaluated by using 
chemical extractants developed to measure the various pools of phosphate. Researchers have 
used this approach to specifically look at various pools of arsenic in soils (Johnson and 
Barnard, 1979; Gruebel et al., 1988), however they did not correlate the arsenic extracted 
with plant or biological uptake. A two-step sequential extraction method has been used 
(Shuman, 1982; Chao and Zhou, 1983) to determine arsenic associated with amorphous iron 
oxides, manganese oxides, and/or organic matter in wastes, however, an inherent problem 
associated with this method is the readsorption of arsenic to soil residue after dissolution of 
37 
iron oxides. Amacher and Kotuby-Amacher (1994) used phosphoric acid to prevent 
readsorption of arsenic onto ferrihydrite minerals in a similar chemical speciation procedure. 
In their extraction, a solution of hydroxylamine hydrochloride and phosphoric acid extracts 
arsenic associated with amorphous iron and manganese oxides. However, the ability of their 
method to measure arsenic bioavailability has not been investigated. 
The objective of our study is to evaluate the ability of previously reported chemical extractants 
to measure the bioavailable fraction of arsenic in contaminated soil and solid waste. The 
chemically extracted arsenic will be evaluated in its correlation with the bioavailable arsenic as 
measured in-vivo (per pig feeding trials). A chemical extractant procedure will provide a rapid, 
inexpensive testing method to obtain scientifically derived data to select appropriate remedies at 
contaminated sites which are cost-effective and protective of human health and the environment. 
A measure of bioavailable arsenic will also serve to lower the uncertainty surrounding the 
quantification of potential risks arising from· exposure to arsenic-contaminated media. 
EXPERIMENTAL METHODS 
Study Soils and Waste Materials 
Two matrices were collected for this study from a typical mining/smelter site in the western 
U.S. where wastes were deposited between 20 and 50 years ago. These aged and weathered 
wastes include a calcine material, a waste product which results from the roasting and smelting of 
arsenopyrite ore for the extraction of arsenic, and an iron slag material, a waste product which 
results from the smelting of ores for lead which is also high in iron. Five calcine (Cl through CS) 
and five iron slag (SI through S5) samples were collected for this study from the same site. In 
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addition to the collected solid study materials, five more samples of solid materials ( designated as 
El through ES) which had been archived following previous studies involving chemical analyses 
and pig feeding trials were included in the study to test the in-vitro method over a broader range 
of matrices. These materials (E 1 - ES) consist of residential soils and slag from smelter areas. 
Chemical and physical properties are shown in Table 1 and total arsenic concentrations (ranging 
from 233 to 17,456 mg kg ·1) are presented in Table 2. 
Mineralogical composition of one calcine (C4) and one slag (S4) was determined by microprobe 
analysis for the various iron and arsenic bearing compounds. The calcine was found to contain: 
38% iron-manganese sulfate, 28% iron-arsenic-oxide, and 35% iron-manganese oxide. The slag 
was found to contain: 17% iron-manganese sulfate, 49% iron-arsenic oxide, 4% iron-manganese 
oxide, 30% lead-manganese oxide, and 2% slag. 
Approximately five gallons of each study material was collected, air dried under ambient 
conditions, and sieved to collect the particle size fraction < 250 µm. This fraction has been 
determined to be the size which adheres to fingers and is thus available for incidental ingestion. 
Study materials were thoroughly homogenized/mixed prior to use and stored in secured, air-tight 
containers. 
Immature Pig Feeding Trial 
Standard operating procedures developed by Dr. Stan Casteel of the University ofMissouri-
Columbia Veterinary Medicine Diagnostic Laboratory have been approved by U.S. Environmental 
Protection Agency (EPA) Region 8 (Castee~ 1995), and were utilized in the immature pig feeding 
trials. Intact male pigs weighing 10 to 12 kg were randomly assigned to treatment groups, 
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consisting of calcine dosing ·group, slag dosing group, negative control group (no soil), and 
positive control group (oral NaiAs04•7H20). Five pigs were used per treatment group, with the 
exception of three pigs per negative control group. All pigs were individually housed in arsenic-
free cages and fed low-arsenic feed and water. After a three day acclimation period, the pigs were 
exposed to soiVtreatment doses. Doses were delivered daily (half in morning and half in evening) 
via 5 g of a vehicle of low-arsenic/low-lead diet material (Ziegler Bros., Inc., Gardners, PA), 
wetted slightly with distilled water to a cookie dough-like consistency. A depression was made 
in the center, the soil dose was placed into the depression, and the material folded to enclose the 
dose. The entire vehicle was hand fed to the pigs on schedule. Every three days thereafter, for 
five collection periods, 24-hour urines were collected from each pig. The urines were filtered 
(Whatman 2), placed into plastic bottles, and preserved to pH 2 with concentrated HCI. Urine 
samples were packed securely in coolers on ice and shipped by overnight carrier under chain of 
custody procedures to Oklahoma State University (OSU) for arsenic analysis. Following an 
additional filtering through 0.45 µm filters, arsenic analysis was performed by a Thermo-Jarell Ash 
Inductively Coupled Plasma (ICP) (Maxim) utilizing Hydride Generation (HG). To prepare the 
urine sample for hydride generation, a 10.0 ml aliquot of urine was placed into a test tube and 
mixed with 3 .3 ml concentrated HCl and 4.0 ml of a solution containing 10% potassium iodide and 
1 % ascorbic acid. After a reaction period of at least one hour, arsenic was determined by ICP-
HG. 
In-Vivo Arsenic Bioavailability Calculations 
The amount of arsenic which is absorbed through the gastrointestinal tract (bioavailable 
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arsenic) may be described in absolute or relative terms (Casteel, 1995). Absolute bioavailability 
(ABA) is the ratio of the amount of arsenic absorbed compared to the amount ingested: 
ABA = Absorbed Dose 
Ingested Dose Equation ( 1) 
Relative bioavailability (RBA) is the ratio of the absolute bioavailability of arsenic present in some 
test material ( study soil) compared to the absolute bioavailability of arsenic in some appropriate . 
reference material: 
ABA (study soil) RBA = --------
ABA (reference material) Equation (2) 
In our study, the reference material was the control N~As04•7H20 (a readily soluble form, 
therefore easily absorbed). Arsenic excretion in urine is found to be a linear function of the 
administered dose (Casteel, 1995), and is approximately independent of time after five days of 
exposure during feeding trials. Because of the rapid excretion of arsenic via the urine, the urinary 
excretion fraction (UEF), defined as the amount excrete in the urine divided by the amount dosed, 
may sometimes be a reasonable approximation of the oral absorption fraction or ABA. However, 
this ratio will underestimate total absorption, because some absorbed arsenic is excreted in the 
feces via the bile and some enters tissue compartments ( eg. skin, hair, etc.) from which it is 
cleared very slowly or not at all. Thus, the urinary excretion fraction is not equated with the ABA. 
The UEF can be used, however, to compute the RBA as follows: 
REA (of soil As vs. reference As) = __ U_'E._'F_(~st_u~dy_so_z_·l) __ 
UEF (reference material) 
All in-vivo bioavailabilities reported in this report were calculated as RBAs. 
Chemical Fractionation Procedures 
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Equation (3) 
The various extracting solutions and conditions for chemical fractionation are described 
below. All samples were extracted in triplicate and included appropriate reagent blanks and 
spikes. Table 3 presents a summary of the form of arsenic species extracted by the chemical 
extractants and their respective literature references. 
Deionized Water Extraction 
One g of soil was placed into a 50 ml polycarbonate centrifuge tube and mixed with 20 ml of 
deionized water. The tube was closed using a neoprene stopper and placed in a horizontal 
position on a reciprocal laboratory shaker. The tubes were shaken for one hour and then 
centrifuged at 8,000 rpm for five minutes. The supernatants were filtered through a 0. 45 µm filter 
using a Luer-lock syringe and acidified to pH 2 with concentrated HCl. Arsenic analysis was 
performed by ICP-HG (following preparation for hydride generation as described above for urine). 
Sodium Acetate Extraction 
One g of soil was placed into a 50 ml polycarbonate centrifuge tube and mixed with 20 ml of 
1 M sodium acetate solution, pH 5. The tube was closed using a neoprene stopper and placed in 
a horizontal position on a reciprocal laboratory shaker. The tubes were shaken for.one hour and 
then centrifuged at 8,000 rpm for five minutes. The supematants were filtered through a 0.45 µm 
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filter using a Luer-lock syringe and acidified to pH 2 with concentrated HCl. Arsenic analysis 
was performed by ICP-HG (following preparation for hydride generation as described above for 
urine). 
Phosphate Extraction 
One g of soil was placed into a 50 ml polycarbonate centrifuge tube and mixed with 20 ml of 
a solution consisting of3 parts of 0.1 M NaifIPO 4 to 2 parts of 0.1 M NaH2PO 4 ( as described by 
Yamamoto, 1975). The tube was closed using a neoprene stopper and placed in a horizontal 
position on a reciprocal laboratory shaker. The tubes were shaken for eight hours and then 
centrifuged at 8,000 rpm for five minutes. The supernatants were filtered through a 0.45 µm filter 
using a Luer-lock syringe and acidified to pH 2 with concentrated HCl. Arsenic analysis was 
performed by ICP. 
Hydroxylamine Hydrochloride Extraction 
One g of soil was placed into a 250 ml polystyrene centrifuge bottle and mixed with 250 ml 
of a solution made of the following: 0.25 M NH20H, 0.25 M HCl, and 0.025 M ~ PO (as 
described by Amacher and Kotuby-Amacher, 1994). The centrifuge bottles were placed into a 
70°C water bath and shaken for two hours. The bottles were then centrifuged for 10 minutes at 
6,000 rpm and the supematants were filtered through a 0.45 µm filter. Arsenic analysis was 
performed by ICP. 
Ammonium Oxalate Extraction 
One g of soil was placed into a 250 ml polystyrene centrifuge bottle and mixed with 50 ml of 
a solution made of the following: 0.2 M (NH4) 2C20 4•HCI, 0.2 M C 2H 20 4•HCI,. and 0.025 M 
HJ>04. The centrifuge bottles were placed into a 100°C water bath for 15 minutes. The bottles 
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· were then removed and filtered through 0.45 µm filter. The solid material on the filter was then 
washed with an additional 50 ml of the fresh extracting solution to yield a final volume of 100 ml. 
Arsenic analysis was performed by ICP. 
Total Arsenic Determinations 
Total arsenic was determined by hot acid extraction using USEPA SW-846 Method 3050 
(USEPA, 1986). 
Chemically Extracted Arsenic Bioavailability Calculations 
The standard analysis for soil metal content, including arsenic, during the investigation of the 
nature and extent of contamination of hazardous waste sites is by hot digestion with HN03 and 
H20:z, USEP A SW 846, Method 3050 (1986). The resulting total metal concentration is then used 
for estimating risks to human health. The realization that probably not all ( < 100%) of the total 
metal measured by complete digestion is bioavailable has led risk assessors to use a fraction 
(percentage) of total metal which better represents the fraction which is bioavailable in the risk 
calculation For our chemically extracted results, bioavailable arsenic is calculated by dividing the 
arsenic concentration measured by the various chemical speciation extractions by that measured 
as total arsenic ( all on a concentration in soil basis), as described by the following equation: 
Extracted bioavailable As, % =(xtracted As, mg kg-I] * 100 
total As, mg kg -I Equation ( 4) 
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RESULTS AND DISCUSSION 
The results of the various arsenic chemical extractants, as well as the total arsenic results, are 
presented in Table 4. Since these extractions were conducted separately, rather than performed 
sequentially, more than one :fraction of arsenic pool was extracted (Table 3). Very little arsenic 
was extracted by the deionized water, generally less than 5 mg kg-1 of water soluble arsenic (Table 
4). The sodium acetate extractant, which measures the weakly exchangeable pool of arsenic as 
well as the water soluble pool, resulted in more arsenic extracted than the water soluble :fraction; 
between 32 and 195 mg kg-1 of arsenic. The phosphate solution extracted a greater portion of 
arsenic; results ranged between 70 and 380 mg kg-1 of arsenic. This :fraction represents the 
strongly (specifically) adsorbed :fraction of arsenic, or some portion of that :fraction, as well as the 
water soluble and weakly exchangeable :fractions. All of these three extractants can best be 
described as extracting non-occluded, or surface layers of the soil particles. 
Hydroxylamine hydrochloride, a much more aggressive extractant that dissolves iron and 
manganese oxides, extracts surficial adsorbed arsenic and some of the occluded arsenic in the 
mineral matrix. Substantially more arsenic is measured by extraction with hydroxylamine 
hydrochloride as compared to the extractions by water, sodium acetate, and phosphate; results 
ranged between 186 and 4,830 mg kg-1 (Table 4). As proposed by Chao and Zhou (1983), 
hydroxylamine hydrochloride extracts arsenic which is associated with amorphous manganese and 
iron oxides. As proposed by Shuman (1982), ammonium oxalate, which is more aggressive than 
hydroxylamine hydrochloride, extracts arsenic associated with both the amorphous and crystalline 
iron oxides, as well as the aluminum oxide :fraction. Ammonium oxalate extracted between 408 
and 12,616 mg kg-1 of arsenic (Table 4). To release arsenic from a crystalline matrix requires a 
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more thorough dissolution of the soil particle. The sodium hydroxide extractant released an 
intermediate amount of arsenic into solution; between 975 and 9,092 mg kg-1 of arsenic (Table 4). 
The sodium hydroxide extractant should measure arsenic associated with the aluminum oxide 
fraction (Olsen and Sommers, 1982). The sodium hydroxide procedure dissolves the aluminum 
oxide surface and some of the mineral fraction. 
To compare the chemically extracted arsenic results with arsenic bioavailability, the extractant 
results were expressed as a percentage of total content (Table 5). The trend of arsenic extracted 
bioavailability is as expected, the more aggressive extractants result in higher chemically measured 
bioavailabilities. Some extractants approach and even exceed 100% of total arsenic (measured by 
USEPA SW-846, Method 3050), such as the ammonium oxalate extractant of some of the study 
materials. The relationship between chemically extracted arsenic and actual in-vivo bioavailable 
arsenic was determined (Figure 1 ). The plots are prepared in xy pairs of data where x represents 
the % bioavailable arsenic as measured in the in-vivo study and the matching y value represents 
the %extracted arsenic as measured in the corresponding chemical extractant. Although fifteen 
soils were tested throughout all chemical extracting experiments, only thirteen xy points are 
presented on each plot. Two of the slag samples had very low arsenic concentrations and were 
below detection limits of the in-vivo method. All of the chemical extractants produced a positive 
linear regression line, however, only one extractant, hydroxylamine hydrochloride, was linearly 
correlated (r = 0.54) with in-vivo bioavailable arsenic (P < 0.10). However, the chemically 
extracted bioavailability for this extractant over-estimated the true bioavailability as evident by the 
high y-intercept (24.4) and slope of the linear regression line greater than one (1.45). 
· Further statistical analysis was performed to determine if there were significant differences 
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between the means of the chemically extracted arsenic methods. An analysis of variance was 
conducted using Duncan's Multiple Range Test (SAS, 1997) (Table 6). For all media tested 
( calcine, slags, and soils) the sodium acetate and sodium hydroxide extractable arsenic were not 
significantly different from the in-vivo bioavailable arsenic (P < 0.05). When the calcine results 
were not included in the analysis and only slags and soils were statistically evaluated, these same 
two chemical extractants were still not significantly different from the in-vivo bioavailable arsenic 
(P < 0. 05). In consideration of the calcine group of materials alone, they were significantly 
different from the in-vivo results. The ratio of arsenic extracted by sodium acetate or sodium 
hydroxide: in-vivo arsenic was much lower for calcine than for soil or slag materials. The 
chemical extractants which dissolve surficially complexed arsenic all underestimated the 
bioavailable arsenic fraction, while the two more aggressive arsenic extractants, the hydroxylamine 
hydrochloride and the ammonium oxalate, both greatly overestimated the bioavailable arsenic 
(Table 6). The sodium hydroxide extractant came closer to the true value ofbioavailable arsenic, 
yet not close enough to be statistically significant. 
To consider the variability of the various chemical extraction methods as compared to the 
variability of the in-vivo method, the coefficients of variation were determined for each (Table 6). 
In evaluating the chemical extractant results for all media, the CV values are all near or greater 
than 1000/o, except for the phosphate (40.8%) and ammonium oxalate (42.3%) extractants. The 
CV for the in-vivo method for all media is 65.6%. For the calcine material alone, the CVs for the 
chemical extractants range from 8.64% (ammonium oxalate) to 50.3% (hydroxylamine 
hydrochloride), while the in-vivo method demonstrates a CV of 88.9%. Evaluating all media 
except the calcine material, the CV s range from 21. 7% (phosphate) to 155% (water), while the 
47 
in-vivo method CV is at its lowest at 49 .1 %. The generally large CV s show low precision with 
the chemical extractants which correspond to the relatively poor correlations (r) (Table 6). 
From the data presented, it appears that the fraction of arsenic in contaminated soils and solid 
wastes which is bioavailable is comprised of arsenic fractions between the surfi.cially complexed 
(desorbable) arsenic and arsenic associated with the iron/manganese/aluminum oxides. Because 
the stomach environment is acidic (pH 1.8) and anaerobic, it is likely that most forms of adsorbed 
and some of the iron and manganese oxide fractions of arsenic are dissolved. The amounts of 
extracted arsenic between surfi.cially adsorbed and sur:ficially adsorbed plus occluded in iron and 
manganese oxide fractions may be similar to the chemical forms of arsenic dissolved in the 
stomach. The extracted arsenic from our experiment followed the trend: ammonium oxalate, 
hydroxylamine hydrochloride > sodium hydroxide, in-vivo > sodium acetate,> phosphate, water. 
It is unlikely that one chemical extractant will measure the fraction of bioavailable arsenic in 
all contaminated soils under all conditions. However, a chemical extractant that is more closely 
related to bioavailable arsenic than total arsenic for most of the major groups of environmental 
media is desirable. Chemical extractants which more closely reflect the environment of the gastro-
intestinal tract have been shown to be better estimators of bioavailable arsenic in contaminated 
soils and solid media (Rodriguez, 1998). The conditions or concentrations of the more aggressive 
chemical extractant methods, such as the hydroxylamine hydrochloride, may eventually be 
designed to provide closer estimates of the true bioavailable arsenic content of contaminated 
materials by better simulating the gastric environment. 
Chemical extractant methods that correlate well with nutrient phytoavailability or crop yield 
are well established in soil science. However, chemical extractant methods can not extract plant 
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nutrients in the same physiochemical manner as plants. Strong correlation between nutrients 
measured by soil extractants and plant uptake of nutrients has allowed soil scientists to make 
reasonable predictions of plant available nutrients in soil and fertilizer recommendations (Amacher, 
1996). Chemical extractants have the ability to extract most chemical pools of arsenic. Further 
research in this area will provide evaluation of important soil exposure pathways, including: 
incidental ingestion, inhalation, and dermal exposure. A more reasonable measurement of the 
bioavailable fraction of arsenic in contaminated soils and wastes will provide for more reasonable 
estimates of risks at hazardous waste sites and more cost effective remedial strategies. 
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Table 1. Major element contentand select properties of study media. 
Study Media 
Properties Cl C2 C3 C4 cs Sl S2 S3 S4 S5 El E2 E3 E4 ES 
plfl) 2.6 2.6 3.1 3.1 5.7 7.4 7.7 7.1 7.4 7.4 3.9 4.6 7.5 7.3 7.6 
TOC (%i2) 0.36 0.22 0.58 0.41 0.61 0.89, 3.13 1.58 3.38 3.22 0.81 1.52 2.28 0.23 4.58 
%< 2 um<3) 5.7 10.1 13.4 9.8 7.4 6.5 18.4 8.4 7.3 7.5 
% < 50 um<3) 51.6 49.8 57.4 45.5 49.4 30.2 59.1 36.5 45.1 45.6 
Soluble Anions<4) 
-------------------- ----·-····---· --······-·····-·--·······-·----·-··········------·······--··------·····-·------------- mgkg- ---------------------·····---··-·- ----------·--··········-------------- ---------·-·········----------
Chloride 2545 2950 1237 1079 1711 944 1172 2198 976 1129 4224 9868 912 2446 14171 
Sulfate 158281 83119 23368 224253 219776 1308 3287 10509 2898 2529 221126 347176 2484 1360 9449 
Nitrate 102.5 159.9 100.3 49.4 297.3 146.9 941.7 507.0 552.2 628.2 323.9 2471.3 53.8 77.5 875.9 
Major Elements<5) 
% 
Si 17.39 17.02 18.00 18.04 22.67 16.83 21.27 23.00 20.05 20.47 22.60 28.83 16.66 12.78 26.54 
Al 1.19 1.17 1.60 1.80 3.02 2.43 3.62 3.20 2.64 2.74 7.56 4.64 1.73 2.48 3.56 
Ca 1.20 0.68 0.41 2.90 2.86 12.15 9.64 8.57 7.50 6.07 2.43 3.98 12.07 13.99 8.43 
Mg 0.16 0.16 0.16 0.22 0.46 1.13 1.53 1.19 1.00 0.95 0.80 0.65 1.33 0.83 1.78 
Na 0.14 0.10 0.22 0.24 0.42 0.13 0.33 0.56 0.36 0.36 0.01 0.50 0.01 2.08 0.24 
K 0.57 0.53 0.68 0.66 1.15 0.70 1.28 1.01 0.81 0.85 2.99 1.54 0.41 0.66 1.15 
Fe 29.66 31.68 28.54 24.97 16.65 20.91 11.68 16.65 17.21 18.33 7.07 2.01 20.37 22.54 6.17 
Mn 0.06 0.07 0.06 0.05 0.07 0.21 0.12 0.09 0.12 0.12 1.58 0.28 0.36 0.88 0.11 
Ti 0.14 0.14 0.17 0.18 0.29 0.22 0.30 0.25 0.22 0.23 0.40 0.24 0.10 0.22 0.20 
Heavy Meta1s<6) 
mg kg-1 
Pb 11072 12105 10983 8431 5528 8736 6835 3512 12612 11526 9196 214 11844 12061 3675 
Cu 385 318 384 524 997 1807 1606 2208 4228 4009 975 8243 2212 2547 954 
Ni 39.1 35.9 31.4 32.2 37.4 24.5 24.4 31.9 35.3 34.0 14.8 17.3 36.7 24.5 24.3 
(1)1 :1, soil:O.OlMCaCh, <2lTotal Organic Carbon (Nelson and Sommers, 1996), <3)pipette Method (Gee and Bauder, 1986) 
<4l1g soil:10 ml H20, Shake 1-hr, Filter 0.45 um, <SJx-Ray Fluor. (Karathanasis and Hajek, 1996 ), (6)sw 846, Method 3050 (USEPA, 1986) 
u, 
~ 
Arsenic Concentration Cl 
Total (mg kg·1i1> 11294 
TCLP (mg L·1i 2> 
TCLP (mg kg·1i 2> 
(l>sw 846, Method 3050 (USEPA, 1986) 
<2>sw 846 Method 1311 (USEPA, 1986) 
3.0 
59.4 
Table 2. Chemical content of arsenic in study media. 
Study Media 
C2 C3 C4 cs SI S2 S3 
17456 13472 11525 6245 405 450 1180 
3.0 3.0 2.9 3.0 3.0 2.8 2.9 
60.3 60.5 58.8 60.0 59.2 55.6 58.1 
S4 S5 El E2 
5022 4650 331 233 
3.2 2.9 2.6 2.8 
63.4 58.6 53.0 55.1 
E3 E4 
799 1463 
2.6 2.7 
52.2 54.5 
ES 
401 
2.9 
59.0 
u, 
u, 
Table 3. Arsenic chemical extractants and their respective literature references. 
Chemical Extractant 
Water 
Sodium Acetate 
1 M NaOAc, pH 5 
Phosphate 
3 parts 0.1 M Na2HP04 
2 parts 0.1 M NaH2P04 
Hydroxylamine HCl 
0.25 M NH20H, 
0.25 MHCl, 0.025 MH3P04 
Ammonium Oxalate 
0.2 M (Nlii)2C204 HCl, 
0.25 M HCl, 0.1 M ascorbic acid 
Sodium Hydroxide 
0.1 N NaOH, IM NaCl 
Arsenic S£ecies Extracted 
water soluble (WS) 
WS + weakly adsorbed (WA) 
WS + WA + strongly adsorbed (SA) 
WS+WA+SA + 
amorphous Mn Oxide (MnO) + 
amorphous Fe Oxide (FeO) 
WS+WA+SA+ 
crystalline and amorphous F eO + 
aluminum oxide (AlO) 
WS +WA+ SA+ AlO 
Reference 
Huang and Fujii, 1996 
Tessier et al., 1979 
Yamamoto, 1975 
Chao and Zhou, 1983; modified 
by Amacher and 
Kotuby-Amacher, 1994 
Shuman, 1982 
Olsen and Sommers, 1982 
Vl 
°' 
Table 4. Arsenic concentrations of study media by various extraction methods. 57 
Sodium Hydroxylamine Ammonium Sodium Total 
Soil Water Acetate Pho~hate Hrdrochloride Oxalate Hrdroxide Method3050 
.................................. mg kg-I " " " " " " " " " " " " " " " " " " " " " " " " " " " " " " 
Cl 1.13 41.6 117 1717 7454 5088 11294 
C2 1.25 44.6 122 2930 12616 9093 17456 
C3 0.60 43.7 151 3018 9047 7341 13472 
C4 0.78 52.9 381 4930 8130 2641 11525 
cs 0.14 35.0 224 3085 4951 1589 6245 
Sl 0.74 88.8 74.4 384 409 983 405 
S2 2.54 58.1 81.6 413 546 1004 450 
S3 1.76 81.1 88.1 701 1214 1181 1180 
S4 4.68 127 172 2619 4030 1641 5022 
ss 3.54 83.0 107 2940 3331- 1503 4650 
El 0.08 32.6 70.0 186 461 1064 331 
E2 1.66 40.4 79.9 207 454 1054 233 
E3 0.16 56.2 121 725 591 976 800 
E4 0.49 195 78.8 1214 438 2313 1463 
E5 1.30 47.6 96.9 308 552 1373 401 
Summary 
Statistics 
mean 1.39 68.6 131 1692 3615 2590 4995 
median 1.13 52.9 107 1214 1214 1503 1463 
minimum 0.08 32.6 70.0 186 409 976 233 
maximum 4.68 195 381 4930 12616 9093 17456 
Table 5. Comparison of chemically extracted arsenic with in-vivo bioavailable arsenic. 58 
Sodium Hydroxylamine Ammonium Sodium 
Soil Water Acetate Pho~hate HCL Oxalate Hydroxide In-Vivo 
----- ·---------------- % bioavailable arsenic - - - - - - - - - - - - - - - - - - - - - - -
Cl 0.010 0.36 1.04 15.2 66.0 9.01 2.7 
C2 0.011 0.39 0.70 16.8 72.3 10.4 3.3 
C3 0.005 0.38 1.12 22.4 67.2 10.9 8.3 
C4 0.007 0.46 3.30 42.8 70.5 4.58 22.1 
C5 0.001 0.30 3.59 49.4 . 79.3 5.09 30.1 
Sl 0.006 0.77 18.4 94.8 101 48.6 
S2 0.051 1.16 18.1 91.9 121 44.6 
S3 0.035 1.62 7.47 59.4 103 20.0 28.7 
S4 0.093 2.54 3.42 52.1 80.2 6.53 30.1 
S5 0.070 1.65 2.31 63.2 71.6 6.47 16.4 
El 0.023 13.6 21.2 56.2 139 64.3 6.2 
E2 0.713 22.3 34.3 89.0 195 90.5 42.8 
E3 0.021 7.92 15.1 90.7 73.9 24.4 29.1 
E4 0.034 18.6 5.38 83.0 29.9 31.6 18.7 
E5 0.324 15.4 ·24.2 76.9 138 68.5 36.5 
Summary 
Statistics 
mean 0.09 5.83 10.64 60.2 93.9 29.7 21.2 
median 0.02 1.62 5.38 59.4 79.3 20.0 22.1 
minimum 0.00 0.30 0.70 15.2 29.9 4.58 2.70 
maximum 0.71 22.3 34.3 94.8 195 90.5 42.8 
Ta~le 6. Analysis of variance using Duncan's Multiple Range Test (SAS, 1997). Values reported are% bioavailable arsenic 
(or extractable arsenic) means for that group. Means that are not different at P < 0.05 have the same letter. 
Sodium Hydroxylamine Ammonium Sodium 
Samples Water Acetate Phosphate HCl Oxalate Hidroxide In-Vivo 
All Media 0.15 d 7.16 cd 1.04 d 81.6 a 93.9 a 29.7b 21.3 be 
(n=13) 
CV*(%) 198 97.7 40.8 108 42.3 90.4 65.6 
Calcine Only 0.01 e 0.39 e 1.48 e 29.3 b 71.1 a 8.00 d 14.1 C 
(n=5) 
CV*(%) 46.2 28.1 29 50.3 8.64 34.7 88.8 
All Media 0.22 d 10.69 cd 0.82 d 107.7 a 105.3 a 40.6 b 25.9 be 
Except Calcine 
(n=8) 
CV*(%) 155 57.8 21.7 90.4 42.2 66.4 49.1 
*CV = Coefficient of variation, % 
V, 
'° 
< 
..2 
's 
<.) 
! 
'$. 
"' < 
..2 
. ..0 
~ 
"' ~ 
'$. 
"' < 
..2 
's 
<.) 
~ i:il 
"$. 
60 
0.8 25 
a) Water 
• 
b) Sodium Acetate 
• 
0.6 20 
• 
15 • 0.4 • 
• 10 
0.2 • 
• intercept= -0.10 5 intercept= 1.07 
0.0 ' slope;,, 0.01 slope= 0.26 
r 2 = 0.41 
0 
r 2 = 0.18 
0 10 20 30 40 50 0 10 20 30 40 50 
40 100 
c) Phosphate d) Hydroxylamine HCI 
• • • 80 • 30 
• • 60 • 
• • 20 , 
40 • 
10 
• intercept= -0.36 20 • intercept= 24.43 
-
• 
• slope = 0.46 slope= 1.45 
0 r 2 = 0.32 0 
r 2 = 0.54 
0 10 20 30 40 50 0 10 20 30 40 50 
220 100 
200 e) Ammonium Oxalate 
• 
f) Sodium Hydroxide 
• 
180 80 
160 
• 140 • • 60 • 
120 
100 
80 , 40 I • • • 60 intercept = 0 • intercept= 7.92 40 slope= 3.59 20 • slope= 0.90 
• 20 r2 =0 fl' 
r 2 = 0.17 
• 0 0 
0 10 20 30 40 50 60 70 0 10 20 30 40 50 
% Bioavailable As, In-Vivo % Bioavailable As, In-Vivo 
Figure 1. Linear regression correlations of in-vivo bioavailable As with As extracted 
by various chemical speciation methods. 
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Chapter3 
Biomethylation of Arsenic in Contaminated Soils and Solid Wastes 
Abstract 
Biomethylation of arsenic from soils is a naturally occurring phenomenon wherein 
indigenous fungi and bacteria methylate inorganic arsenic to form volatile, biomethylated 
forms of arsenic. Utilization of biomethylation as a remediation method for soils and wastes 
heavily contaminated with arsenic has not been shown. An experiment was conducted on 
calcine and lead slag waste materials (smelter wastes) high in total arsenic (10,920 and 3,160 
mg kg·1, respectively) and lead (8,430 and 12,610 mg kg·1, respectively) concentrations to 
determine ifbiomethylation could be promoted as a remediation method to lower soil arsenic 
levels. Contaminated materials were supplemented with ground soybean meal (60,000 mg 
kg·1), glutamine (1%), vermiculite (1 :4, by volume), kept moist with distilled water and then 
incubated under a~robic and anaerobic conditions. After a 20 week incubation period, the 
calcine waste demonstrated 5.3 µg of arsenic lost via biomethylation (0.0005% of the total 
calcine arsenic). An experiment conducted on an uncontaminated soil spiked with a known 
amount of arsenic was performed to determine if the biomethylation conditions were adequate 
to promote biomethylation. Biomethylation resulted in 20.4 µg of arsenic volatilized over a 
20 week period (0.002% of the total calcine arsenic). Another experiment was conducted to 
determine if the high lead concentrations inhibited the biomethylation process. The calcine 
waste material was supplemented with reagent grade lime to raise the pH to 7.4 and reduce 
the bioavailable fraction of lead. Biomethylation resulted in the formation of 96.8 µg of 
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volatilized arsenic (0.009% of the total calcine arsenic), a> 17-fold increase. Further 
optimization of this enhanced biomethylation technique may present a cost-effective remedial 
technology for some arsenic contaminated soils and solid wastes. 
Key Words: bioremediation, biomethylation, arsenic contamination, bioavailable arsenic, 
INTRODUCTION 
As early as 1839, mysterious poisonings have been attributed to a volatile organic 
compound liberated from moldy wall-paper in damp rooms (Challenger et al., 1933). Work 
by Gosio in 1839 led to the discovery thatAspergillus sp. and Penicillium sp. are responsible 
for the production of this gas (referred to as Gosio gas) via their production of hydrogen, 
which reduced the arsenic in the wall-paper pigments to hydrogen arsenide (Challenger et al. 
1933). In 1945, Challenger published a comprehensive paper describing previous experiments 
which established that the primary component of the fatal Gosio gas was trimethylarsine 
formed from biomethylation of arsenic compounds by microorganisms. Challenger (1945) 
also showed that selenium and tellurite (also metalloids) were capable of being metabolized 
by fungi in a similar manner. 
The volatile forms of arsenic produced via microbially mediated biomethylation 
include monomethyl arsine (MMA), dimethyl arsine (DMA), and trimethyl arsine (TMA). 
Several studies have shown that various microorganisms convert soil arsenic to the volatile 
forms: methanogenic bacteria, under anaerobic conditions (McBride and Wolfe, 1971; 
McBride et al., 1978); the fungi Candida Jmmicola (Cox and Alexander, 1974); wood-rotting 
fungi Lenzites trabea (Merrill and French, 1964); Penicillium sp.(Huysmans and 
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Frankenberger, 1991 ); Scopulariopsis brevicaulis, under aerobic conditions (McBride and 
Wolfe, 1971); and the marine algae Tetraselmis chui (Bottino et al., 1978). Studies have 
been conducted to evaluate the production of arsine derivatives in soil (Cheng and Focht, 
1979; Woolson 1977), sewage sludge (Cox and Alexander, 1973), surface waters (Braman 
and Foreback, 1973), and in humans (Braman and Foreback, 1973). 
The mechanism for fungal biomethylation proposed by Cox and Alexander ( 1973) for 
the three species Candida humicola, Gliocladium roseum, and Penicillium sp. is as follows: 
monomethylarsonic acid ~ dimethylarsinic acid ~ trimethylarsine oxide ~ TMA 
In addition, C. humicola was also found to use arsenate and arsenite as substrates to produce 
triinethylarsine. According to Cullen et al. (1977), it is expected that another product of 
fungal biomethylation by these species would include OMA. However, the authors suggest 
that OMA would have a very short life time in an air stream, consequently, even if it were 
formed as a metabolic product under aerobic conditions it would be chemically transformed 
quickly to dimethylarsenic acid and then metabolized to TMA (Cullen et al., 1977). 
The hiomethylation process requires a methyl-donor, or precursor (Cullen et al., 1977; 
Cullen and Reimer, 1989; Tamaki and Frankenberger, 1992). Methylation is thought to occur 
via S-adenosylmethionine (SAM) (Tamaki and Frankenberger, 1992). SAM, which is an 
"active" form of methionine, is thought to be involved in the transfer of the methionine methyl 
group to arsenic during fungal methylation (Cullen and Reimer, 1989). 
Numerous species of bacteria have been found to methylate arsenic under both aerobic 
and anaerobic conditions. The most widely studied, Methanobacterium sp., has been shown 
to produce volatile OMA when incubated anaerobically with a variety of arsenic derivatives, 
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Hz, ATP, and a methyl donor (methylcobalamin) (McBride and Wolfe, 1971). TMA has not 
been shown to be an end product of methanogenic bacterial methylation. 
Since 1971, a number of nonmethanogenic bacteria have been identified as 
methylarsine producers (Cullen and Reimer, 1989). The bacteria identified were first isolated 
from soils and sediments and acclimated to grow in arsenate at concentrations < 100 mg kg-1. 
The bacterial cultures were exposed to sodium arsenate and sodium methylarsonate herbicides 
under aerobic conditions. The response noted was the production ofDMA and TMA arsenic 
species. 
Under laboratory conditions Hassler et al .. (1984) studied the biomethylation of 
organoarsenicals, dimethylarsinic acid and methanearsonic acid, when added to soil at the rate 
of20 mg kg-1. Crushed soybean meal, at the concentration of 60,000 mg kg-1, was added to 
each soil as an organic matter source to provide carbon and nitrogen. Under aerobic 
conditions, the methylated arsenic products measured after a 12 week incubation period were: 
3.37 mg kg-1 of dimethylarsinic acid, 0.75 mg kg-1 ofmethanearsonic acid, and 0.07 mg kg-1 
of sodium arsenate. Anaerobic conditions were maintained in a separate experiment by 
continually flushing their reactors with nitrogen gas. Results of the anaerobic experiment at 
the end of 12 weeks were: 0.25 mg kg-1 dimethylarsinic acid and 0.009 mg kg 
methanearsonic acid. 
In another study (Akins and Lewis, 1976) soil was treated with 100 mg kg-1 of a 
labeled organoarsenical, disodium methanearsonate, and loss of soil arsenic was measured as 
a function of redox conditions, organic matter, and moisture content. The greatest loss 
(11.0%) was found under moist, anaerobic conditions with added organic matter. The moist, 
65 
aerobic conditions with added organic matter soil was found to lose 7. 9%. Without added 
organic matter, 8.1 % arsenic was lost under moist anaerobic conditions, while only 2.2% 
arsenic was lost under moist aerobic conditions. 
Biomethylation of selenium, a metalloid similar to arsenic, has also been demonstrated 
experimentally. Abu-Erreish et al. (1968) measured methylated selenium (by tluorometric 
methods) produced by incubating soils containing 0.67 to 9.1 mg kg·1 natural selenium. Other 
researchers, using gas chromatography-mass spectrometry techniques have demonstrated 'that 
selenium in soil is biomethylated by indigenous microorganisms to form biomethylated end 
products, ( eg. dimethyl selenide) when the soils are enhanced with organic materials under 
both aerobic and anaerobic conditions (Doran and Alexander, 1977; Reamer and Zoller, 1980; 
Cooke and. Bruland, 1987;Karlson and Frankenberger, Jr., 1989; Thompson-Eagle and 
Frankenberger, Jr., 1990). A methyl-group supplying amino acid, L-methionine, was shown 
to enhance biomethylation of selenium at more than twice the rate of the control 
(Frankenberger and Karlson, 1989); an optimum concentration of L-methionine was 
determined to be 100 mg kg·1 in soil. Some metals have been demonstrated to inhibit 
biomethylation of selenium. Karlson and Frankenberger (1988) found that the addition of 5 
mmol kg·1 of other metals, molybdenum, mercury, chromium, and lead, to seleniferous soils 
greatly inhibited selenium volatilization; whereas arsenic, boron, and manganese had little 
effect. 
To date, there are no reports in the literature that describe the utilization of 
bioremediation as a technology to remediate arsenic contaminated · soils. The research 
published to date has been demonstrated only on soils with low level arsenic contamination; 
66 
100 mg kg-1 and less. The primary objective of our study was to document biomethylation of 
inorganic arsenic would occur in materials heavily contaminated with arsenic and heavy 
metals. A second objective was to compare biomethylation under aerobic (using air) and 
anaerobic (using argon) conditions. 
EXPERIMENTAL METHODS 
Study Materials 
Two matrices were collected for this study from a typical mining/smelter site in the 
western U.S. where wastes were deposited between 20 and 50 years ago. These aged and 
weathered wastes include a calcine material, a waste product which results from the roasting 
and smelting of arsenopyrite ore for the extraction of arsenic, and an iron slag material, a 
waste product which results from the smelting of ores for lead which is also high in iron. 
Approximately five gallons of each solid material was collected, air dried under ambient 
conditions, and sieved to collect the particle size fraction < 2 µm. Soils were thoroughly 
homogenized/mixed prior to use and stored in secured, air-tight containers. A background 
location was determined and five gallons of soil was collected and prepared in the same 
manner as the calcine and slag materials. 
The chemical and physical properties of the calcine, slag, and background materials 
are presented in Table 1. Arsenic characterization of the two study materials is presented in. 
Table 2. Total arsenic is extracted from the study materials by hot nitric acid/peroxide 
digestion (USEPA, 1986) and arsenic analysis was performed by a Thenno-Jarell Ash 
Inductively Coupled Plasma (ICP) (Maxim). However, the entire fraction of total arsenic will 
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not be available (or bioavailable) to the microorganisms responsible for biomethylation. To 
consider other pools of arsenic, a variety of chemical extractants were performed and are 
presented in Table 2. 
Mineralogical composition of the calcine and slag were determined by microprobe 
analysis for the various iron and arsenic bearing compounds. The calcine was found to 
contain: 38% iron-manganese sulfate, 28% iron-arsenic-oxide, and 35% iron-manganese 
oxide. The slag was found to contain: 17% iron-manganese sulfate, 49% iron-arsenic oxide, . 
4% iron-manganese oxide, 30% lead-manganese oxide, and 2% slag. 
Biomethylation Reactor Conditions 
Arsenic contaminated soil/waste material, 100 g, was placed into a 500 ml ErlellII_leyer 
vacuum flask, as depicted in Figure 1. Organic material (nutrient source) was added in the 
form of crushed soybean meal to achieve a concentration of 60,000 mg kg-1 CW oolson, 1976); 
12 g to each flask. A methyl group-containing amino acid, 1. 0 g glutamine was added as a 
source of methyl-precursor (Huysmans and Frankenberger, Jr., 1991). Vermiculite was added 
to each flask as a bulking agent at the ratio of 1 part vermiculite to 4 parts of soil. To create 
moist conditions, 25 ml distilled water was added to each flask. 
Anaerobic or aerobic conditions were maintained during the biomethylation 
experiment. Aerobic conditions were maintained by continuously passing a stream of 
humidified breathing air (Hassler et al., 1984) into some of the bioreactors at a flow rate of 
approximately 1 L min-1 through Tygon and glass tubing held in place with neoprene stoppers 
(Figure 1). Anaerobic conditions were maintained in the other reactors in the same manner 
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using humidified argon gas, at the same flow rate. Volatile arsenic gas formed during 
incubation was flushed out of the flasks with the air or argon and into a polycarbonate test 
tube containing 50 ml of 0.1 M potassium iodide (KI) solution. A small amount of crystal 
iodine was added to the KI to maintain iodine in excess. Volatilized arsenic in the forms of 
monomethylarsine (MMA) and dimethylarsine (DMA) are trapped in KI/iodine solution 
(Woolson, 1977). A second tube of 50 ml KI/iodine was placed sequentially to trap any 
MMA or OMA not trapped in the first KI tube (Figure 1). In order to trap any 
trimethylarsine (TMA) formed during the biomethylation experiment, a preformed carbon 
adsorption tube (ORB0-100, SUPELCO, Bellefonte, PA) was positioned to adsorb TMA 
from the effluent air or argon. 
The .bioreactor flasks were housed in the dark in a temperature controlled room with 
the temperature maintained at 85 °F throughout the experiment. The KI solutions and carbon 
adsorption tubes were collected and exchanged for new solutions and tubes on the following 
sampling schedule: 2, 4, 8, 12, 16, and 20 weeks. 
Biomethylation Experimental Design 
The biomethylation experiment was performed with the two arsenic contaminated 
study materials, lead slag and calcine, under both aerobic and anaerobic conditions. Four 
replicates of each treatment was performed. To demonstrate that biomethylation of soil 
arsenic occurs via microbially mediated mechanisms, sterilized controls (performed in 
duplicate) were included to evaluate abiotic arsenic losses. Sterilization was first 
accomplished by autoclaving. However, after two weeks of incubation, microbial mats were 
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visually observed in some of the control bioreactor flasks. A second sterilization was 
accomplished by adding a solution ofHgC12 to achieve a concentration of 500 mg kg·1 in soil 
(Wolf and Skipper, 1994). 
Analysis of Volatilized Arsenic 
Arsenic trapped in the KI solutions was measured by utilizing the hydride generation 
(HG) technique with ICP. To prepare the KI solutions for hydride generation, a 10.0 ml 
aliquot of KI was placed into a test tube and mixed with 3.3 ml concentrated hydrochloric 
acid and 4.0 ml of a solution containing 10% KI and 1 % ascorbic acid. After a reaction 
period of at least 1 hour, arsenic was determined by ICP-HG. During hydride generation, the 
sample solution is mixed with a solution of 1 % NaBH4 made up in 0.1 M NaOH, which 
results in the development of arsine gas. Arsenic was extracted from the carbon adsorbent 
by hot digestion with nitric acid, followed by hydrogen peroxide and hydrochloric acid as 
described in SW-846, Method 3050 (USEPA, 1986). The resulting extract was then analyzed 
by ICP-HG as described above for the KI solutions. 
Positive Control Experiment 
An experiment was conducted using the uncontaminated background soil to evaluate 
the biomethylation of a known amount ( controlled spike) of arsenate. It was determined 
experimentally that adding 20 ml of a solution of sodium arsenate, 500 mg L-1 arsenic, shaking 
at low speed for 4 hours, filtering and allowing to air dry, resulted in a water soluble arsenic 
extract of 10 mg kg·1. The positive control biomethylation experiment was performed 
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aerobically, in triplicate, and all reactor conditions as described for the biomethylation 
experiment were maintained. Samples of KI and adsorbing carbon were collected and 
analyzed on the same schedule as the above biomethylation experiment. 
Lead Stabilized Calcine Experiment 
To evaluate the effect of lead inhibition of the biomethylation process, a lead 
stabilizing experiment was conducted using the calcine waste material. The calcine material 
had a pH of 3.1 and total lead content of 8,430 mg kg-1 (Table 1). Lime, in the form of 
reagent grade CaC03, was added to the calcine at 10 g kg-1 to achieve a pH of 7.4. The 
biomethylation experiment, as described above, was conducted on the lead-stabilized calcine 
waste. Treatments were performed in triplicate under aerobic conditions. Samples of KI and 
the carbon adsorbents were collected and analyzed on the same schedule as the above 
biomethylation experiment. 
RESULTS AND DISCUSSION 
Biomethylation Experiment 
The biomethylation experiment conducted on the lead slag and calcine waste materials 
was incubated for a period of 20 weeks. Cumulative volatile arsenic produced over this time 
period is presented in Figure 2. Results of MMA + OMA, TMA, and total arsenic are all 
presented separately in Figure 2. Only the calcine waste under aerobic conditions 
demonstrated appreciable amounts of methylated arsenic. Over the incubation period of 20 
weeks, a total of 5.31 µg of arsenic was methylated (which represents 0.0005% of the total 
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calcine arsenic); 2.17 µg ofMMA + DMA, 3.14 µg of TMA (Table 3). In the calcine 
sterilized contro~ 1. 08 µg of total arsenic was methylated over the incubation period ( which 
represents 0.0001% of the total calcine arsenic). As previously reported in the literature, 
under aerobic conditions, both fungi and bacteria biomethylate soil arsenic to MMA, DMA, 
and TMA (Cox and Alexander, 1973; Cullen et al., 1977). Our results for the aerobic calcine 
treatments are in agreement with these reports. However, the amounts of volatilized arsenic 
produced are quite low by comparison with previously published research. Hassler et al. 
{1984) produced 343 µg volatilized arsenic (5.1 % of the total soil arsenic) from incubating 
soils aerobically (over a period of 12 weeks). Their original study soil had 47 mg kg·1 total 
arsenic, to which they added a dimethylarsinic acid at the rate of20 mg kg·1 arsenic-in soil. 
Comparing the results of the calcine biomethylated arsenic under aerobic conditions 
with the arsenic concentrations presented in Table 2, we can evaluate which pool ( or fraction) 
of arsenic is the bioavailable form. The mass ofbiomethylated arsenic produced, 5.31µg 
arsenic, corresponds to an arsenic concentration of 0.053 mg kg·1 {100 g of soil in the 
bioreactor). As shown in Table 2, the water soluble extracted arsenic content of the calcine 
waste material is represented by 0.73 mg kg·1. Therefore, by subjecting the calcine waste to 
biomethylation conditions, we have only biomethylated a small portion of the water soluble 
extracted arsenic. 
The anaerobic calcine biomethylation treatment was not substantially different from 
the sterilized control; there was very little biomethylation activity. The lead slag 
biomethylation results, under aerobic and anaerobic conditions, did not show appreciable 
amounts of methylated arsenic over the sterilized lead slag controls. Previous reports in the 
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literature have shown substantial amounts of volatilized arsenic produced under anaerobic 
conditions. Cheng and Focht (1979) measured 80 µg of volatilized arsenic (5% of the total 
soil arsenic) produced over a three week incubation period of soil amended with arsenate 
(160 mg kg-1) and maintained under flooded conditions. Another experiment (Woolson, 
1977) conducted under anaerobic conditions (reactors flushed with N2 gas), with soils 
amended with arsenic to achieve a rate of 10 mg kg-1, showed up to 78 µg of the amended 
arsenic (7. 8% of the total soil arsenic) was converted to volatilized species after 160 days. 
Redox measurements were not reported for either of these two reports. Redox measurements 
in our study rangedfrom approximately-4 to -12 mV (pH 3) for the calcine bioreactors and 
from -6 to +25 m V (pH 7) for the lead slag bioreactors, which reflect anaerobic conditions 
but not methanogenic. Primary anaerobic microorganisms responsible for biomethylation in 
natural systems require a redox potential of< -250 m V to be methanogenic. Perhaps greater 
amounts of volatilized arsenic would have been produced in the anaerobic bioreactors if the 
redox potentials were low enough. 
Because the experimental results ofbiomethylation of the lead slag and calcine waste 
materials do not compare well with the amounts of arsenic reported to be biomethylated 
under aerobic conditions in the literature, further evaluations were deemed necessary. The 
first objective was to determine if the biomethylation process as performed in the initial 
experiments could be demonstrated for an uncontaminated, clean background soil that had 
a known amount of soil arsenic. This was accomplished by adding a known amount of 
arsenate (spike) to a "clean" soil and incubating under the same experimental conditions. 
Second, because there are reports in the literature of the presence of lead inhibiting the 
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selenium biomethylation process (Karlson and Frankenberger, 1988), a biomethylation 
experiment on lead stabilized calcine was performed. 
Positive Control Experiment 
Sodium arsenate additions to background soil resulted in 10 mg kg·1 water soluble 
arsenic. Methylated arsenic produced over the 20 week incubation period was 20.4 µg 
(Figure 3a) {0.002% of the total calcine arsenic), which is a > 3-fold increase in the . 
biomethylated arsenic produced from the untreated calcine waste (Table 3). The amount of 
biomethylated arsenic produced for the spiked background experiment (20.4 µg) is more 
comparable to the biomethylated arsenic reported in past reports of the scientific literature 
(Hassler et al ., 1984). However, given the high concentration of arsenic in the calcine 
material (8,430 mg kg·1), it is likely that another condition present in the calcine may be 
inhibiting biomethylation. 
Lead Stabilized Calcine Experiment 
The chemical form of lead in smelter waste controls the bioavailability of lead 
(Gradwohl and Basta, 1998). Bioavailable lead is the form which can be readily assimilated 
and toxic to microorganisms. Treatment of the calcine media with alkaline amendments (i.e. 
CaC03) will raise the soil pH and convert bioavailable lead into insoluble metal precipitates, 
complexes, and secondary minerals (Pierzynski and Schwab, 1993). Treatment of the calcine 
media with CaC03 should reduce lead bioavailability and increase microbial activity and 
biomethylation of arsenic. Therefore, to determine if lead was inhibiting the biomethylation 
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process, the biomethylation experiment conditions were repeated on the lead stabilized calcine 
waste material (in triplicate). 
The amount of total volatilized arsenic produced from biomethylation of the lead 
stabilized calcine waste material over a 20 week period was 96.8 µg arsenic (0.009% of the 
total calcine arsenic), nearly all from MMA + DMA (92.4 µg arsenic, or 95.4%) (Figure 3b). 
By stabilizing the lead in the original calcine waste material, an increase of > 17-fold of 
biomethylated arsenic was produced. 
The amount ofbiomethylated arsenic from the lead stabilized calcine waste (96.8µg) 
equates to a soil arsenic content of0.97 mg kg-1. Comparing this amount ofbiomethylated 
arsenic with the various pools of arsenic extracted from the calcine (as shown on Table 2) 
suggests the pool of arsenic available for biomethylation under these conditions falls between 
the water soluble plus weakly adsorbed arsenic (WA+WS) and the pool of arsenic more 
strongly adsorbed to the soil particles (WA+WS+SA). 
It is important to note that all the biomethylation experiments were conducted over 
a 20 week period and were not re-supplied with nutrients or methyl-precursor at any other 
time. The low amounts of arsenic biomethylated in later time periods may be indicative of a 
deficiency of nutrients or methyl groups, rather than exhausting the bioavailable pool of 
arsenic. While the biomethylation results are low in concentration as compared to the total 
arsenic content, this bioremediation technique may be well-suited for areas which are difficult 
to treat by other, more traditional remedial technologies. With the prevalence of indigenous 
microorganisms responsible for methylating soil arsenic, it is certain that these processes are 
occurring naturally in areas where the appropriate environmental conditions exist, perhaps as 
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an example of "intrinsic bioremediation". Further research may be designed to optimize 
biomethylation of arsenic in contaminated soils and wastes to result in a cost-effective, natural 
remediation technology. 
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Table 1. Elemental content and select chemical properties of study media. 80 
Study Media 
Properties Calcine Slag Background Soil 
pltl) 
TOC (%i2) 
% < 2 um<3) 
% < 50 um<3) 
Soluble Anions<4) 
Chloride 
Sulfate 
Nitrate 
Major Elements<5) 
3.1 
0.51 
9.8 
45.5 
3029 
947 
753 
7.1 7.3 
2.87 0.54 
7.3 12.2 
45.1 55.2 
k -1 mg g----------------
10530 855 
225383 
291 
1978 
291 
---------------- %- - - - - - - - - - - - - - - - -
Si 
Al 
Ca 
Mg 
Na 
K 
Fe 
Mn 
Ti 
Heavy Metal Contaminants<6) 
Pb 
Zn 
Cu 
Ni 
(1)1: 1, soil:0.01 M CaC}z 
18.1 
1.38 
3.34 
0.19 
0.19 
0.56 
26.6 
0.05 
0.14 
8430 
1660 
524 
32.2 
<2)Total Organic Carbon (Nelson and Sommers, 1996) 
<3>ffydrometer Method (Gee and Bauder, 1986) 
<4)1 g soil: 10 ml H20, Shake 1 hr. 
<5)X-Ray Fluorescence (Karathanasis and Hajek, 1996) 
<6)SW 846, Method 3050 (USEP A, 1986) 
19.9 28.0 
2.34 5.09 
9.22 6.26 
0.97 1.60 
0.30 0.82 
0.66 1.91 
19.7 4.56 
0.12 0.05 
0.20 0.41 
k -1 mg g ---------------
12610 
4040 
4230 
35.3 
Table 2. Arsenic characterization of study media. 
Method Reference Arsenic Fraction Extracted 
Water Huang and Fujii, 1996 water soluble (WS) 
Sodium Acetate Tessier et al., 1979 WS + weakly adsorbed (WA). 
lM NaOAc, pH 5 
Phosphate Yamamoto, 1975 WS + WA + strongly adsorbed (SA) 
3 parts 0.1 M Na2HP04 
2 parts O .1 M NaH2P04 
Hydroxylamine HCl Chao and Zhou, 1983; WS +WA+ SA+ amorphous Mn oxide (MnO) 
0.25 M NH20H, modified by Amacher and + amorphous Fe oxide (FeO) 
0.25 M HCl, 0.025 M H3P04 Kotuby-Amacher, 1994 
Ammonium Oxalate Shuman, 1982 WS + WA + SA + crystalline and amorphous FeO + 
0.2 M {Nl4)zC204 HCI, aluminum oxide (AIO) 
0.25 M HCl, 0.025 M H3P04 
Sodium Hydroxide Olsen and Sommers, 1982 WS +WA+ SA+ AIO 
0.1 N NaOH, IM NaCl 
Hot Acid Digestion SW 846, Method 3050 all of the above + residual 
(USEPA, 1986) 
Study Media 
Calcine Slag Background 
k -1 . 
--------- mg g ---------
0.73 3.81 
41.3 108 
255 98.5 
375 213 
5403 2135 
188 191 
10920 3160 
0.31 
32.9 
61.7 
33.2 
288 
69.2 
00 
...... 
Table 3. Summarized results of arsenic spiked background soil and lead 
stabilized calcine biomethylation as compared to calcine biomethylation. 
Aerobic conditions, 20 weeks of incubation. Mean values are presented. 
Volatilized Arsenic 
Study Soil MMA+DMA TMA Total 
ug - - - - - - - - - - - - - - - - - -
Calcine 2.2 3.1 5.3 
Positive Control, 19.8 0.58 20.4 
Spiked Background Soil 
Lead Stabilized Calcine 92.4 4.4 96.8 
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air/argon in 
• 11 
' deionized bioreactor 0.1 M KI 
water Traps 
Figure I. Bioreactor design. 
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Figure 2. Volatile arsenic biomethylated from contaminated media under aerobic 
or anaerobic conditions. 
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Figure 3. Volatilized (methylated) arsenic produced over a 20 week incubation period; 
positive control and lead stabilized calcine experiments. 
Appendix I 
In-Vitro Data 
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Table I - 1 
. Ruby In-Vitro (PBEn Method - Time Study 
GI Phase Solution 
Sample No. Sample ID Time (min) Rep No. As (ug/L) Dil'n Factor As (ug/L) As (mg/L) As (mg/kg) 
1429 C4 S-20 1 655.496 2 1310.992 1.311 131.099 
1430 C4 S-20 2 613.658 2 1227.316 1.227 122.732 
1431 C4 S-20 3 632.025 2 1264.05 1.264 126.405 
1432 C4 S-40 1 982.300 2 1964.6 1.965 196.460 
1433 C4 S-40 2 913.940 2 1827.88 1.828 182.788 
1434 C4 S-40 3 995.318 2 1990.636 1.991 199.064 
1435 C4 S-60 1 1093.324 2 2186.648 2.187 218.665 
1436 C4 S-60 2 1000.127 2 2000.254 2.000 200.025 
1437 C4 S-60 3 1115.646 2 2231.292 2.231 223.129 
1438 C4. 1-60 1 1171.615 2 2343.23 2.343 234.323 
1438 C4 1-60 2 1150.356 2 2300.712 2.301 230.071 
1440 C4 1-60 3 1157.976 2 2315.952 2.316 ·. 231.595 
1441 C4 1-120 1 1225.761 2 2451.522 2.452 245.152 
1442 C4 1-120 2 1210.206 2 2420.412 2.420 242.041 
1443 C4 1-120 3 1282.595 2 2565.19 2.565 256.519 
1444 C4 1-180 1 1257.266 2 2514.532 2.515 251.453 
1445 C4 1-180 2 673.885 4 2695.54 2.696 269.554 
1446 C4 1-180 3 662.824 4 2651.296 2.651 265.130 
1447 S4 S-20 1 222.379 40 8895.16 8.895 889.516 
1448 S4 S-20 2 188.120 40 7524.8 7.525 752.480 
1449 S4 S-20 . 3 177.717 40 7108.68 7.109 710.868 
1450 S4 S-40 ' 1 217.743 40 8709.72 8.710 870.972 
1451 S4 S-40 2 115.869 40 4634.76 4.635 463.476 
1452 S4 S-40 3 187.055 40 7482.2 7.482 748.220 
1453 S4 S-60 1 216.116 40 8644.64 8.645 864.464 
1454 S4 S-60 2 120.643 40 4825.72 4.826 482.572 
1455 S4 S-60 3 191.940 40 7677.6 7.678 767.760 
Ave 
As (mg/kg) 
126.75 
192.77 
213.94 
232.00 
247.90 
262.05 
784.29 
694.22 
704.93 
Bioavailable As 
(%) std dev Average 
1.14 0.04 1.10 
1.06 
1.10 
1.70 0.08 1.67 
1.59 
1.73 
1.90 0.11 1.86 
1.74 
1.94 
2.03 0.02 2.01 
2.00 
2.01 
2.13 0.07 2.15 
2.10 
2.23 
2.18 0.08 2.27 
2.34 
2.30 
17.71 1.86 15.62 
14.98 
14.16 
17.34 4.16 13.82 
9.23 
14.90 
17.21 3.95 14.04 
9.61 
15.29 
00 
-..J 
Table I - 1 
Ruby In-Vitro (PBET) Method - Time Study 
GI Phase Solution 
Sample No. Sample ID Time(min) Rep No. As (ug/L) Dil'n Factor As·(ug/L) As (mg/L) As (mg/kg) 
1456 S4 1-60 . 1 141.855 40 5674.2 5.674 567.420 
1457 S4 1-60 2 101.522 40 4060.88 4.061 406.088 
1458 S4 1-60 3 140.479 40 5619.16 5.619 561.916 
1459 S4 1-120 1 150.726 40 6029.04 6.029 602.904 
1460 S4 1-120 2 105.930 40 4237.2 4.237 423.720 
1461 S4 1-120 3 142.093 40 5683.72 5.684 568.372 
1462 S4 1-180 1 142.750 40 5710 5.710 571.000 
1463 S4 1-180 2 102.076 40 4083.04 4.083 408.304 
1464 S4 1-180 3 136.452 40 5458.08 5.458 545.808 
1465 SI S-20 1 25.949 40 1037.96 1.038 103.796 
1466 SI S-20 2 29.192 40 1167.68 1.168 116.768 
1467 SI S-20 3 26.904 40 1076.16 1.076 107.616 
1468 SI S-40 1 29.013 40 1160.52 1.161 116.052 
1469 SI . S-40 2 32.015 40 1280.6 1.281 128.060 
1470 Sl . S-40 3 29.590 40 1183.6 1.184 118.360 
1471 SI S-60 1 30.777 40 1231.08 1.231 123.108 
1472 SI S-60 2 36.141 40 1445.64 1.446 144.564 
1743 SI S-60 3 33.860 40 1354.4 1.354 135.440 
1474 SI 1-60 2 5.658 40 226.32 0.226 22.632 
1475 Sl 1-60 3 5.957 40 238.28 0.238 23.828 
1476 SI 1-120 2 3.985 40 159.4 0.159 15.940 
1477 SI 1-120 3 3.999 40 159.96 0.160 15.996 
1478 SI 1-180 2 3.583 40 143.32 0.143 14.332 
1479 SI 1-180 3 3.740 40 149.6 0.150 14.960 
Ave 
As (mg/kg) 
511.81 
531.67 
508.37 
109.39 
120.82 
134.37 
23.23 
15.97 
14.65 
Bioavailable As 
(%) std dev Average 
11.30 1.82 10.19 
8.09 
11.19 
12.01 1.89 10.59 
8.44 
11.32 
11.37 1.74 10.12 
8.13 
10.87 
25.88 1.66 27.01 
29.12 
26.84 
28.94 1.59 29.83 
31.94 
29.52 
30.70 2.69 33.18 
36.05 
33.78 
5.64 1.06 5.74 
5.94 
3.98 0.24 3.94 
3.99 
3.57 0.11 3.62 
3.73 
00 
00 
Table I - 2 
Ruby In-Vitro Method (PBET) 
Corrected 
Sample No. Sample ID GI Phase Rep No. As (mg/L) As (mg/L) Std Dev As (mg/kg) 
2309 Cl s 1 0.866 0.884 0.084 88.363 
2310 Cl s 2 0.632 0.644 64.413 
2311 Cl s 3 0.749 0.763 76.347 
2312 Cl I 1 1.000 1.020 0.092 102.000 
2313 Cl I 2 0.888 0.906 90.596 
2314 Cl I 3 1.067 1.088 108.834 
2315 C2 s 1 1.184 1.208 0.274 120.768 
2316 C2 s 2 0.737 0.751 75.123 
2317 C2 s 3 0.704 0.718 71.777 
2318 C2 I 1 1.269 1.294 0.589 129.438 
2319 C2 I 2 2.040 2.081 208.080 
2320 C2 I 3 0.911 0.929 92.881 
2321 C3 s 1 1.619 1.651 0.365 165.138 
2322 C3 s 2 1.193 1.217 121.686 
2323 C3 s 3 0.907 0.925 92.504 
2324 C3 I 1 1.783 1.819 0.149 181.866 
2325 C3 I 2 1.587 1.619 161.874 
2326 C3 I 3 1.497 1.527 152.694 
2327 cs s 1 2.051 2.092 0.629 209.202 
2328 cs s 2 1.318 1.344 134.436 
2329 cs s 3 2.544 2.595 259.488 
Ave Bioavailable A 
As (mg/kg) % average 
76.37 0.78 0.68 
0.57 
0.68 
100.48 0.90 0.89 
0.80 
0.96 
89.22 0.69 0.51 
0.43 
0.41 
143.47 0.74 0.82 
1.19 
0.53 
126.44 1.23 0.94 
0.90 
0.69 
165.48 1.35 1.23 
1.20 
1.13 
201.04 3.35 3.22 
2.15 
4.16 
3050 As 
mg/kg 
11294 
11294 
11294 
11294 
11294 
11294 
17456 
17456 
17456 
17456 
17456 
17456 
13472 
13472 
13472 
13472 
13472 
13472 
6245 
6245 
6245 
00 
ID 
Table I- 2 
Ruby In-Vitro Method (PBET) 
Corrected 
Sample No. Sample ID GI Phase Rep No. As (mg/L) As (mg/L) Std Dev As (mg/kg) 
2330 cs ' I 1 1.835 1.872 0.319 187.170 
2331 cs I 2 1.343 1.370 136.986 
2332 cs I 3 1.255 1.280 . 128.010 
2333 SI s 1 1.691 1.725 . 0.156 172.482 
2334 Sl s 2 1.395 1.423 ' 142.290 
2335 Sl s 3 1.612 1.644 164.424 
2336 Sl I 1 0.658 0.672 0.290 67.157 
2337 Sl I 2 0.834 0.850 85.048 
2338 Sl I 3 0.277 0.283 28.264 
2339 S2 s 1 1.878 1.916 0.366 191.556 
2340 S2 s: 2 1.611 1.643 164.322 
2341 S2 s: 3 2.322 2.368 236.844 
2342 S2 I 1 0.662 0.675 0.156 67.534 
2343 S2 I 2 0.927 0.675 67.534 
2344 S2 I 3 0.466 0.946 94.574 
2345 S3 s 1 2.777 0.475 1.237 47.522 
2346 S3 s 2 2.260 2.833 283.254 
2347 S3 s 3 2.39 2.305 230.520 
2348 S3 I 1 1.940 1.979 0.026 197.880 
.2349 S3 I 2 1.906 1.944 194.412 
2350 S3 I 3 1.890 1.928 192.780 
Ave Bioavailable A 
As (mg/kg) % average 
150.72 3.00 2.41 
2.19 
2.05 
159.73 42.59 39.44 
35.13 
40.60 
60.16 16.58 14.85 
21.00 
6.98 
197.57 42.57 43.91 
36.52 
52.63 
76.55 15.01 17.01 
15.01 
21.02 
187.10 4.03 15.86 
24.00 
19.54 
195.02 16.77 16.53 
16.48 
16.34 
3050As 
mg/kg 
6245 
6245 
6245 
405 
405 
405 
405 
405 
405 
450 
450 
450 
450 
450 
450 
1180 
1180 
1180 
11.80 
1180 
1180 
'° 0 
Table I - 2 
. Ruby In-Vitro Method (PBET) 
Corrected Ave Bioavailable A 3050 As 
Sample No. Sample ID GI Phase Rep No. As (mg/L) As (mgi{,) Std Dev As (mg/kg) As (mg/kg) % average mg/kg 
2351 S5 s 1 5.600 5.712 0.467 571.200 544.00 12.28 11.70 4650 
2352 S5 s 2 4.805 4.901 490.110 10.54 4650 
2353 S5 s 3 5.595 5.707 570.690 12.27 4650 
2354 S5 I 1 4.350 4.437 0.117 . 443.700 430.24 9.54 9.25 4650 
2355 S5 I 2 4.146 4.229 422.892 : 9.09 4650 
2356 S5 I 3 4.158 4.241 424.116 9.12 4650 
2357 El s 1 0.135, 0.138 0.028 i 13.790 16.88 4.17 5.10 331 
2358 El s 2 0.172 0.176 17.575 5.31 331 
2359 El s 3 0.189 0.193 19.278 5.82 331 
2360 El I 1 0.180 0.183 I 0.130 18.309 25.04. 5.53 7.56 331 
2361 El I 2 0.393 0.401 40.066 12.10 331 
2362 El I. 3 0.164 0.167 16.738 5.06 331 
2363 E2 s 1 0.496 0.506 · 0.069 50.592 46.82 21.71 20.09 233 
2364 E2 s 2 0.381 0.388 38.821 16.66 233 
2365 E2 s 3 0.500 0.510 51.041 21.91 233 
2366 E2 I 1 0.336 0.342 0.163 34.241 46.35 14.70 19.89 233 
2367 E2 I 2 0.636 0.648 64.821 27.82 233 
2368 E2 I 3 0.392 0.400 39.984 17.16 233 
2369 E3 . s 1 1.927 1.966 0.184 196.554 214.27 24.57 26.78 800 
2370 E3 s 2 2.088 2.130 212.976 26.62 800 
2371 E3 s 3 2.287 2.333 233.274 29.16 800 
'° ...... 
Table I - 2 
Ruby In-Vitro Method (PBET) 
Corrected 
Sample No. Sample ID GI Phase Rep No. As (mg/L) As (mg/L) Std Dev As (mg/kg) 
2372 E3 I 1 0.8358 0.853 0.114 85.252 
2373 E3 I 2 0.6626 9.676 67.585 
2374 E3 I 3 0.872 0.889 88.944 
2375 E4 s 1 2.375 2.423 0.453 242.250 
2376 E4 s 2 1.665 1.698 169.830 
2377 E4 s 3 2.481 2.531 253.062 
2378 E4 I 1 1.288 1.314 0.087 131.376 
2379 E4 I 2 1.132 1.155 115.464 
2380 E4 I 3 1.271 1.296 129.642 
2381 ES s 1 1.365 1.392 0.265 139.230 
2382 ES s 2 1.282 1.308 130.764 
2383 ES s 3 1.768 1.803 180.336 
2384 ES I 1 0.7628 0.778 0.126 77.806 
2385 ES I 2 0.7905 0.806 80.631 
2386 ES I 3 0.5634 0.575 57.467 
2387 Ruby Blank 0.1048 0.107 
Ave Bioavailable A 
As (mg/kg) % average 
80.59 10.66 10.07 
8.45 
11.12 
221.71 16.56 47.89 
11.61 
17.30 
125.49 8.98 8.58 
7.89 
8.86 
150.11 34.72 37.43 
32.61 
44.97 
71.97 19.40 17.95 
20.11 
14.33 
3050 As 
mg/kg 
800 
800 
800 
1463 
1463 
1463 
1463 
1463 
1463 
401 
401 
401 
401 
401 
401 
\0 
N 
Table I - 3 
In-Vitro Gastrointestinal Method (IVG) 
As Corrected As Ave As As 
Sample No. Sample ID GI Phase Rep No. m_g/L As (ml!!L) mg m~ mg/lee; 
2388 Cl s 1 1.292 1.318 0.791 0.714 197.676 
2389 Cl s 2 1.057 1.078 0.647 161.721 
2390 Cl s 3 1.153 1.176 0.706 176.409 
2391 Cl I 1 0.928 0.947 0.568 0.562 142.015 
2392 Cl I 2 0.928 0.946 0.568 141.953 
2393 Cl I 3 0.897 0.915 0.549 137.210 
2394 C2 s 1 1.093 1.115 0.669 0.682 167.229 
2395 C2 s 2 1.126 1.149 0.689 172.278 
2396 C2 s 3 U23 1.145 0.687 171.819 
2397 C2 I 1 1.122 1.144 0.687 0.683 171.666 
2398 C2 I 2 1.071 1.092 0.655 163.863 
2399 C2 I 3 1.154 1.177 0.706 176.562 
2400 C3 s 1 2.019 2.059 1.236 1.189 308.907 
2401 C3 s 2 1.870 1.907 1.144 286.110 
2402 C3 s 3 1.941 1.980 1.188 296.973 
2403 C3 I 1 1.906 1.944 1.166 1.199 291.618 
2404 C3 I 2 2.074 2.115 1.269 317.322 
2405 C3 I 3 1.899 1.937 1.162 290.547 
2406 C4 s 1 4.484 4.574 2.744 2.752 686.052 
2407 C4 s 2 4.531 4.622 2.773 693.243 
2408 C4 s 3 4.474 4.563 2.738 684.522 
2409 C4 I 1 4.438 4.527 2.716 2.659 679.014 
2410 C4 I 2 4.400 4.488 2.693 673.200 
2411 C4 I 3 4.197 4.281 2.569 642.141 
2412 C5 s 1 3.117 3.179 1.908 1.888 476.901 
2413 C5 s 2 3.054 3.115 1.869 467.262 
2414 C5 s 3 3.083 3.145 1.887 471.699 
Ave As 
nwk~ Std Dev 
178.60 18.08 
140.39 2.76 
170.44 2.79 
170.70 6.40 
297.33 11.40 
299.83 15.16 
687.94 4.66 
664.79 19.82 
471.95 4.82 
Bioavailable As 
(%) std dev avera~e 
1.75 0.16 1.58 
1.43 
1.56 
1.26 0.02 1.24 
1.26 
1.21 
0.96 0.02 0.98 
0.99 
0.98 
0.98 0.04 0.98 
0.94 
1.01 
2.29 0.08 2.21 
2.12 
2.20 
2.16 0.11 2.23 
2.36 
2.16 
5.95 0.04 5.97 
6.02 
5.94 
5.89 0.17 5.77 
5.84 
5.57 
7.64 0.08 7.56 
7.48 
7.55 
3050 As 
m!!.lke: 
11294 
17456 
13472 
11525 
6245 
IO 
w 
Table I - 3 
In-Vitro Gastrointestinal Method (IVG) 
As Corrected As Ave As As 
Sample No. Sample ID GI Phase Rep No. mg/L As (mg/L) mg mg mg/kg 
2415 C5 I 1 3.059 3.120 1.872 1.841 468.027 
2416 C5 I 2 3.022 3.082 1.849 462.366 
2417 C5 I 3 2.944 3.003 1.802 450.432 
2418 SI s 1 0.728 0.742 0.445 0.434 111.369 
2419 SI s 2 0.658 0.671 0.403 100.643 
2420 SI s 3 0.742 0.757 0.454 113.541 
2421 Sl I 1 0.647 0.660 0.396 0.364 99.022 
2422 SI I 2 0.570 0.581 0.349 87.149 
2423 SI I 3 0.568 0.580 0.348 86.935 
2424 S2 s 1 1.106 1.128 0.677 0.695 169.218 
2425 S2 s 2 1.046 1.067 0.640 160.038 
2426 S2 s 3 1.255 · 1.280 0.768 192.015 
2427 S2 I 1 0.843 0.860 0.516 0.607 129.010 
2428 S2 I 2 1.059 1.080 0.648 162.027 
2429 S2 I 3 1.071 1.092 0.655 163.863 
2430 S3 s 1 2.611 2.663 1.598 1.469 399.483 
2431 S3 s 2 2.184 2.228 1.337 334.152 
2432 S3 s 3 2.404 2.452 1.471 367.812 
2433 S3 I 1 2.550 2.601 1.561 1.349 390.150 
2434 S3 I 2 2.005 2.045 1.227 306.765 
2435 S3 I 3 2.060 2.101 1.261 315.180 
2436 S4 s 1 10.250 10.455 6.273 5.146 1568.250 
2437 S4 s 2 7.465 7.614 4.569 1142.145 
2438 S4 s 3 7.512 7.662 4.597 1149.336 
2439 S4 I 1 9.628 9.821 5.892 4.789 1473.084 
2440 S4 I 2 6.987 7.127 4.276 1069.011 
2441 S4 I 3 6.859 6.996 4.198 1049.427 
Ave As 
mg/kg Std Dev 
460.28 8.98 
108.52 6.91 
91.04 6.92 
173.76 16.46 
151.63 19.61 
367.15 32.67 
337.37 45.91 
1286.58 243.96 
1197.17 239.15 
Bioavailable As 
(%) std dev average 
7.49 0.14 7.37 
7.40 
7.21 
27.50 1.71 26.79 
24.85 
28.03 
24.45 1.71 22.48 
21.52 
21.47 
37.60 3.66 38.61 
35.56 
42.67 
28.67 4.36 33.70 
36.01 
36.41 
33.85 2.77 31.11 
28.32 
31.17 
33.06 3.89 28.59 
26.00 
26.71 
31.23 4.86 25.62 
22.74 
22.89 
29.33 4.76 23.84 
21.29 
20.90 
3050 As 
mg/kg 
405 
450 
1180 
' 
5022 
\0 
~ 
Table I - 3 
In-Vitro Gastrointestinal Method (IVG) 
As Corrected As Ave As As 
Sample No. Sample ID GI Phase Rep No. mg/L As (mg/L) mg mg mg/kg 
2442 S5 s 1 6.705 6.839 4.103 3.312 1025.865 
2443 S5 s 2 4.753 4.848 2.909 727.209 
2444 S5 s 3 4.777 4.873 2.924 730.881 
2445 S5 I 1 6.390 6.518 3.911 2.901 977.670 
2446 S5 I 2 3.509 3.579 2.148 536.877 
2447 S5 I 3 4.323 4.409 2.646 661.419 
2448 El s 1 0.232 0.236 0.142 0.126 35.450 
2449 El s 2 . 0.182 0.185 0.111 27.815 
2450 El s 3 0.206 0.210 0.126 31.533 
2451 El I I 0.203 0.207 0.124 0.113 31.044 
2452 El I 2 . 0.173 0.177 0.106 26.530 
2453 El I 3 0.180 0.183 0.110 27.479 
2454 E2 s I 0.636 0.649 0.389 0.329 97.277 
2455 E2 s 2 0.464 0.474 0.284 71.053 
2456 E2 s 3 0.511 0.521 0.312 78.107 
2457 E2 I I 0.473 0.482 0.289 0.255 72.354 
2458 E2 I 2 0.393 0.401 0.241 60.190 
2459 E2 I 3 0.385 0.392 0.235 58.829 
2460 E3 s I 1.693 1.727 1.036 1.040 259.029 
2461 E3 s 2 1.7 1.734 1.040 260.100 
2462 E3 s 3 1.706 1.740 1.044 261.018 
2463 E3 I I 1.453 1.482 0.889 0.906 222.309 
2464 E3 I 2 1.459 1.488 0.893 223.227 
2465 E3 I 3 1.527 1.558 0.935 233.631 
2466 E4 s I . 0.839 0.856 0.513 0.499 128.367 
2467 E4 s 2 0.7961 0.812 0.487 121.803 
2468 E4 s 3 0.8086 0.825 0.495 123.716 
Ave As 
mg/kg Std Dev 
827.99 171.38 
725.32 227.24 
31.60 3.82 
28.35 2.38 
82.15 13.57 
63.79 7.45 
260.05 1.00 
226.39 6.29 
124.63 3.38 
Bioavailable As 
(%) std dev average 
22.06 3.69 17.81 
15.64 
15.72 
21.03 4.89 15.60 
11.55 
14.22 
10.71 1.15 9.55 
8.40 
9.53 
9.38 0.72 8.57 
8.02 
8.30 
41.75 5.82 35.26 
30.49 
33.52 
31.05 3.20 27.38 
25.83 
25.25 
32.38 0.12 32.51 
32.51 
32.63 
27.79 0.79 28.30 
27.90 
29.20 
8.77 0.23 8.52 
8.33 
8.46 
3050 As 
mg/kg 
4650 
331 
233 
800 
1463 
'° Vl 
Table I - 3 
In-Vitro Gastrointestinal Method (IVG) 
As Corrected As AveAs · As 
Sample No. Sample ID GI Phase Rep No. mg/L As (mg/L) mg mg mg/kg 
2469 E4 I I 0.6786 0.692 0.415 0.430 103.826 
2470 E4 I 2 0.6974 0.711 0.427 106.702 
2471 E4 I 3 0.7295 0.744 0.446 111.614 
2472 E5 s 1 1.099 1.121 0.673 0.615 168.147 
2473 E5 s 2 0.9797 0.999 0.600 149.894 
2474 E5 s 3 0.9363 0.955 0.573 143.254 
2475 E5 I 1 0.9972 1.017 0.610 0.575 152.572 
2476 E5 I 2 0.912 0.930 0.558 139.536 
2477 E5 I 3 0.9072 0.925 0.555 138.802 
Ave As 
mg/kg Std Dev 
107.38 3.94 
153.77 12.89 
143.64 7.75 
Bioavailable As 
(%) std dev average 
7.10 0.27 7.34 
7.29 
7.63 
41.93 3.21 38.35 
37.38 
35.72 
38.05 1.93 35.82 
34.80 
34.61 
3050 As 
mg/kg 
401 
'° O'I 
Table I - 4 
In-Vitro Gastrointestinal Method with FeOx Adsorption (IVG-AB) 
Sample Sample As Corrected As Ave As As Ave As Std Bioavailable As 3050 As 
No. ID GI Phase Rep No. mg/L As (mg/L) mg mg mg/kg mg/kg Dev (%) std dev averae;e m!!lke: 
2908 Cl s 1 1.369 1.396 0.838 0.738 209.457 177.43 23.35 1.85 0.21 L57 11294 
2909 Cl s 2 1.067 1.088 0.653 163.251 1.45 
-2910 Cl s 3 1.180 1.204 0.722 180.540 1.60 
2911 Cl I 1 1.232 1.257 0.754 0.644 188.496 161.08 23.87 1.67 0.21 1.43 
2912 . Cl I 2 0.979 0.999 0.599 149.833 1.33 
2913 Cl I 3 0.947 0.966 0.580 144.906 1.28 
2999 Cl FeOx I 0.3164 0.316 0.063 0.038 204.316 170.48 30.30 1.81 0.27 1.51 
3000 Cl FeOx 2 0.2284 0.228 0.046 161.253 1.43 
3001 Cl FeOx 3 0.01902 0.019 0.004 145.857 1.29 
2914 C2 s 1 1.403 1.431 0.859 0.799 214.659 199.67 13.31 1.23 0.08 1.14 17456 
2915 C2 s 2 1.237 1.262 0.757 189.261 1.08 
2916 C2 s 3 1.275 1.301 0.780 195.075 1.12 
2917 C2 I 1 1.394 1.422 0.853 0.761 213.282 190.13 20.24 1.22 0.12 1.09 
2918 C2 I 2 1.185 1.209 0.725 181.305; 1.04 
2919 C2 I 3 1.149 1.172 0.703 175.797 1.01 
3002 C2 FeOx 1 0.03951 0.040 0.008 0.008 215.258 192.18 20.17 1.23 0.12 1.10 
3003 C2 FeOx 2 0.04133 0.041 0.008 183.372 1.05 
3004 C2 FeOx 3 0.042 0.042 0.008 177.913 1.02 
2920 C3 s 1 2.347 2.394 1.436 1.351 359.091 337.67 18.56 2.67 0.14 2.51 13472 
2921 C3 s 2 2.134 2.177 1.306 326.502 2.42 
2922 C3 s 3 2.140 2.183 1.310 327.420 2.43 
2923 C3 I 1 2.024 2.064 1.239 1.180 309.672 294.88 13.94 2.30 0.10 2.19 
2924 C3 I 2 1.843 1.880 1.128 281.979 2.09 
2925 C3 I 3 1.915 1.953 1.172 292.995 2.17 
3005 C3 FeOx 1 0.058 0.058 0.012 0.011 312.578 297.71 13.92 2.32 0.10 2.21 
3006. C3 FeOx 2 0.060 0.060 0.012 284.992 2.12 
3007 C3 FeOx 3 0.052 0.052 0.010 295.572 2.19 
2926 C4 s 1 5.652 5.765 3.459 3.215 864.756 803.66 53.06 7.50 0.46 6.97 11525 
2927 C4 s 2 5.027 5.128 3.077 769.131 6.67 
2928 C4 s 3 5.079 5.181 3.108 777.087 6.74 ,.. 
......:i 
Sample Sample 
No. ID GI Phase Rep No. 
2929 C4 l 1 
2930 C4 I 2 
2931 C4 I 3 
3008 C4 FeOx I 
3009 C4 FeOx 2 
3010 C4 FeOx 3 
2932 cs s I 
2933 cs s 2 
2934 cs s 3 
2935 cs I I 
2936 cs I 2 
2937 cs I 3 
3011 cs FeOx I 
3012 cs FeOx 2 
3013 cs FeOx 3 
2938 SI s I 
2939 SI s 2 
2940 SI s 3 
2941 SI I I 
2942 SI I 2 
2943 SI I 3 
3014 SI FeOx I 
3015 SI FeOx 2 
3016 SI FeOx 3 
2944 S2 s I 
2945 S2 s 2 
2946 S2 s 3 
2947 S2 I I 
2948 S2 I 2 
2949 S2 I 3 
Table I -4 
In-Vitro Gastrointestinal Method with FeOx Adsorption (IVG-AB) 
As •Corrected As Ave As As Ave As Std 
mg/L As (mg/L) mg mg mg/kg mg/kg Dev 
5.221 5.325 3.195 3.099 798.813 774.84 44.73 
5.245 5.350 3.210 802.485 
4.727 4.822 2.893 723.231 
0.168 0.168 0.034 0.034 807.213 783.40 46.22 
0.207 0.207 0.041 812.855 
0.138 0.138 0.028 730.121 
3.732 3.807 2.284 2.189 570.996 547.13 21.21 
3.467 3.536 2.122 530.451 
3.529 3.600 2.160 539.937 
3.496 3.566 2.140 2.009 534.888 502.15 30.53 
3.101 3.163 l.898 474.453 
3.249 3.314 1.988 497.097 
0.200 0.200 0.040 0.051 544.878 514.89 26.15 
0.448 0.448 0.090 496.848 
0.117 0.117 0.023 502.952 
0.858 0.875 0.525 0.487 131.320 121.79 8.35 
0.773 0.789 0.473 118.284 
0.757 0.772 0.463 115.775 
0.718 0.732 0.439 0.413 109.793 103.36 8.21 
0.615 0.627 0.376 94.110 
0.694 0.708 0.425 106.167 
0.045 0.045 0.009 0.008 112.053 105.42 8.22 
0.042 0.042 0.008 96.225 
0.037 0.037 0.007 107.994 
1.218 1.242 0.745 0.770 186.354 192.40 7.11 
1.298 1.324 · 0.794 198.594 
1.217 1.241 0.745 186.201 
1.137 1.160 0.696 0.693 173.961 173.25 9.66 
1.067 1.088 0.653 163.251 
1.193 1.217 0.730 182.529 
Bioavailable As 
(%) std dev average 
6.93 0.39 6.72 
6.96 
6.28 
7.00 0.40 6.80 
7.05 
6.34 
9.14 0.34 8.76 
8.49 
8.65 
8.57 0.49 8.04 
7.60 
7.96 
8.73 0.42 8.24 
7.96 
8.05 
32.42 2.06 30.07 
29.21 
28.59 
27.11 2.03 25.52 
23.24 
26.21 
27.67 2.03 26.03 
23.76 
26.67 
41.41 1.58 42.76 
44.13 
41.38 
38.66 2.15 38.50 
36~28 
40.56 
· 3050 As 
nu!lkl! 
6245 
405 
450 
\0 
00 
Table I - 4 
In-Vitro Gastrointestinal Method with FeOx Adsorption (IVG-AB) 
Sample Sample As Corrected As Ave As As Ave As Std Bioavailable As 3050 As 
No. ID GI Phase Rep No. mg/L As (mg/L) mg mg m!!/lrn: mg/kg Dev (%) std dev average mg/kg 
3017 S2 FeOx 1 0.103 0.103 0.021 0.018 179.091 177.86 9.88 39.80 2.19 39.52 
3018 S2 FeOx 2 0.083 0.083 0.017 167.420 37.20 
3019 S2 FeOx 3 0.091 0.091 0.018 187.056 41.57 
2950 S3 s 1 2.396 2.444 1.466 1.586 366.588 396.53 68.23 31.07 5.78 33.60 1180 
2951 S3 s 2 2.277 2.323 1.394 348.381 29.52 
2952 S3 s 3 3.102 3.164 1.898 474.606 40.22 
2953 S3 I 1 2.105 2.147 1.288 1.303 322.065 325.69 11.53 27.29 0.98 27.60 
2954 S3 I 2 2.213 2.257 1.354 338.589 28.69 
2955 S3 I 3 2.068 2.109 1.266 316.404 26.81 
3020 S3 FeOx 1 0.179 0.179 0.036 0.028 331.010 332.62 9.72 28.05 0.82 28.19 
3021 S3 FeOx 2 0.089 0.089 0.018 343.045 29.07 
3022 S3 FeOx 3 0.148 0.148 0.030 323.809 27.44 
2956 S4 s 1 10.050 10.251 6.151 5.448 1537.650 1362.11 155.10 30.62 3.09 27.12 5022 
2957 S4 s 2 8.128 8.291 4.974 1243.584 24.76 
2958 S4 s 3 8.53 8.701 5.220 1305.090 25.99 
2959 S4 I 1 9.189 9.373 5.624 4.856 1405.917 1213.90 167.29 28.00 3.33 24.17 
2960 S4 I 2 7.187 7.331 4.398 1099.611 21.90 
2961 S4 I 3 7.426 7.575 4.545 1136.178 22.62 
3023 S4 FeOx 1 0.450 0,450 0.090 0.076 1428.412 1232.85 170.27 28.44 3.39 24.55 
3024 S4 FeOx 2 0.358 0.358 0.072 1117.501 22.25 
3025 S4 FeOx 3 0.329 0.329 0.066 1152.638 22.95 
2962 S5 s 1 6.318 6.444 3.867 3.568 966.654 891.94 66.17 20.79 1.42 19.18 4650 
2963 S5 s 2 5.676 5.790 3.474 868.428 18.68 
2964 S5 s 3 5.495 5.605 3.363 840.735 18.08 
2965 S5 I 1 5.531 5.642 3.385 3.172 846.243 793.08 75.19 18.20 9.91 17.06 
2966 S5 I 2 0.000 0.000 0.000 0.00 
2967 S5 I 3 4.836 4.933 2.960 739.908 15.91 
3026 S5 FeOx 1 0.331 0.331 0.066 #VALUE! 862.778 809.83 74.88 18.55 1.61 17.42 
3027 S5 FeOx 2 no daata #VALUE! #VALUE! #VALUE! #VALUE! 
3028 S5 FeOx 3 0.340 0.340 0.068 756.883 16.28 
-
'° 
Table I - 4 
In-Vitro Gastrointestinal Method with FeOx Adsorption (IVG-AB) 
Sample Sample As Corrected As Ave As As Ave As Std Bioavailable As 3050 As 
No. ID GI Phase Rep No. mg/L As (mg/L) mg mg mg/kg mg/kg Dev (%) std dev average mg/kg 
2968 El s 1 0.197 0.201 0.121 0.119 30.126 29.84 1.75 9.10 0.53 9.02 331 
2969 El s 2 0.183 0.186 0.112 27.968 8.45 
2970 El s 3 0.205 0.210 0.126 31.426 9.49 
2971 El I 1 0.245 0.249 0.150 0.154 37.409 38.41 9.35 11.30 2.82 11.61 
2972 El I 2 0.315 0.322 0.193 48.226 14.57 
2973 El I 3 0.194 0.197 0.118 29.606 8.94 
3029 El FeOx 1 0.134 0.134 0.027 0.015 44.114 42.22 8.44 13.33 2.55 12.75 
3030 El FeOx 2 0.026 0.026 0.005 49.547 14.97 
3031 El FeOx 3 0.068 0.068 0.014 32.993 9.97 
2974 E2 s 1 -1-:-049 +,Q+O 0.642 0.400 no use 69.79 1.96 #VALUE! 0.84 29.95 233 
2975 E2 s 2 0.447 0.456 0.274 68.406 29.36 
2976 E2 s 3 0.465 0.475 0.285 71.176 30.55 
2977 E2 I 1 0.455 0.464 0.278 0.253 69.584 63.15 5.62 29.86 2.41 27.10 
2978 E2 I 2 0.397 0.405 0.243 60.680 26.04 
2979 E2 I 3 0.387 0.395 0.237 59.180 25.40 
3032 E2 FeOx 1 0.062 0.062 0.012 0.006 72.664 64.76 6.89 31.19 2.96 27.79 
3033 E2 FeOx 2 0.019 0.019 0.004 61.626 26.45 
3034 E2 FeOx 3 0.016 0.016 0.003 59.997 25.75 
2980 E3 s 1 2.071 2.112 1.267 1.188 316.863 296.92 17.70 39.61 2.21 37.12 800 
2981 E3 s 2 1.901 1.939 1.163 290.853 36.36 
2982 E3 s 3 1.85 1.887 1.132 283.050 35.38 
2983 E3 I 1 1.898 1.936 1.162 1.030 290.394 257.50 28.49 36.30 3.56 32.19 
2984 E3 I 2 1.578 1.610 0.966 241.434 30.18 
2985 E3 I 3 1.573 1.604 0.963 240.669 30.08 
3035 E3 FeOx 1 0.149 0.149 0.030 0.025 297.819 263.78 29.61 37.23 3.70 32.97 
3036 . E3 FeOx 2 0.050 0.050 0.010 243.937 30.49 
3037 E3 FeOx 3 0.179 0.179 0.036 249.594 31.20 
2986 E4 s 1 0.8469 0.864 0.518 0.635 129.576 127.65 2.73 8.86 0.19 8.73 1463 
2987 E4 s 2 1.446 1.475 0.885 no use #VALUE! 
2988 E4 s 3 0.8217 0.838 0.503 125.720 8.59 
-0 0 
Table I - 4 
In-Vitro Gastrointestinal Method with FeOx Adsorption (IVG-AB) 
Sample Sample As Corrected As Ave As As Ave As Std Bioavailable As 3050 As 
No. ID GI Phase Rep No. mg/L As (mg/L) mg mg mwkg mg/kg Dev (%) std dev average m_g/kg 
2989 E4 I 1 0.6989 0.713 0.428 0.454 106.932 113.55 5.73 7.31 0.39 7.76 
2990 E4 I 2 0.7628 0.778 0.467 116.708 7.98 
2991 E4 I 3 0.7647 0.780 0.468 116.999 8.00 
3038 E4 FeOx 1 0.336 0.336 0.067 0.033 123.717 121.84 1.64 8.46 0.11 8.33 
3039 E4 FeOx 2 0.089 0.089 0.018 121.158 8.28 
3040 E4 FeOx 3 0.073 0.073 0.015 120.658 8.25 
2992 E5 s 1 1.108 1.130 0.678 0.634 169.524 158.47 9.61 42.28 2.40 39.52 401 
2993 E5 s 2 0.9942 1.014 0.608 152.113 37.93 
2994 E5 s 3 1.005 1.025 0.615 153.765 38.35 
2995 E5 I 1 0.000 0.000 0.529 no data 132.35 8.07 #VALUE! 2.01 33.00 
2996 E5 I 2 0.9023 0.920 0.552 138.052 34.43 
2997 E5 I 3 0.8277 0.844 0.507 126.638 31.58 
3041 E5 FeOx 1 0.067 0.067 0.013 0.014 no data 135.97 6.72 #VALUE! 1.68 33.91 
3042 E5 FeOx 2 0.053 0.053 0.011 140.722 35.09 
3043 E5 FeOx 3 0.092 0.092 0.018 131.221 32.72 
...... 
0 
...... 
Sample 
ID Rep 
Cl 1 
Cl 2 
Cl 3 
Cl 4 
Cl 5 
C2 1 
C2 2 
C2 3 
C2 4 
C2 5 
C3 1 
C3 2 
C3 3 
C3 4 
C3 5 
C4 1 
C4 2 
C4 3 
C4 4 
C4 5 
cs 1 
cs 2 
cs 3 
cs 4 
cs 5 
Table I - 5 
Arsenic Bioavailability by Experimental Method; Summary Statistics 
GI-IV GI-IV-AB PBET 
Stomach As (%) Intestine As (%) Stomach As(%) Intestine As (%) Stomach As(%) Intestine As (%) 
1.75 1.26 1.85 1.81 0.78 0.90 
1.43 1.26 1.45 1.43 0.57 0.80 
1.56 1.21 1.60 1.29 0.68 0.96 
". ". ". . .. ". . " 
. " ". ". . .. ... ... 
0.96 0.98 1.23 1.23 0.69 0.74 
0.99 0.94 1.08 1.05 0.43 1.19 
0.98 1.01 1.12 1.02 0.41 0.53 
... ... ... . .. . .. .. . 
... ... . .. . .. ... . " 
2.29 2.16 2.67 2.32 1.23 1.35 
2.12 2.36 2.42 2.12 0.90 1.20 
2.20 2.16 2.43 2.19 0.69 1.13 
... ... . .. . .. . .. .. . 
... ... ... ". . .. . .. 
5.95 5.89 7.50 7.00 1.90 2.03 
6.02 5.84 6.67 7.05 1.74 2.00 
5.94 5.57 6.74 6.34 1.94 2.01 
... ". ... ... ". .. . 
". ". ". ... ". . " 
7.64 7.49 9.14 8.73 3.35 3.00 
7.48 7.40 8.49 7.96 2.15 2.19 
7.55 7.21 8.65 8.05 4.16 2.05 
... ". ... ... ". " . 
". ". 
... 
"' ". ". 
In-Vivo 
individual(%) 
0.60 
5.51 
3.13 
1.64 
2.68 
4.62 
3.72 
3.87 
-0.15 
4.47 
10.43 
10.28 
7.00 
5.96 
8.04 
19.36 
19.36 
26.81 
23.83 
20.85 
38.73 
38.73 
23.83 
23.83 
29.79 
..... 
0 
N 
Table I- 5 
Arsenic Bioavailability by Experimental Method; Summary Statistics 
Sample GI-IV GI-IV-AB PBET In-Vivo 
ID Rep Stomach As (%) Intestine As(%) Stomach As (%) Intestine As(%) Stomach As (%) Intestine As(%) individual(%) 
SI 1 27.50 24.45 32.42 27.67 42.59 16.58 ... 
SI 2 24.85 21.52 29.21 23.76 35.13 21.00 ... 
SI 3 28.03 21.47 28.59 26.67 40.60 6.98 ... 
SI 4 ... . .. . .. . .. ... . .. . .. 
SI 5 ... . .. . .. ... . .. . .. . .. 
S2 1 37.60 28.67 41.41 39.80 42.57 15.01 ... 
S2 2 35.56 36.01 44.13 37.20 36.52 15.01 ... 
S2 3 42.67 36.41 41.38 41.57 52.63 21.02 ... 
S2 4 ... . .. . .. ... ... . .. . .. 
S2 5 ... . .. . .. . .. ... . .. . .. 
S3 1 33.85 33.06 31.07 28.05 4.03 16.77 29.79 
S3 2 28.32 26.00 29.52 29.07 24.00 16.48 36.42 
S3 3 31.17 26.71 40.22 27.44 19.54 16.34 16.24 
S3 4 ... . .. . .. . .. . .. . .. 15.49 
S3 5 ... . .. . .. . .. ... . .. 45.58 
S4 1 31.23 29.33 30.62 28.44 17.21 11.30 38.73 
S4 2 22.74 21.29 24.76 22.25 9.61 8.09 38.73 
S4 3 22.89 20.90 25.99 22.95 15.29 11.19 23.83 
S4 4 ... . .. . .. . .. . .. . .. 23.83 
S4 5 ... . .. ... . .. . .. . .. 29.79 
S5 1 22.06 21.03 20.79 18.55 12.28 9.54 22.05 
S5 2 15.64 11.55 18.68 ... 10.54 9.09 12.81 
S5 3 15.72 14.22 18.08 16.28 12.27 9.12 16.68 
S5 4 ... . .. . .. . .. . .. . .. 14.75 
S5 5 ... . .. . .. . .. ... . .. 15.94 
-0 w 
Table I - 5 
Arsenic Bioavailability by Experimental Method; Summary Statistics 
Sample GI-IV GI-IV-AB PBET In-Vivo 
ID Rep Stomach As(%) Intestine As (%) Stomach As(%) Intestine As (%) Stomach As(%) Intestine As(%) individual (%) 
El 1 10.71 9.38 9.10 13.33 4.17 5.53 12.96 
El 2 8.40 8.02 8.45 14.97 5.31 12.10 6.26 
El 3 9.53 8.30 9.49 9.97 5.82 5.06 1.12 
El 4 ... . .. . .. . .. . .. . .. 4.36 
El 5 ... . .. . .. . .. . .. . .. 6.13 
E2 1 41.75 31.05 ... 31.19 21.71 14.70 55.64 
E2 2 30.49 25.83 29.36 26.45 16.66 27.82 37.09 
E2 3 33.52 25.25 30.55 25.75 21.91 17.16 45.13 
E2 4 ... ... . .. ... . .. . .. 33.31 
E2 5 ... . .. . .. . .. . .. . .. . .. 
E3 1 32.38 27.79 39.61 37.23 24.57 10.66 29.05 
E3 2 32.51 27.90 36.36 30.49 26.62 8.45 34.19 
E3 3 32.63 29.20 35.38 31.20 29.16 11.12 25.47 
E3 4 ... . .. . .. . .. . .. . .. 33.52 
E3 5 ... . .. . .. . .. . .. . .. 23.46 
E4 1 8.77 7.10 8.86 8.46 16.56 8.98 15.64 
E4 2 8.33 7.29 ... 8.28 11.61 7.89 18.77 
E4 3 8.46 7.63 8.59 8.25 17.30 8.86 16.53 
E4 4 ... ... . .. . .. . .. . .. 23.68 
E4 5 ... . .. ... . .. . .. ... . .. 
E5 1 41.93 38.05 42.28 ... 34.72 19.40 36.64 
E5 2 37.38 34.80 37.93 35.09 32.61 20.11 32.62 
E5 3 35.72 34.61 38.35 32.72 44.97 14.33 37.98 
E5 4 ... ... . .. . .. . .. . .. 37.54 
E5 5 ... ... . .. . .. . .. . .. 37.54 
...... 
~ 
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Table II - I 
Feeding Trial I: Soils C4 and S4 
Dav-I Dav3 
Sample ID Pig No. As, ug/L Urine Vol, ml As, ug As, ug/L Urine Vol, ml 
CT-OSUI 221 5.091 1500 7.637 6.429 1380 
CT-OSUI 230 5.95 860 5.117 2.836 2140 
CT-OSUI 243 11.19 720 8.057 10.104 1140 
Rl-OSUI 222 4.866 2360 11.484 38.565 1040 
Rl-OSUI 227 5.521 1160 6.404 12.338 3220 
Rl-OSUI 235 5.871 820 4.814 28.397 1140 
Rl-OSUI 249 6.647 840 5.583 18.442 1900 
Rl-OSUI 251 6.543 · 1460 9.553 34.794 820 
R2-0SUI 216 14.95 680 10.166 84.383 900 
R2-0SUI 218 4.017 2460 9.882 34.643 3020 
R2-0SUI 225 8.925 1020 9.104 59.566 1540 
R2-0SUI 235 5.247 1260 6.611 96.275 1080 
R2-0SUI 240 15.59 760 11.848 244.409 1080 
R3-0SUI 205 8.728 1460 12.743 135.983 1380 
R3-0SUI 208 8.197 1200 9.836 153.783 1980 
R3-0SUI 215 16.05 760 12.198 81.068 3580 
R3-0SUI 224 15.62 1460 22.805 585.417 1560 
R3-0SUI 252 9.059 1200 10.871 173.946 1800 
Cl-OSUI 201 6.106 740 4.518 18.443 1420 
Cl-OSUI 206 7.337 680 4.989 17.621 1320 
Cl-OSUI 217 6.668 1560 10.402 42.91 600 
Cl-OSUI 223 9.813 980 9.617 8.126 2560 
Cl-OSUI 238 14.4 640 9.216 105.752 500 
C2-0SUI 214 14.33 750 10.748 139.762 520 
C2-0SUI 233 15.88 480 7.622 61.879 820 
C2-0SUI 241 14.25 700 9.975 54.224 880 
C2-0SUI 246 8.262 800 6.610 32.062 1560 
C2-0SUI 248 3.133 3020 9.462 34.124 1800 
As, ug As, ug/L 
8.872 12.061 
6.069 6.545 
11.519 10.688 
40.108 42.619 
39.728 13.698 
32.373 33.265 
35.040 16.125 
28.531 31.511 
75.945 76.892 
104.622 52.743 
91.732 77.551 
103.977 137.907 
263.962 111.746 
187.657 202.313 
304.490 288.957 
290.223 214.822 
913.251 629.925 
313.103 202.713 
26.189 42.607 
23.260 28.208 
25.746 33.326 
20.803 3.591 
52.876 4.909 
72.676 50.451 
50.741 52.931 
47.717 100.274 
50.017 64.015 
61.423 29.816 
Day7 
Urine Vol, ml 
1100 
2500 
1220 
1200 
3760 
1400 
2850 
1380 
1400 
2440 
1300 
920 
1120 
1750 
1200 
1600 
740 
1800 
1240 
1500 
880 
7740 
** 
1240 
1220 
860 
1350 
2680 
As, ug 
13.267 
16.363 
13.039 
51.143 
51.504 
46.571 
45.956 
43.485 
107.649 
128.693 
100.816 
126.874 
125.156 
354.048 
346.748 
343.715 
466.145 
364.883 
52.833 
42.312 
29.327 
27.794 
62.559 
64.576 
86.236 
86.420 
79.907 
...... 
0 
0\ 
Table II - 1 
Feeding Trial 1: Soils C4 and S4 
Dav-I 
Sample ID Pig No. As, ug/L Urine Vol, ml As, ug 
C3-0SUI 202 7.885 1200 9.462 
C3-0SUI 203 11.65 800 9.320 
C3-0SUI 229 9.05 820 7.421 
C3-0SUI 231 2.433 3900 9.489 
C3-0SUI 250 3.49 · 2440 8.516 
Sl-OSUI 204 3.044 2260 6.879 
SI-OSUl 228 20.68 460 9.513 
SI-OSUI 237 11.92 780 9.298 
Sl-OSUI 239 12.91 1020 13.168 
SI-OSUI 253 17.92 760 13.619 
S2-0SUI 207 19.9 720 14.328 
S2-0SUI 212 6.609 1720 11.367 
S2-0SUI 213 11.23 740 8.310 
S2-0SUI 220 22.31 380 8.478 
S2-0SUI 244 8.575 940 8.061 
S3-0SUI 211 19.74 420 8.291 
S3-0SUI 219 10.9 1240 13.516 
S3-0SUI 232 1.504 4000 6.016 
S3-0SUI 234 0.657 10980 7.214 
S3-0SUI 242 2.528 2520 6.371 
**Pig 238 had waterer leak. Leak ran into pig 223's pen. 
3 buckets: 10,000 = light 
11500 = clear 
5640 = medium 
took sample from medium bucket 
Dav3 
As, uwL Urine Vol, ml 
78.478 1140 
80.447 1020 
94.201 680 
37.929 1940 
nosamo 3380 
22.788 1180 
31.137 1060 
68.156 1040 
29.533 1260 
3.757 4460 
86.473 1260 
48.255 1700 
71.028 980 
78.733 680 
85.53 1000 
170.095 640 
52.025 2800 
99.239 1940 
23.84 6260 
14.434 4940 
As, ug As, ug/L 
89.465 137.516 
82.056 170.733 
64.057 145.041 
73.582 98.499 
46.927 
26.890 37.679 
33.005 72.345 
70.882 60.013 
37.212 42.762 
16.756 16.883 
108.956 71.435 
82.034 88.989 
69.607 44.836 
53.538 112.912 
85.530 123.615 
108.861 85.548 
145.670 91.347 
192.524 88.901 
149.238 20.059 
71.304 18.115 
Day7 
Urine Vol, ml 
1100 
1040 
900 
1680 
3020 
1400 
640 
1260 
1080 
3760 
1600 
1560 
1320 
860 
1020 
1280 
4600 
2540 
5680 
6600 
As, ug 
151.268 
177.562 
130.537 
165.478 
141.720 
52.751 
46.301 
75.616 
46.183 
63.480 
114.296 
138.823 
59.184 
97.104 
126.087 
109.501 
420.196 
225.809 
113.935 
119.559 
...... 
0 
....J 
Sample ID Pig No. As, ug/L 
CT-OSUl 221 5.962 
CT-OSUl 230 22.14 
CT-OSUl 243 6.596 
Rl-OSUl 222 44.1 
Rl-OSUl 227 15.488 
Rl-OSUl 235 24.165 
Rl-OSUl 249 4.539 
Rl-OSUl 251 27.654 
R2-0SU1 216 70.531 
R2-0SU1 218 46.582 
R2-0SU1 225 122.578 
R2-0SU1 235 198.452 
R2-0SU1 240 102.74 
R3-0SU1 205 326.355 
R3-0SU1 208 112.586 
R3-0SU1 215 98.962 
R3-0SU1 224 261.326 
R3-0SU1 252 424.316 
Cl-OSUl 201 24.895 
Cl-OSUl 206 34.389 
Cl-OSUl 217 63.57 
Cl-OSUl 223 9.812 
Cl-OSUl 238 14.921 
C2-0SU1 214 100.966 
C2-0SU1 233 47.288 
C2-0SU1 241 115.292 
C2-0SU1 246 75.981 
C2-0SU1 248 34.54 
Table II - 1 
Feeding Trial 1: Soils C4 and S4 
Dav 11 Day 15 
Urine Vol, ml As, ug As, ug/L Urine Vol, ml 
2820 16.813 6.712 3240 
2040 45.166 7.281 2820 
700 4.617 13.967 1420 
1280 56.448 32.94 1520 
4820 74.652 15.492 5400 
2600 62.829 59.246 1100 
11000 49.929 17.483 4480 
1740 48.118 51.507 2580 
1500 105.797 23.592 4500 
2480 115.523 19.38 3780 
1180 144.642 40.582 1340 
850 168.684 130.95 1200 
1330 136.644 152.359 1680 
1240 404.680 262.199 2220 
3100 349.017 120.086 3620 
2880 285.011 39.578 12260 
740 193.381 317.732 1820 
1240 526.152 300.397 1440 
1320 32.861 146.119 1060 
1400 48.145 24.975 2620 
580 36.871 77.302 960 
3820 37.482 6.919 6700 
1920 28.648 23.499 2880 
750 75.725 67.078 1700 
1460 69.040 98.88 1160 
880 101.457 175.884 820 
1160 88.138 85.874 1400 
2260 78.060 34.671 3300 
As, ug 
21.747 
20.532 
19.833 
50.069 
83.657 
65.171 
78.324 
132.888 
106.164 
73.256 
54.380 
157.140 
255.963 
582.082 
434.711 
485.226 
578.272 
432.572 
154.886 
65.435 
74.210 
46.357 
67.677 
114.033 
114.701 
144.225 
120.224 
114.414 
..... 
0 
00 
SamoleID Pie:No. 
C3-0SU1 202 
C3-0SU1 203 
C3-0SU1 229 
C3-0SU1 · 231 
C3-0SU1 250 
Sl-OSUl 204 
Sl-OSUl 228 
S1-0SU1 237 
Sl-OSUl 239 
Sl-OSUl 253 
S2-0SU1 207 
S2-0SU1 212 
S2-0SU1 213 
S2-0SU1 220 
S2-0SU1 244 
S3-0SU1 211 
S3-0SU1 219 
S3-0SU1 232 
S3-0SU1 234 
S3-0SU1 242 
**Pig 238 had watere 
3 buckets: 10,000 = li 
11500 = 
5640 = 
took sample from med 
As, ue:/L 
172.032 
131.478 
155.64 
59.642 
24.994 
43.435 
150.903 
86.903 
57.81 
30.552 
79.24 
50.7 
64.193 
109.664 
152.487 
28.463 
68.33 
46.353 
71.871 
106.495 
Table II - 1 
Feeding Trial I: Soils C4 and S4 
Davll Dayl5 
Urine Vol, ml As, ue: As, ue:/L Urine Vol, ml As,ug 
900 154.829 394.798 660 260.567 
1400 184.069 131 2000 262.000 
1020 158.753 96.599 1640 158.422 
2200 131.212 73.985 2720 201.239 
4980 · 124.470 64.277 3000 192.831 
1980 86.001 44.488 2200 97.874 
650 98.087 83.299 860 71.637 
960 83.427 20.897 4060 84.842 
1360 78.622 84.907 1020 86.605 
2840 86.768 36.79 2580 94.918 
1940 153.726 96.961 1940 188.104 
2760 139.932 177.481 1100 195.229 
1660 106.560 108.015 1500 162.023 
840 92.118 140.193 860 120.566 
880 134.189 67.487 1640 110.679 
2540 72.296 53.723 1740 93.478 
3600 245.988 77.118 4780 368.624 
2960 137.205 108.812 3100 337.317 
4720 339.231 38.74 6780 262.657 
2320 247.068 86.62 3100 268.522 
-0 
'° 
Table II - 2 
Feeding Trial 1: Soils C4 and S4 
Kidney Digests (Second Set) 
Sample Date 3/24/97 and 3/26/97 Analysis Date 8/12/97 and 8/14/97 
UMC Sample Description As 
OSU Sample No. Sample ID Pig No. Day No. Tissue ug/1 
1953 CT 221 16 K 1.125 
1954 CT 230 16 K 1.156 
1955 CT 243 16 K 1.036 
1956 Rl 222 16 K 2.733 
1957 Rl 227 16 K 1.415 
1958 Rl 235 16 K 1.108 
1959 Rl 249 16 K 1.151 
1960 Rl 251 16 K 1.861 
1961 R2 216 16 K 3.779 
1962 R2 218 16 K 2.453 
1963 R2 225 16 K 2.292 
1964 R2 236 16 K 2.208 
1965 R2 240 16 K 1.522 
1966 R3 205 16 K 5.453 
1967 R3 208 16 K 4.654 
1968 R3 215 16 K 3.11 
1969 R3 224 16 K 6.228 
1970 R3 252 16 K 3.386 
1971 Cl 201 16 K 2.548 
1972 Cl 206 16 K 1.393 
1973 Cl 217 16 K 1.637 
1974 Cl 223 16 K 1.639 
1975 Cl 238 16 K 1.911 
1976 C2 214 16 K 1.62 
1977 C2 233 16 K 2.781 
1978 C2 241 16 K 3.471 
1979 C2 246 16 K 5.158 
1980 C2 248 16 K 3.834 
1981 C3 202 16 K 5.315 
1982 C3 203 16 K 6.172 
1983 C3 229 16 K 4.764 
1984 C3 231 16 K 5.05 
1985 C3 250 16 K 4.974 
1986 Sl 204 16 K 2.777 
1987 Sl 228 16 K 2.641 
1988 Sl 237 16 K 3.392 
1989 Sl 239 16 K 2.939 
1990 Sl 253 16 K 3.221 
1991 S2 207 16 K 4.592 
1992 S2 212 16 K 4.188 
1993 S2 213 16 K 3.461 
1994 S2 220 16 K 3.283 
1995 S2 244 16 K 4.616 
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Feeding Trial 1: Soils C4 and S4 
Kidney Digests (Second Set) 
Sample Date 3/24/97 and 3/26/97 Analysis Date 8/12/97 and 8/14/97 
UMC Sample Description As 
OSU Sample No. Sample ID Pig No. Day No. Tissue ug/1 
1996 S3 211 16 K 4.318 
1997 S3 219 16 K 7.051 
1998 S3 232 16 K 7.346 
1999 S3 234 16 K 5.603 
2000 S3 242 16 K 6.392 
2001 R2 218L 16 K 4.514 
2002 C3 2203 16 K 6.343 
2003 Rl 2222 16 K 4.101 
2004 P. Blank * 
2005 P. Blank * 
2006 P. Blank * 
*Because the digestion blanks were so high in nitric acid (too oxidizing) 
they could not be read by hydride generation without dilution by 50%. This would 
have resulted in losing the arsenic value by dilution, therefore no arsenic concentration 
could be measured. If "trace metal" grade nitric acid was used in the digest, there should 
be no appreciable arsenic contamination. 
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Table II - 3 
Feeding Trial 1: Soils C4 and S4 
Liver Digests 
Sample Date 3/24/97 and 3/26/97 Analysis Date 7/10/97 
UMC Sample Description 
OSU Sample No. Sample ID Pig No. Day No. Tissue 
1534 CT 221 16 Li 
1535 CT 230 16 Li 
1536 CT 243 16 Li 
1537 Rl 222 16 Li 
1538 Rl 227 16 Li 
1539 Rl 235 16 Li 
1540 Rl 249 16 Li 
1541 Rl 251 16 Li 
1542 R2 216 16 Li 
1543 R2 218 16 Li 
1544 R2 225 16 Li 
1545 R2 236 16 Li 
1546 R2 240 16 Li 
1547 R3 205 16 Li 
1548 R3 208 16 Li 
1549 R3 215 16 Li 
1550 R3 224 16 Li 
1551 R3 252 16 ···-- Li 
1552 Cl 201 16 Li 
1553 Cl 206 16 Li 
1554 Cl 217 16 Li 
1555 Cl 223 16 Li 
1556 Cl 238 16 Li 
1557 C2 : 214 16 Li 
1558 C2 233 16 Li 
1559 C2 241 16 Li 
1560 C2 246 16 Li 
1561 C2 248 16 Li 
1562 C3 202 16 Li 
1563 C3 203 16 Li 
1564 C3 229 16 Li 
1565 C3 231 16 Li 
1566 C3 250 16 Li 
1567 Sl 204 16 Li 
1568 Sl 228 16 Li 
1569 Sl 237 16 Li 
1570 Sl 239 16 Li 
1571 Sl 253 16 Li 
1572 S2 207 16 Li 
1573 S2 212 16 Li 
1574 S2 213 16 Li 
1575 S2 220 16 Li 
1576 S2 244 16 Li 
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As 
ug/1 
0.382 
1.394 
1.031 
0.783 
0.659 
0.467 
0.604 
<0.3 
0.565 
<0.3 
0.393 
<0.3 
<0.3 
0.886 
0.644 
<0.3 
0.935 
0.788 
0.417 
<0.3 
<0.3 
0.446 
0.451 
0.385 
0.347 
0.778 
0.544 
0.785 
0.841 
1.036 
0.764 
1.051 
0.826 
0.717 
0.711 
0.709 
0.864 
0.653 
0.897 
0.786 
0.315 
<0.3 
<0.3 
Table II - 3 
Feeding Trial 1: Soils C4 and S4 
Liver Digests 
Sample Date 3/24/97 and 3/26/97 Analysis Date 7/10/97 
UMC Sample Description 
OSU Sample No. Sample ID Pig No. Day No. Tissue 
1577 S3 211 16 Li 
1578 S3 219 16 Li 
1579 S3 232 16 Li 
1580 S3 234 16 Li 
1581 S3 242 16 Li 
1582 C3 2203 16 Li 
1583 R3 2205 16 Li 
1584 S3 2234 16 Li 
1585 PBlank 
1586 PBlank 
1587 PBlank 
*Because the digestion blanks were so high in nitric acid (too oxidizing) 
As 
ug/1 
<0.3 
<0.3 
<0.3 
0.376 
0.301 
0.664 
0.931 
<0.3 
* 
* 
* 
they could not be read by hydride generation without dilution by 50%. This would 
have resulted in losing the arsenic value by dilution, therefore no arsenic concentration 
could be measured. If "trace metal" grade nitric acid was used in the digest, there shou 
be no appreciable arsenic contamination. 
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Table II - 4 
Feeding Trial I: Soils C4 and S4 
Bile Digests 
Sample Date 3/24/97 and 3/26/97 Analysis Date 10/9/97 
UMC Sample Description 
OSU Sample No Sample ID Pig No. Day No. Tissue 
2534 CT 221- 16 K 
2535 CT 230 16 K 
2536 CT 243 16 K 
2537 RI 222 16 K 
2538 Rl 227 16 K 
2539 Rl 235 16 K 
2540 Rl 249 16 K 
2541 Rl 251 16 K 
2542 R2 216 16 K 
2543 R2 218 16 K 
2544 R2 225 16 K 
2545 R2 236 16 K 
2546 R2 240 16 K 
2547 R3 205 16 K 
2548 R3 208 16 K 
2549 R3 215 16 K 
2550 R3 224 16 K 
2551 R3 252 16 K 
2552 Cl 201 16 K 
2553 Cl 206 16 K 
2554 Cl 217 16 K 
2555 Cl 223 16 K 
2556 Cl 238 16 K 
2557 C2 214 16 K 
2558 C2 233 16 K 
2559 C2 241 16 K 
2560 C2 246 16 K 
2561 C2 248 16 K 
2562 C3 202 16 K 
2563 C3 203 16 K 
2564 C3 229 16 K 
2565 C3 231 16 K 
2566 C3 250 16 K 
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As 
ug/1 
<0.3 
<0.3 
<0.3 
0.277 
0.421 
0.376 
0.475 
2.342 
<0.3 
0.164 
<0.3 
0.014 
0.975 
<0.3 
<0.3 
<0.3 
5.14 
0.188 
0.14 
0.922 
<0.3 
0.318 
0.204 
<0.3 
<0.3 
2.071 
0.775 
0.244 
1.736 
0.377 
0.436 
0.347 
1.434 
Table II - 4 
Feeding Trial 1: Soils C4 and S4 
Bile Digests 
Sample Date 3/24/97 and 3/26/97 Analysis Date 10/9/97 
UMC Sample Description 
OSU Sample No Sample ID Pig No. Day No. Tissue 
2567 Sl 204 16 K 
2568 Sl 228 16 K 
2569 Sl 237 16 K 
2570 Sl 239 16 K 
2571 Sl 253 16 K 
2572 S2 207 16 K 
2573 S2 212 16 K 
2574 S2 213 16 K 
2575 S2 220 16 K 
2576 S2 244 16 K 
2577 S3 211 16 K 
2578 S3 219 16 K 
2579 S3 232 16 K 
2580 S3 234 16 K 
2581 S3 242 16 K 
2582 S3 2234 16 K 
2583 C2 2248 16 K 
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As 
ug/1 
< 0.3 
1.344 
< 0.3 
4.362 
1.401 
1.155 
0.946 
0.624 
0.873 
0.71 
0.637 
0.386 
0.301 
0.796 
0.617 
0.699 
0.631 
osu 
Sample No. Sample ID 
769 OSUl-01 
770 OSUl-02 
771 OSUl-04 
772 OSUl-05 
osu 
Sample No. Sample ID 
1014 OSUl-03 
- Table II - 5 
Analysis Date 3/27 /97 
UMC Sample Description 
Date Collected Matrix Remarks 
3/7/97 water WK 1 - pig 205 pen 
3/7/97 water WK 1- pig 204 pen 
3/24/97 water WK 2 - pig 242 pen 
3/24/97 water WK 2 - pij!; 203 pen 
Analysis Date 5/12/97 
UMC Sample Description 
Date Collected Matrix Remarks 
3/7/97 feed S-2 feed, from UMC 
Feedmill 
Feed sample prepared by first grinding to powder, then 1.00 g samples digested using 
USEPA SW-846, Method 3050 
116 
As 
ug!L 
0.3991 
0.6569 
0.7071 
0.9702 
As 
ug/g 
0.253 
Table 11-6 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
DayO Day4 Day8 
Sample ID Pig No. As, ug/L Urine Vol, ml As,ug As, ug/L Urine Vol, ml As,ug As, ul!!L Urine Vol, ml As, ug 
CT 302 2.228 1970 4.389 4.07 1720 7.000 3.865 1920 7.421 
CT 338 3.782 1060 4.009 5.274 1630 8.597 2.103 3160 6.645 
CT 341 10.786 480 5.177 12.621 490 6.184 7.665 700 5.366 
Cl 306 12.334 470 5.797 38.179 220 8.399 13.847 620 8.585 
Cl 317 9.523 620 5.904 22.193 580 12.872 12.83 1220 15.653 
Cl 324 8.622 630 5.432 71.905 200 14.381 21.75 620 13.485 
Cl 327 4.293 1600 6.869 9.168 1220 11.185 7.695 2020 15.544 
Cl 348 18.915 290 5.485 29.445 180 5.300 21.154 300 6.346 
C2 318 4.049 1600 6.478 8.945 1180 10.555 9.366 2040 19.107 
C2 319 1.29 3700 4.773 16.176 1080 17.470 10.386 1480 15.371 
C2 325 7.553 640 4.834 22.322 780 17.411 9.27 2120 19.652 
C2 337 0.3 7900 2.370 18.066 500 9.033 3.014 1200 3.617 
C2 339 8.287 350 2.900 18.667 770 14.374 10.391 1700 17.665 
C3 309 4.229 1740 7.358 8.983 2800 25.152 17.061 1300 22.179 
C3 313 2.308 700 1.616 11.486 1640 18.837 11.571 1740 20.134 
C3 322 9.345 520 4.859 24.741 730 18.061 26.254 680 17.853 
C3 336 7.253 800 5.802 25.36 840 21.302 7.005 2020 14.150 
C3 350 9.878 560 5.532 16.946 600 10.168 29.755 880 26.184 
C5 303 1.194 880 1.051 4.274 3000 12.822 12.143 1500 18.215 
C5 315 1.033 7480 7.727 17.381 1060 18.424 19.416 760 14.756 
C5 328 15.369 450 6.916 28.898 420 12.137 20.666 950 19.633 
C5 334 0.3 6560 1.968 35.107 460 16.149 14.133 530 7.490 
C5 346 15.811 660 10.435 23.738 640 15.192 21.471 1080 23.189 
SI 307 4.531 1670 7.567 6.993 840 5.874 5.349 1180 6.312 
SI 312 1.238 1210 1.498 18.783 340 6.386 5.638 940 5.300 
SI 326 10.593 520 5.508 17.412 280 4.875 20.563 400 8.225 
SI 333 13.198 450 5.939 17.135 300 5.141 16.421 200 3.284 
SI 335 7.942 740 5.877 4.928 1410 6.948 9.508 600 5.705 
-
-....J 
Table II - 6 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2·, 3, 5 
DayO Day4 
Sample ID Pig No. As, ug/L Urine Vol, ml As, ug As, ug/L Urine Vol, ml As, ug 
S2 301 16.304 440 7.174 17.683 740 13.085 
S2 304 9.009 790 7.117 12.751 500 6.376 
S2 308 6.594 600 3.956 9.548 680 6.493 
S2 311 2.579 1560 4.023 2.398 3060 7.338 
S2 343 1.19 2060 2.451 3.3 1960 6.468 
S3 316 4.192. 1330 5.575 3.58 3200 11.456 
S3 329 4.888 590 2.884 10.393 980 10.185 
S3 331 3.453 1360 4.696 4.156 1700 7.065 
S3 340 4.854 1120 5.436 9.111 870 7.927 
S3 345 8.978 490 4.399 22.151 520 11.519 
S5 305 9.859 700 6.901 21.577 1020 22.009 
S5 320 8.227 760 6.253 7.059 1880 13.271 
S5 342 5.35 930 4.976 5.904 1600 9.446 
S5 344 2.597 360 0.935 66.09 220 14.540 
S5 349 9.15 330 3.020 34.998 460 16.099 
As, ug/L 
14.191 
7.179 
6.11 
2.081 
1.511 
1.601 
3.708 
5.41 
10.626 
23.989 
9.915 
9.183 
38.467 
25.275 
Day8 
Urine Vol, ml 
640 
1580 
1260 
no volume 
2560 
9660 
no sample 
1880 
1980 
1560 
1000 
1500 
1400 
380 
740 
As,ug 
9.082 
11.343 
7.699 
3.868 
15.466 
6.971 
10.712 
16.577 
23.989 
14.873 
12.856 
14.617 
18.704 
,._. 
,._. 
00 
Sample ID Pig No. As, ug/L 
CT 302 6.118 
CT 338 4.439 
CT 341 15.597 
Cl 306 7.866 
Cl 317 10.278 
Cl 324 18.423 
Cl 327 4.517 
Cl 348 31.934 
C2 318 8.538 
C2 319 7.712 
C2 325 8.815 
C2 337 4.975 
C2 339 17.612 
C3 309 27.537 
C3 313 52.463 
C3 322 19.384 
C3 336 15.074 
C3 350 36.488 
C5 303 19.455 
C5 315 16.827 
C5 328 19.126 
C5 334 10.339 
C5 346 36.079 
SI 307 5.24 
Sl 312 7.547 
SI 326 6.232 
SI 333 28.69 
SI 335 7.638 
Table II - 6 
Feeding Trial 2: Soils Cl, 2, 3, 5 and Sl, 2, 3, 5 
Day 12 Day 15 
Urine Vol, ml As, ug As, ug/L Urine Vol, ml 
1630 9.972 3.88 2760 
2320 10.298 1.643 4320 
540 8.422 12.404 610 
680 5.349 17.086 840 
1420 14.595 10.389 2080 
620 11.422 10.561 1400 
1800 8.131 2.891 2560 
560 17.883 77.725 1080 
2280 19.467 8.784 2380 
2220 17.121 12.605 1640 
1980 17.454 3.819 4400 
2360 11.741 2.645 3220 
1240 21.839 9.173 2040 
1730 47.639 7.055 3540 
670 35.150 27.228 1530 
940 18.221 14.359 2580 
1440 21.707 12.486 2400 
660 24.082 23.629 1240 
1220 23.735 19.87 5200 
1900 31.971 93.029 1380 
1960 37.487 20.365 2700 
1040 10.753 39.205 3800 
840 30.306 14.066 2020 
2200 11.528 3.499 1560 
1040 7.849 8.834 740 
1160 7.229 23.039 320 
260 7.459 19.438 600 
1380 10.540 4.391 2640 
As, ug 
10.709 
7.098 
7.566 
14.352 
21.609 
14.785 
7.401 
83.943 
20.906 
20.672 
16.804 
8.517 
18.713 
24.975 
41.659 
37.046 
29.966 
29.300 
103.324 
128.380 
54.986 
148.979 
28.413 
5.458 
6.537 
7.372 
11.663 
11.592 
-...... \0 
Sample ID Pig No. As, ug/L 
S2 301 5.138 
S2 304 11.839 
S2 308 7.238 
S2 311 5.418 
S2 343 1.963 
S3 316 3.027 
S3 329 15.734 
S3 331 · 6.434 
S3 340 7.41 
S3 345 16.153 
S5 305 21.16 
S5 320 7.323 
S5 342 15.051 
S5 344 46.913 
S5 349 17.992 
Table II - 6 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
Day 12 Dayl5 
Urine Vol, ml As,ug As, ug/L Urine Vol, ml 
720 3.699 13.296 820 
1460 17.285 5.62 1520 
1240 8.975 7.808 1260 
1600 8.669 4.588 2240 
3500 6.871 1.719 6360 
2600 7.870 4.679 3800 
900 14.161 20.962 890 
1620 10.423 5.713 3020 
1450 10.745 14.002 820 
880 14.215 22.256 860 
1360 28.778 19.694 900 
2200 16.111 8.564 2500 
2000 30.102 12.796 1360 
530 24.864 12.437 1320 
960 17.272 28.312 820 
As, ug 
10.903 
8.542 
9.838 
10.277 
10.933 
17.780 
18.656 
17.253 
11.482 
19.140 
17.725 
21.410 
17.403 
16.417 
23.216 
..... 
N 
0 
Table II - 7 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
Kidney Digests (Second Set) 
Sample Date 5/27/97 Analysis Date 9/3/97 
UMC Sample Description 
OSU Sample No Sample ID Pig No. Day No. Tissue 
2019 CT 302 16 K 
2020 CT 338 16 K 
2021 CT 341 16 K 
2022 CI 306 16 K 
2023 Cl 317 16 K 
2024 Cl 324 16 K 
2025 Cl 327 16 K 
2026 CI 348 16 K 
2027 Cl 318 16 K 
2028 Cl 319 16 K 
2029 Cl 325 16 K 
2030 Cl 337 16 K 
2031 Cl 339 16 K 
2032 C3 309 16 K 
2033 C3 313 16 K 
2034 C3 322 16 K 
2035 C3 336 16 K 
2036 C3 350 16 K 
2037 C5 303 16 K 
2038 C5 315 16 K 
2039 C5 328 16 K 
2040 C5 334 16 K 
2041 C5 346 16 K 
2042 SI 307 16 K 
2043 SI 312 16 K 
2044 SI 326 16 K 
2045 SI 333 16 K 
2046 SI 335 16 K 
2047 S2 301 16 K 
2048 S2 304 16 K 
2049 S2 308 16 K 
2050 S2 311 16 K 
2051 S2 343 16 K 
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As 
ug/1 
0.964 
0.872 
0.517 
1.192 
1.356 
0.967 
1.147 
1.313 
1.376 
1.517 
1.45 
1.424 
2.304 
2.474 
2.999 
2.395 
1.8 
2.078 
2.892 
3.034 
2.095 
2.239 
1.836 
0.803 
0.841 
1.59 
1.414 
0.99 
0.913 
0.866 
0.851 
0.932 
0.876 
Feeding Trial 2: Soils Cl, 2, 3, 5 and Sl, 2, 3, 5 
Kidney Digests (Second Set) 
Sample Date 5/27 /97 Analysis Date 9/3/97 
UMC Sample Description 
OSU Sample No Sample ID Pig No. Day No. Tissue 
2052 S3 316 16 K 
2053 S3 329 16 K 
2054 S3 331 16 K 
2055 S3 340 16 K 
2056 S3 345 16 K 
2057 S5 305 16 K 
2058 S5 320 16 K 
2059 S5 342 16 K 
2060 S5 344 16 K 
2061 S5 349 16 K 
2062 C3 2322 16 K 
2063 Sl 2307 16 K 
2064 CT 338M 16 K 
2065 Cl 317H 16 K 
122 
As 
ug/1 
0.726 
0.779 
0.903 
1.079 
0.831 
1.621 
2.042 
1.985 
1.631 
0.972 
1.535 
1.138 
2.985 
3.793 
Table II - 8 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
Liver Digests 
Sample Date 5/27 /97 and 5/29/97 Analysis Date 8/11/97 and 8/12/97 
UMC Sample Description As 
OSU Sample No. Sample ID Pig No. Day No. Tissue ug/1 
1692 CT 302 16 Li 0.888 
1693 CT 338 16 Li 0.617 
1694 CT 341 16 Li 0.711 
1695 Cl 306 16 Li 0.444 
1696 Cl 317 16 Li 0.679 
1697 Cl 324 16 Li 0.903 
1698 Cl 327 16 Li 0.42 
1699 Cl 348 16 Li 1.554 
1700 C2 318 16 Li 2.635 
1701 C2 319 16 Li 0.605 
1702 C2 325 16 Li 2.341 
1703 C2 337 16 Li 2.584 
1704 C2 339 16 Li 2.094 
1705 C3 309 16 Li 3.14 
1706 C3 313 16 Li 2.148 
1707 C3 322 16 Li 2.35 
1708 C3 336 16 Li 2.362 
1709 C3 350 16 · Li 2.351 
1710 C5 303 16 Li 2.832 
1711 C5 315 16 Li 11.386 
1712 C5 328 16 Li 4.793 
1713 C5 334 16 Li 2.057 
1714 C5 346 16 Li 3.709 
1715 SI 307 16 Li 1.762 
1716 SI 312 16 Li 2.806 
1717 SI 326 16 Li 1.855 
1718 SI 333 16 Li 1.694 
1719 SI 335 16 Li 2.117 
1720 S2 301 16 Li 2.118 
1721 S2 304 16 Li 5.458 
1722 S2 308 16 Li 4.174 
1723 S2 311 16 Li 2.484 
1724 S2 343 16 Li 1.662 
1725 S3 316 16 Li 1.679 
1726 S3 329 16 Li 7.08 
1727 S3 331 16 Li 1.755 
1728 S3 340 16 Li 2.022 
1729 S3 345 16 Li 1.56 
1730 S5 305 16 Li 1.62 
1731 S5 320 16 Li 0.858 
1732 S5 342 16 Li 1.367 
1733 S5 344 16 Li 1.648 
1734 S5 349 16 Li 1.673 
123 
Table II - 8 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
Liver Digests 
Sample Date 5/27/97 and 5/29/97 Analysis Date 8/11/97 and 8/12/97 
UMC Sample Description As 
OSU Sample No. Sample ID Pig No. Day No. Tissue ug/1 
1735 C3 2322 16 Li 1.804 
1736 SI 2307 16 Li 2.805 
1737 CT 338M 16 Li 3.86 
1738 CI 317H 16 Li 5.25 
1739 P.Blank * 
1740 P.Blank * 
1741 P.Blank * 
*Because the digestion blanks were so high in nitric acid (too oxidizing) 
they could not be read by hydride generation without dilution by 50%. This would 
have resulted in losing the arsenic value by dilution, therefore no arsenic concentration 
could be measured. If "trace metal" grade nitric acid was used in the digest, there should 
be no appreciable arsenic contamination. 
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Table II - 9 
Feeding Trial 2: Soils Cl, 2, 3, 5 and Sl, 2, 3, 5 
Bile Digests 
Sample Date 5/27/97 and 5/29/97 Analysis Date 10/10/97 
UMC Sample Description As 
OSU Sample No Sample ID Pig No. Day No. Tissue ug/l 
2584 CT 302 16 B 0.748 
2585 CT 338 16 B 1.194 
2586 CT 341 16 B 1.192 
2587 Cl 306 16 B 1.431 
2588 Cl 317 16 B 1.511 
2589 Cl 324 16 B 2.048 
2590 Cl 327 16 B 6.914 
2591 Cl 348 16 B 3.446 
2592 C2 318 16 B 2.431 
2593 C2 319 16 B <0.3 
2594 C2 325 16 B 0.652 
2595 C2 337 16 B 0.466 
2596 C2 339 16 B 0.315 
2597 C3 309 16 B 0.336 
2598 C3 313 16 B <0.3 
2599 C3 322 16 B 0.368 
2600 C3 336 16 B 0.447 
2601 C3 350 16 B 0.123 
2602 C5 303 16 B 0.415 
2603 C5 315 16 B 0.481 
2604 C5 328 16 B 0.54 
2605 C5 334 16 B 0.846 
2606 C5 346 16 B 0.341 
2607 Sl 307 16 B 0.272 
2608 Sl 312 16 B 0.092 
2609 SI 326 16 B 1.175 
2610 SI 333 16 B <0.3 
2611 Sl 335 16 B 0.21 
2612 S2 301 16 B 0.07 
2613 S2 304 16 B 0.128 
2614 S2 308 16 B <0.3 
2615 S2 311 16 B <0.3 
2616 S2 343 16 B < 0.3 
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Table II - 9 
Feeding Trial 2: Soils Cl, 2, 3, 5 and SI, 2, 3, 5 
Bile Digests 
Sample Date 5/27/97 and 5/29/97 Analysis Date 10/10/97 
UMC Sample Description As 
OSU Sample No Sample ID Pig No. Day No. Tissue ug/1 
"2617 S3 316 16 B 0.225 
2618 S3 329 16 B <0.3 
2619 S3 331 16 B 0.288 
2620 S3 340 16 B < 0.3 
2621 S3 345 16 B 0.302 
2622 S5 305 16 B 0.157 
2623 S5 320 16 B 0.389 
2624 S5 342 16 B 0.301 
2625 S5 344 16 B 0.393 
2626 S5 349 16 B 0.354 
2627 S5 2349 16 B 0.681 
2628 Cl 324 16 B 0.307 
2629 SI 326L 16 B 0.906 
2630 S2 308M 16 B 1.795 
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Table II - 10 
Feeding Trial 2: Soils Cl, 2, 3, 5 and Sl, 2, 3, 5 
Lost Arsenic Investigation - Bile and Blood 
Collection Date 5/29/97 Analysis Date 10/10/97 
UMC Sample Description 
OSU Sample No. Sample ID Pig No. Day No. Tissue 
2631 R3-0SU2 322 16 B 
2632 R3-0SU2 314 16 B 
2633 R3-0SU2 2314 16 B 
2634 R3-0SU2 332 16 BL 
2635 R3-0SU2 314 16 BL 
2636 R3-0SU2 347 16 BL 
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As 
ug/1 
3.258 
0.83 
1.872 
0.937 
0.808 
0.958 
Table II - 11 128 
Feeding Trial 2: Soils C1, 2, 3, 5 and S1, 2, 3, 5 
Lost Arsenic Investigation 
Analysis Date 9/4/97 
UMC Sample Description As 
CSU Sample No. Sample ID Pig No. Day No. ID ug/1 
2073 CT-OSU2 302 15 A 4.266 
2074 CT-OSU2 302 15 8 4.938 
2075 CT-OSU2 302 15 C 4.286 
2076 CT-OSU2 302 15 D 4.13 
2077 CT-OSU2 302 15 E 19.24 
2078 CT-OSU2 302 15 F 3.008 
2079 CT-OSU2 338 15 A 3.135 
2080 CT-OSU2 338 15 8 3.287 
2081 CT-OSU2 338 15 C 2.887 
2082 CT-OSU2 338 15 D 2.925 
2083 CT-OSU2 338 15 E 4.908 
2084 CT-OSU2 338 15 F 14.254 
2085 R3-0SU2 314 15 A 84.951 
2086 R3-0SU2 314 15 8 86.395 
2087 R3-0SU2 314 15 C 84.333 
2088 R3-0SU2 314 15 D 83.394 
2089 R3-0SU2 314 15 E 61.9 
2090 R3-0SU2 314 15 F 14.402 
2091 R3-0SU2 332 15 A 107.67 
2092 R3-0SU2 332 15 8 105.19 
2093 R3-0SU2 332 15 C 102.39 
2094 R3-0SU2 332 15 D 109.31 
2095 R3-0SU2 332 15 E . 61.538 
2096 R3-0SU2 332 15 F 28.502 
2097 R3-0SU2 347 15 A 50.67 
2098 R3-0SU2 347 15 8 50.04 
2099 R3-0SU2 347 15 C 6.052 
2100 R3-0SU2 347 15 D 48.34 
2101 R3-0SU2 347 15 E 50.978 
2102 R3-0SU2 347 15 F 50.844 
2103 CT-OSU2 2302 15 D 48.943 
·2104 CT-OSU2 2302 15 F 4.196 
2105 R3-0SU2 2332 15 A 102.23 
2106 CT-OSU2 338L 15 A 14.37 
2107 R3-0SU2 347M 15 8 76.991 
Sheet2 c:\excel\research\in-vivo\trial-2\lost-As.xls 
Table II - 12 
Assorted Tissues - OSU2B 
Sample Date 5/29/97 Analysis Date 7/11/97 and 7/14/97 
UMC Sample Description As 
OSU Samole No. Pie:No. Tissue ue:/1 
1588 314 LI 1.043 
1589 2314 LI 0.863 
1590 314 LU 1.217 
1591 2314 LU <0.3 
1592 314 SP 1.298 
1593 2314 SP 1.302 
1594 314 KI 4.729 
1595 314 TE - <0.3 
1596 314 SM <0.3 
1597 314 ST <0.3 
1598 314 HE <0.3* 
1599 314 ID 1.114 
1600 314 II 1.032 
1601 314 IJ 1.494 
1602 314 IC 1.596 
1603 314 SC 1.313 
1604 314 SK 1.838 
1605 2314 SK 2.774 
1606 3314 SK 2.492 
1607 314 HA 1.616 
1608 314 HO 1.496 
1609 314 BE 0.751 
1610 314 BR <0.3 
1611 312 LI 0.83 
1612 312 LU 1.181 
1613 2312 LU 1.105 
1614 3312 LU 3.502 
1615 312 SP 1.262 
1616 312 KI 3.604 
1617 312 TE 1.002 
1618 312 SM 1.166 
1619 2312 SM 1.407 
1620 312 ST 1.332 
1621 312 HE 0.716 
1622 312 ID 0.59 
1623 312 II 1.042 
1624 312 IJ 1.098 
1625 312 IC 1.167 
1626 312 SC 2.7 
1627 312 SK 2.939 
1628 312 HA 2.196 
1629 312 HO 1.308 
1630 312 BE <0.3 
1631 312 BR <0.3 
1632 2312 BR <0.3 
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Table II - 12 
Assorted Tissues - OSU2B 
Sample Date 5/29/97 Analysis Date 7/11/97 and 7/14/97 
UMC Sample Description As 
OSU Sample No. Pig No. Tissue ug/1 
1633 347 HZ 2.486 
1634 2347 HZ 3.774 
1635 3347 HZ 4.021 
1636 4347 HZ 3.091 
1637 5347 HZ 3.082 
1638 6347 HZ 2.874 
1639 P. Blank ** 
1640 P. Blank ** 
164.1 P. Blank ** 
*Because of the low sample weight on this sample, the digest had to be diluted 
by 50% to be able to read it by hydride generation. The low concentration result 
may be therefore due to dilution. 
**Because the digestion blanks were so high in nitric acid (much too oxidizing) 
they could not be read by hydride generation without dilution by 50%. This would 
have resulted in losing the arsenic value by dilution, therefore no arsenic concentration 
could be measured. If "trace metal" grade nitric acid was used in the digest, there should 
be no appreciable arsenic contamination. 
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Table II - 13 
Soil Dosing - Feeding Trial 1 
As intake Pig As intake Pig 
Group Treatment ug/kg/day # Group Treatment ug/kg/day # 
1 Na2As04.7H20 10 222 8 Site 2 Soil 80 207 
227 212 
235 S-4 213 
249 220 
251 244 
2 Na2As04. 7H20 30 216 9 Site 2 Soil 160 211 
218 219 
225 S-4 232 
236 234 
240 242 
3 Na2As04. 7H20 90 205 10 Control 0 221 
208 230 
215 243 
224 
4 Site 1 Soil 40 201 
Calcine 206 
C-4 217 
223 
238 
5 Site 1 Soil · 80 214 
233 
C-4 241 
246 
248 
6 Site 1 Soil 160 202 
203 
C-4 229 
231 
250 
7 Site 2 Soil 40 204 
Slag 228 
S-4 237 
239 
253 
Appendix ill 
Chemical Speciation Data 
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Sample No. Soil Particle Size Rep No. 
2206 Cl <250u I 
2207 Cl <250u 2 
2208 Cl <250u 3 
2209 . C2 <250u I 
2210 C2 <250u 2 
2211 C2 <250u 3 
2212 C3 <250u 1 
2213 C3 <250u 2 
2214 C3 <250u 3 
1748 C4 <250u 1 
1749 C4 <250u 2 
1750 C4 <250u 3 
2215 C5 <250u 1 
2216 C5 <250u 2 
2217 C5 <250u 3 
2218 C4 <2mm 1 
2219 C4 <2mm 2 
2220 C4 <2mm 3 
2221 SI <250u 1 
2222 SI <250u 2 
2223 SI <250u 3 
2224 S2 <250u 1 
2225 S2 <250u 2 
2226 S2 <250u 3 
2227 S3 <250u 1 
2228 S3 <250u 2 
2229 S3 <250u 3 
Table III - I 
Water Soluble Extracts 
I g soil:20 ml, shake I hour, room temperature 
As Corrected Average Standard 
mg/L As,mg/L As, mg/kg As, mg/kg Deviation 
0.0647 0.0664 1.33 1.13 0.183 
0.0470 0.0482 0.96 
0.0540 0.0554 1.11 
0.0591 0.0606 1.21 1.25 0.097 
0.0660 0.0677 1.35 
0.0570 0.0585 1.17 
0.0290 0.0298 0.60 0.60 0.041 
0.0270 0.0277 0.55 
0.0310 0.0318 0.64 
0.0384 0.0394 0.79 0.78 0.050 
0.0404 0.0414 0.83 
0.0355 0.0364 0.73 
0.0067 0.0069 0.14 0.14 0.000 
0.0067 0.0069 0.14 
0.0067 0.0069 0.14 
0.0340 0.0349 0.70 0.73 0.031 
0.0350 0.0359 0.72 
0.0370 0.0380 0.76 
0.0360 0.0369 0.74 0.74 0.308 
0.0510 0.0523 1.05 
0.0210 0.0215 0.43 
0.1100 0.1129 2.26 2.54 0.256 
0.1280 0.1313 2.63 
0.1340 0.1375 2.75 
0.0880 0.0903 1.81 1.76 0.188 
0.0760 0.0780 1.56 
0.0940 0.0964 1.93 
Method 3050 Bioavable As, % 
As, mg/kg Ind. Ave 
11294 0.012 0.010 
0.009 
0.010 
17456 0.007 0.007 
0.008 
0.007 
13472 0.004 0.004 
0.004 
0.005 
11525 0.007 0.007 
0.007 
0.006 
6245 0.002 0.002 
0.002 
0.002 
10918 0.006 0.007 
0.007 
0.007 
405 0.182 0.182 
0.258 
0.106 
450 0.502 0.565 
0.584 
0.611 
1180 0.153 0.150 
0.132 
0.163 
-w 
w 
Sample No. Soil Particle Size Rep No. 
1766 S4 <250u 1 
1767 S4 <250u 2 ,. 
1768 S4 <250u 3 
2230 S5 <250u 1 
2231 S3 <250u 2 
2232 S5 <250u 3 
2233 S4 <2mm 1 
2234 S4 <2mm 2 
2235 S4 <2mm 3 
2236 El <250u 1 
2237 El <250 u 2 
2238 El <250u 3 
2239 E2 <250u 1 
2240 E2 <250u 2 
2241 E2 <250u 3 
2242 E3 <250u 1 
2243 E3 <250u 2 
2244 E3 <250u 3 
2245 E4 <250u 1 
2246 E4 <250u 2 
2247 E4 <250u 3 
2248 E5 <250u 1 
2249 E5 <250u 2 
2250 E5 <250u 3 
2251 BG <2mm 1 
2252 BG <2mm 2 
2253 BG <2mm 3 
Table III - l 
Water Soluble Extracts 
1 g soil:20 ml, shake 1 hour, room temperature 
As Corrected Average Standard 
mg/L As,mg/L As, mg/kg As, mg/kg Deviation 
0-:+l-&+ ~ ~ 3.12 1.325 
0.2392 0.2454 4.91 
0.2174 0.2231 4.46 
0.1810 0.1857 3.71 3.54 0.211 
0.1750 0.1796 3.59 
0.1610 0.1652 3.30 
0.1800 0.1847 3.69 3.77 0.113 
0.1810 0.1857 3.71 
0.1900 0.1949 3.90 
0.0040 0.0041 0.08 0.08 0.012 
0.0030 0.0031 0.06 
0.0040 0.0041 0.08 
0.0220 0.0226 0.45 1.66 2.115 
0.0210 0.0215 0.43 
0.2000 0.2052 4.10 
0.0080 0.0082 0.16 0.16 0.000 
0.0080 0.0082 0.16 
0.0080 0.0082 0.16 
0.0280 0.0287 0.57 0.49 0.198 
0.0310 0.0318 0.64 
0.0130 0.0133 0.27 
0.0680 0.0698 1.40 1.30 0.085 
0.0600 0.0616 1.23 
0.0620 0.0636 1.27 
0.0160 0.0164 0.3~ 0.31 0.012 
0.0150 0.0154 0.31 
0.0150 0.0154 0.31 
Method 3050 Bioavable As, % 
As, mg/kg Ind. Ave 
5022 0:04& 0.062 
0.098 
0.089 
4650 0.080 0.076 
0.077 
0.071 
3158 0.117 0.119 
0.118 
0.123 
331 0.025 0.023 
0.019 
0.025 
233 0.194 0.713 
0.185 
1.761 
800 · 0.021 0.021 
0.021 
0.021 
1463 0.039 0.034 
0.043 
0.018 
401 0.348 0.324 
0.307 
0.317 
-w 
~ 
As 
Sample No. Soil Particle Size Rep No. mg/L 
1802 S4 <250 u I 6.242 
1803 S4 <250 u 2 6.175 
1804 S4 <250 u 3 6.209 
2129 S5 <250 u 1 3.886 
2130 S3 <250 u 2 4.166 
2131 S5 <250 u 3 4.079 
2135 S4 <2mm 1 5.188 
2136 S4 <2mm 2 5.25 
2137 S4 <2mm 3 5.281 
2141 El <250 u 1 1.641 · 
2142 El <250 u 2 1.582 
2143 El <250 u 3 1.54 
2144 E2 <250 u 1 2.044 
2145 E2 <250 u 2 2.045 
2146 E2 <250u 3 1.824 
2147 E3 <250 u 1 2.688 
2148 E3 <250 u 2 2.835 
2149 E3 <250u 3 2.698 
2150 E4 <250 u 1 9.302 
2151 E4 <250u 2 9.552 
2152 E4 <250u 3 9.694 
2153 E5 <250u 1 2.303 
2154 ES <250u ·2 2.38 
2155 ES <250 u 3 2.275 
2138 BG <2mm 1 1.618 
2139 BG <2mm 2 1.609 
2140 BG <2mm 3 1.578 
Table III· 2 
Sodium Acetate Extracts 
lg:20 ml, shake l hr, rt 
Corrected* Individual Average 
As, mg/L As, mg/kg As, mg/kg 
6.4043 128.086 127.402 
6.3356 126.711 
6.3704 127.409 
3.9870 79.741 82.976 
4.2743 85.486 
4.1851 83.701 
· 5.3229 106.458 107.518 
5:3865 107.730 
5.4183 108.366 
1.6837 33.673 . 32.579 
1.6231 32.463 
1.5800 31.601 
2.0971 41.943 40.445 
2.0982 41.963 
1.8714 37.428 
2.7579 55.158 56.232 
2.9087 58.174 
2.7681 55.363 
9.5439 190.877 195.268 
9.8004 196.007 
9.9460 198.921 
2.3629 47.258 47.593 
· 2.4419 48.838 
2.3342 46.683 
1.6601 33.201 32.866 
1.6508 33.017 
1.6190 32.381 
Standard Method 3050 
Deviation As, mg/kg 
0,687 5022 
2.941 4650 
0.972 3158 
1.041 331 
2.612 233 
1.685 800 
4.072 1463 
1.116 401 
0.431 
Bioavable As, mg/kg 
Indiv.' 
2.550 
2.523 
2.537 
1.715 
1.838 
1.800 
3.371 
3.411 
3.431 
10.173 
9.807 
9.547 
18.001 
18.010 
16.064 
6.895 
7.272 
6.920 
13.047 
·13.398 
13.597 
11.785 
12.179 
11.642 
Ave. 
2.54 
1.78 
3.40 
9.84 
17.36 
7.03 
13.35 
11.81 
-w Ul 
As 
Sample No. Soil Particle Size Rep No. mg/L 
2108 Cl <250 u l 2.088 
2109 Cl <250 u 2 2.005 
2110 Cl <250u 3 l.996 
2111 C2 <250 u l . 2.131 
2112 C2 <250 u 2 2.103 
2113 C2 <250 u 3 2.288 
2114 C3 <250 u 1 2.278 
2ll5 C3 <250 u 2 2.072 
2116 C3 <250 u 3 2.042 
1784 C4 <250 u 1 2.447 
1785 C4 <250 u 2 2.696 
1786 C4 <250 u 3 2.594 
2117 C5 <250 u I l.727 
2118 C5 <250 u 2 1.73 
2119 C5 <250u 3 1.655 
2132 C4 <2mm l 2.033 
2133 C4 <2mm 2 l.99 
2134 C4 <2mm 3 2.009 
2120 SI <250 u I 4.395 
2121 SI <250 u 2 4.217 
2122 SI <250 u 3 4.366 
2123 S2 <250 u I 2.825 
2124 S2 <250 u 2 2.886 
2125 S2 <250 u 3 2.793 
2126 S3 <250 u l 3.804 
2127 S3 <250 u 2 3.683 
2128 S3 <250u 3 4.377 
Table III - 2 
Sodium Acetate Extracts 
lg:20 ml, shake I hr, rt 
Corrected* Individual Average 
As, mg/L As, mg/kg As, mg/kg 
2.1423 42.846 41.649 
2.0571 41.143 
2.0479 40.958 
2.1864 43.728 44.610 
2.1577 43.154 
2.3475 46.950 
2.3372 46.745 43.721 
2.1259 42.517 
2.0951 41.902 
2.5106 50.212 52.921 
2.7661 55.322 
2.6614 53.229 
1.7719 35.438 34.966 
1.7750 35.500 
1.6980 33.961 
2.0859 41.717 41.259 
2.0417 40.835 
2.0612 41.225 
4.5093 90.185 88.770 
4.3266 86.533 
4.4795 89.590 
2.8985 57.969 58.ll2 
2.9610 59.221 
2.8572 57.145 
3.9029 78.058 81.150 
3.7788 75.575 
4.4908 89.816 
Standard 
Deviation 
1.041 
2.046 
2.636 
2.569 
0.871 
0.442 
1.960 
1.045 
7.607 
Method 3050 Bioavable As, mg/kg 
As, mg/kg Indiv. 
11294 0.379 
0.364 
0.363 
17456 0.251 
0.247 
0.269 
13472 . 0.347 
0.316 
0.311 
11525 0.436 
0.480 
0.462 
6245 0.567 
0.568 
0.544 
10918 0.382 
0.374 
0.378 
405 22.268 
21.366 
22.121 
450 12.882 
13.160 
12.699 
1180 6.615 
6.405 
7.612 
Ave. 
0.37 
0.26 
0.32 
0.46 
0.56 
0.38 
21.92 
12.91 
6.88 
-w 
0\ 
As 
Sample No. Soil Particle Size ReoNo. mg/L 
2157 Cl <250 u I 5.562 
2158 Cl <250u 2 5.778 
2159 Cl <250 u 3 5.836 
2160 C2 < 250 u I 5.833 
2161 C2 <250u 2 5.809 
2162 C2 <250u 3 6.221 
2163 CJ <250u I 7.262 
2164 CJ <250u 2 7.398 
2165 Cl <250u 3 7.475 
1856 C4 <250u 1 10.806 
1857 C4 <250u 2 10.768 
1858 C4 <250u 3 10.487 
2166 cs <250 u I 10.2 
2167 cs <250 u 2 10.79 
2168 cs <250 u 3 11.83 
2181 C4 <2mm 1 12.266 
2182 C4 <2mm 2 12.494 
. 2183 C4 <2mm 3 12.497 
2169: SI <250 u I . 3.576 
2170 SI <250 u 2 3.716 
2171 Sl <250u 3 3.588 
2172 S2 <250 u I 4.38 
2173 S2 <250 u 2 lost 
2174 S2 <250 u 3 4.38 
2175 SJ <250 u I . 4.302 
2176 SJ <250 u 2 4.167 
2177 SJ < 250 u 3 4.333 
Table III - 3 
Yamoto Phosphate 
I g:20 ml, shake I hr, room temf)f:rature 
Corrected* Individual Average Standard 
As, mg/L As, mglkii As, mf!/ke Deviation 
5.7066 114.132 117.484 2.963 
5.9282 118.565 
5.9877 119.755 
5.9847 119.693 122.183 4.745 
5.9600 119.201 
6.3827 127.655 
7.4508 149.016 1~1.403 2.213 
7.5903 151.807 
7.6694 153.387 
11.0870 221.739 219.297 3.575 
11.0480 220.959 
10.7597 215.193 
10.4652 209.304 224.489 16.935 
11.0705 221.411 
12.1376 242.752 
12.5849 251.698 254.838 2.719 
12.8188 256.377 
12.8219 256.438 
3.6690 73.380 74.419 1.592 
3.8126 76.252 
3.6813 73.626 
4.4939 89.878 81.644 11.644 
--- ---
3.6705 73.410 
4.4939 89.878 88.099 2.296 
4.2753 85.507 
.4.4457 88.913 
Method 3050 
As, mg/kg 
11294 
11294 
11294 
11294 
11294 
11294 
11294 
11294 
11294 
Bioavable As, % 
Indiv. Ave. 
1.011 1.040 
LOSO 
1.060 
1.060 1.082 
1.055 
1.130 
1.319 1.341 
1.344 
1.358 
1.963 1.942 
1.956 
1.905 
1.853 1.988 
1.960 
2.149 
2.229 2.256 
2.270 
2.271 
0.650 0.659 
0.675 
0.652 
0.796 0.723 
---
0.650 
0.796 0.780 
0.757 
0.787 
-w 
......:i 
As 
Sample No. Soil Particle Size Rep No. mwl 
1874 S4 < 250u 1 6.397 
1875 S4 < 250 u 2 6.59 
1876 S4 < 250u 3 6.745 
2178 S5 <250 u 1 5.363 
2179 S3 <250 u 2 5.003 
2180 S5 < 250u 3 5.306 
2184 S4 <2mm 1 4.676 
2185 S4 <2mm 2 4.787 
2186 S4 <2mm 3 4.812 
2190 El <250 u I 3.392 
2191 El < 250u 2 3.394 
2192 El <250 u 3 3.455 
2193 E2 < 250 u I 3.895 
2194 E2 < 250 u 2 3.857 
2195 E2 < 250 u 3 3.93 
2196 E3 <250 u 1 5.65 
2197 E3 <250 u 2 5.82 
2198 E3 <250u 3 6.206 
2199 E4 <250 u 1 3.895 
2200 E4 <250 u 2 3.743 
2201 E4 <250 u 3 3.879 
2202 ES <250u 1 4.695 
2203 ES <250u 2 4.832 
2204 ES < 250 u 3 4.642 
2187 BG <2mm 1 2.896 
· 2188 BG <2mm 2 3.092 
2189 BG <2mm 3 3.031 
2205 blank < 0.133 
Table III - 3 
Yamoto Phosphate 
1 g:20 ml, shake 1 hr, room temperature 
Corrected* Individual Average Standard 
As,mwl As, mwkii As, mwkii Deviation 
4.4139 88.277 120.637 28.070 
6.7613 135.227 
6.9204 138.407 
5.5024 110.049 107.196 3.971 
5.1331 102.662 
5.4440 108.879 
4.7976 95.952 97.641 1.485 
4.9115 98.229 
4.9371 98.742 
3.4802 69.604 70.048 0.735 
3.4822 69.645 
3.5448 70.897 
3.9963 79.925 79.905 0.749 
3.9573 79.146 
4.0322 80.644 
5.7969 115.938 120.904 5.846 
5.9713 119.426 
6.3674 127.347 
3.9963 79.925 78.776 l.714 
3.8403 76.806 
3.9799 79.597 
4.8171 96.341 96.916 2.012 
4.9576 99.153 
4.7627 95.254 
2.9713 59.426 61.690 2.058 
3.1724 63.448 
3.1098 62.196 
Method 3050 
As, mg/kg 
11294 
11294 
11294 
11294 
11294 
11294 
11294 
11294 
Bioavable As, % 
· lndiv. Ave. 
0.782 1.068 
1.197 
1.225 
0.974 0.949 
0.909 
0.964 
0.850 0.865 
0.870 
0.874 
0.616 0.620 
0.617 
0.628 
0.708 0.707 
0.701 
0.714 
1.027 1.071 
. 1.057 
1.128 
0.708 0.698 
0.680 
0.705 
0.853 0.858 
0.878 
0.843 
-w 
00 
As 
Sample No. Soil Particle Size Rep No. mg/L 
2254 Cl <250 u I 6.838 
2255 Cl <250 u 2 8.17 
2256 Cl <250u 3 5.074 
2257 C2 <250u I 10.412 
2258 C2 <250 u 2 13.105 
2259 C2 < 250u 3 10.747 
2260 C3 < 250u 1 11.351 
2261 C3 <250u 2 13.6 
2262 CJ <250 u 3 10.352 
2263 C4 <250 u 1 19.037 
2264 C4 <250u 2 20.043 
2265 C4 <250 u 3 18.586 
2266 cs <250u 1 11.833 
2267 cs < 250u 2 11.317 
2268 cs <250u 3 12.931 
2284 C4 <2mm 1 16.121 
2285 C4 <2mm 2 16.831 
2286 C4 <2mm 3 21.884 
2269 SI <250 u 1 1.332 
2270 SI < 250u 2 1.671 
2271 SI < 2S0u 3 1.487 
2272 S2 < 250 u 1 1.64 
2273 S2 <250u 2 1.712 
2274 S2 <250 u 3 3.348 
2275 S3 < 250 u 1 3.348 
2276 SJ <250 u 2 3.329 
2277 S3 < 250 u 3 3.228 
Table III - 4 
Hydroxylamine HCI 
1 g:250 ml, shake 2 hr, 70 C 
Corrected Average 
As, mg/L As,mwkg As, ml!lke 
7.0158 1753.947 1717.011 
8.3824 2095.605 
5.2059 1301.481 
10.6827 2670.678 2929.572 
13.4457 3361.433 
11.0264 2756.606 
11.6461 2911.532 3018.407 
13.9536 3488.400 
10.6212 2655.288 
19.5320 4882.991 4930.443 
20.5641 5141.030 
19.0692 4767.309 
12.1407 3035.165 3084.926 
11.6112 2902.811 
13.2672 3316.802 
16.5401 4135.037 4688.478 
17.2686 4317.152 
22.4530 5613.246 
1.3666 341.658 383.895 
1.7144 428.612 
1.5257 381.416 
1.6826 420.660 413.363 
l.7565 439.128 
1.5212. 380.300 
1.6826 420.660 700.844 
3.4156 853,889 
3.3119 827.982 
Standard Method 3050 
Deviation As, mJVkg 
398.348 11294 
376.462 17456 
426.715 13472 
191.326 11525 
211.434 6245 
806.032 4650 
43.530 10918 
30.085 405 
242.992 450 
Bioavailable As, % 
lndiv. Ave. 
15.53 15.20 
18.56 
11.52 
15.30 16.78 
19.26 
15.79 
21.61 22.41 
25.89 
19.71 
42.37 42.78 
44.61 
41.36 
48.60 49.40 
46.48 
53.ll 
88.93 100.83 
92.84 
120.71 
3.13 3.52 
3.93 
3.49 
103.87 102.06 
108.43 
93.90 
93.48 155.74 
189.75 
184.00 
..... 
w 
l,C) 
As 
Sample No. Soil Particle Size Rep No. mivl.. 
2278 S4 < 250 u l 15.422 
2279 S4 <250 u 2 13.849 . 
2280 S4 < 250u 3 13.43 
2281 S5 < 250 u I 11.641 
2282 S5 < 250 u 2 10.539 
2283 S5 <250u 3 12.207 
2287 S4 <2mm I 9.747 
2288 S4 <2mm 2 10.85 
2289 S4 <2mm 3 10.582 
2293 El < 250 u I 0.779 
2294 El < 250 u 2 0.677 
2295 El < 250 u 3 0.72 
2296 E2 < 250 u I 0.685 
2297 E2 <250 u 2 0.749 
2298 E2 <250u 3 0.991 
2299 E3 <250 u I 2.888 
2300 E3 <250u 2 2.763 
2301 E3 <250 u 3 2.834 
2302 E4 < 250u l 4.708 
2303 E4 <250 u 2 4.713 
2304 E4 <250 u 3 4.773 
2305 ES < 250 u I 1.241 
2306 ES < 250u 2 1.163 
2307 E5 <250u 3 1.203 
2290 BG <2mm I 0.124 
2291* BG <2mm 2 0.066 
2292 BG <2mm 3 0.198 
2308 blank < 0.133 
Table Ill - 4 
Hydroxylamine HCI 
I g:250 ml, shake 2 hr, 70 C 
Corrected Average 
As, mivl.. · As, mg/kg As, mg/kg 
15.8230 3955.743 3650.936 
14.2091 3552.269 
13.1792 3444.795 
11.9437 2985.917 2940.089 
10.8130 2703.254 
12.5244 3131.096 
10.0004 2500.106 2665.805 
11.1321 2783.025 
10.8571 2714.283 
0.7993 199.814 186.048 
0.6946 173.651 
0.7387 184.680 
0.7028 175.703 207.338 
0.7685 192.119 
1.0168 254.192 
2.9631 740.772 725.468 
2.8348 708.710 
2.9077 726.921 
4.8304 1207.602 1213.587 
4.8355 1208.885 
4.8971 1224.275 
l.2733 318.317 308.399 
l.1932 298.310 
1.2343 308.570 
0.1272 31.806 33.174 
0.0677 16.929 
0.2031 50.787 
Standard Method 3050 Bioavailable As, % 
Deviation As, mg/kg Indiv. Ave. 
269.385 1180 335.23 309.40 
301.04 
291.93 
217.571 5022 59.46 58.54 
53.83 
62.35 
147.558 3158 79.17 84.41 
88.13 
85.95 
13.135 331 85.76 79.85 
74.53 
79.26 
41.399 233 21.96 25.92 
24.01 
31.77 
16.081 800 50.63 49.59 
48.44 
49.69 
9.278 1463 301.15 302.64 
301.47 
305.31 
10.005 401 79.38 76.91 
74.39 
76.95 
16.970 
* As concentration represents 1/2 detection limit as this was too low to read. 
-..(::,. 
0 
Table Ill- 5 
Ammonium Oxalate/Oxalic Acid/ Ascorbic Acid Extracts 
- ,..... - - - ----, - - ----- -- - . -
As As; Ave Standard Method 3050 Bioavailable As, % 
Sample No. Soil Particle Sizt Rep No. ml!/1... mWk~ ml!lke: ·oeviation As, mg/kg Indiv. Ave. 
2479 Cl <250u I 75.606 7560.60 7454.07 177.30 11294 66.94 66.00 
2480 Cl <250u 2 72.494 7249.40 64.19 
2481 Cl <250u 3 75.522 7552.20 66.87 
2482 C2 <250 u I ll5.27 ll527.30 12616.03 992.28 17456 66.04 72.27 
2483 C2 <250u 2 134.7 13469.60 77.16 
2484 C2 <250u 3 128.51 12851.20 73.62 
2485 C3 <250u 1 85.898 8589.80 9046.93 462.13 13472 63.76 67.15 
2486 C3 <250u 2 90.371 9037.10 67.08 
2487 C3 <250u 3 95.139 9513.90 70.62 
2488 C4 <250u 1 80.06 8006.00 8129.97 728.01 11525 69.47 70.54 
2489 C4 <250u 2 89.12 8912.00 77.33 
2490 C4 <250u 3 74.719 7471.90 64.83 
2491 cs <250u 1 48.248 4824.80 4951.30 216.94 6245 77.26 79.28 
2492 cs <250u 2 48.273 4827.30 77.30 
2493 cs <250u 3 52.018 5201.80 83.30 
2509 C4 <2mm 1 52.536 5253.60 5402.87 371.09 10918 48.12 49.49 
2510 C4 <2mm 2 52.151 5215.10 47.77 
2511 C4 <2mm 3 57.399 5739.90 52.57 
2494 SI <250u I 4.29 429.00 408.63 17.65 405 105.93 100.90 
\ 
2495 SI <250u 2 3.991 399.10 98.54 
2496 SI <250u 3 3.978 397.80 98.22 
2497 S2 <250 u 1 5.324 532.40 545.93 12.86 450 118.31 121.32 
2498 S2 <250u 2 5.58 558.00 124.00 
2499 S2 <250u 3 5.474 547.40 121.64 
2500 S3 < 250u I 12.855 1285.50 1213.97 73.36 1180 108.94 102.88 
2501 S3 < 250u 2 11.389 1138.90 96.52 
2502 S3 < 250 u. 3 12.175 1217.50 103.18 
,_. 
.i:,.. 
,_. 
Table III - 5 
Ammonium Oxalate/Oxalic Acid/ Ascorbic Acid Extracts 
- ~-- - ----,, -- ------ --1 - - -
As As,Ave Standard Method 3050 Bioavailable As, % 
Sample No. Soil Particle Size Rep No. mJUL mw'k2 mw'k2 Deviation As, mw'k2 lndiv. Ave. 
2503 . S4 <250u 1 39.662 3966.20 4030.07 117.53 5022 78.98 80.25 
2504 S4 < 250u 2 41.657 4165.70 82.95 
2505 S4 <250u 3 39.583 3958.30 78.82 
2506 S5 <250 u 1 33.028 3302.80 3330.57 25.99 4650 71.03 71.63 
2507 S5 <250u 2 33.346 3334.60 71.71 
2508 S5 <250u 3 33.543 3354.30 72.14 
2512 S4 <2mm I 19.426 1942.60 2134.73 44.26 3158 61.51 67.60 
2513 S4 <2mm 2 21.995 2199.50 69.65 
2514 S4 <2mm 3. -22.621 2262.10 71.63 
2518 El < 250u I 4.634 463.40 461.47 15.89 331 140.00 139.42 
2519 El <250u 2 4.763 476.30 143.90 
2520 El <250u 3 4.447 444.70 134.35 
2521 E2 <250u 1 4.551 455.10 454.33 5.29 233 195.32 194.99 
2522 E2 <250u 2 4.487 448.70 192.58 
2523 E2 <250u 3 4.592 459.20 197.08 
2524 E3 <250u 1 5.941 594.10 591.37 10.76 800 74.26 73.92 
2525 E3 <250u 2 6.005 600.50 75.06 
2526 E3 <250u 3 5.795 579.50 72.44 
2527 E4 <250u I 4.111 411.10 437.93 25.28 1463 28.10 29.93 
2528 E4 <250u 2 4.613 461.30 31.53 
2529 E4 <250u 3 4.414 441.40 30.17 
2530 E5 <250 u 1 5.678 567.80 551.73 18.91 401 141.60 137.59 
2531 ES <250u 2 5.565 556.50 138.78 
2532 E5 <250u 3 5.309 530.90 132.39 
2515 BG <2mm I 2.914 291.40 287.77 1.34 
2516 BG <imm 2 2.869 286.90 
2517 BG <2mm 3 2.85 285.00 
2533 lank 0.25 
-~ 
Sample No. Soil Particle Size Rep No. 
2771 Cl <250 u 1 
2772 Cl <250 u 2 
2773 Cl <250 u 3 
2774 C2 <250u I 
2775 · C2 <250 u 2 
2776 C2 <250 u 3 
2777 CJ <250 u I 
2778 CJ <250 u 2 
2779 CJ <250 u 3 
2780 C4 <250u I 
2781 C4 <250 u 2 
2782 C4 <250u 3 
2783 cs <250u 1 
2784 cs <250 u 2 
2785 cs <250 u 3 
2801 C4 <2mm I 
2802 C4 <2mm 2 
2803 C4 <2mm 3 
2786 SI <250 u I 
2787 SI <250 u 2 
2788 SI <250u 3 
2789 S2 <250 u 1 
2790 S2 <250u 2 
2791 S2 <250u 3 
2792 S3 <250 u 1 
2793 S3 <250 u 2 
2794 SJ <250u 3 
Table III - 6 
Sodium Hydroxide/Sodium Chloride Extracts 
0.8 g:40 ml, shake 17 hr@ RT, dilute to 50 ml 
As Standard 3505 As 
mg/L . mgtkg Ave, mg/kg . Deviation mg/kg 
17.14 1071.25 1017.58 64.997 11294 
16.579 1036.19 
15.125 945.31 
29.603 lisoo.44 1818.54 51.541 17456 
28.224 1764.00 
29.203 1825.19 
24.7 1543.75 1468.27 65.388 13472 
22.862 1428.88 
22.915 1432.19 
8.639 539.94 528.21 12.645 11525 
8.237 514.81 
8.478 529.88 
5.148 321.75 317.73 3.632 6245 
5.035 314.69 
5.068 316.75 
0 0.UlJ 187.63 IU918 
3.002 187.63 
0 0.00 
3.U92 193.25 190.09 3.241 405 
3.154 197.13 
3.195 199.69 
3.185 199.06 200.90 l.91SJ 450 
3.21 200.63 
3.248 203.00 
3.765 235.31 2]6.17 3.115] 1180 
3.725 232.81 
3.846 240.38 
B10available As, % 
lndiv. Ave . 
9.485 9.01 
9.175 
8.370 
10.692 IU.42 
10.105 
10.456 
11.459 10.90 
10.606 
10.631 
4.b85 4.58 
4.467 
4.598 
5.152 5.09 
5.039 
5.072 
0.000 0.57 
1.718 
0.000 
47.716 48.~6 
48.673 
49.306 
44.236 44.64 
44.583 
45.111 
19.942 20.01 
19.730 
20.371 
..... 
..r:,. 
w 
Sample No. Soil Particle Size Rep No. 
2795 S4 <250 u 1 
2796 S4 <250 u 2 
2797 S4 <250 u 3 
2798 S5 <250 u 1 
2799 S5 <250 u 2 
2800 S5 <250 u 3 
2804 S4 <2mm I 
2805 S4 <2mm 2 
2806 S4 <:'.2mm 3 
2807 El <250 u 1 
2808 El <250u 2 
2809 EI <250 u 3 
2810 E2 <250 u 1 
2811 E2 <250 u 2 
2812 E2 <250 u 3 
2813 E3 <250 u 1 
2814 E3 <250 u 2 
2815 E3 <250 u 3 
2816 E4 <250 u 1 
2817 E4 <250 u 2 
2818 E4 <250 u 3 
2819 ES <250 u 1 
2820 ES <250 u 2 
2821 ES <250u 3 
Table III - 6 
Sodium Hydroxide/Sodium Chloride Extracts 
0.8 g:40 ml, shake 17 hr@ RT, dilute to 50 ml 
As Standard 3505 As 
mg/L mg/kg Ave, mg/kg Deviation mg/kg 
5.15 321.88 328.10 9.264 5022 
5.42 338.75 
5.179 323.69 
4.768 298.UO 300.63 2.565 4650 
4.85 303.13 
4.812 300.75 
3.052 190.75 190.88 110.202 3158 
0 0.00 
3.056 191.00 
3.446 215.38 212.90 2.147 331 
3.387 211.69 
3.386 211.63 
3.314 207.13 210.81 3.356 233 
3.386 211.63 
3.419 213.69 
3.082 192.63 195. I 9 2.967 800 
3.175 198.44 
3.112 194.50 
6.917 432.31 462.54 27.311 1463 
7.767 485.44 
7.518 469.88 
4.376 273.50 274.58 1.823 401 
4.427 276.69 
4.377 273.56 
B1oavailable As, % 
Indiv. Ave. 
6.409 6.53 
6.745 
6.445 
6.409 6.47 
6.519 
6.468 
6.040 4.03 
0.000 
6.048 
65.068 64.32 
63.954 
63.935 
88.895 90.48 
90.826 
91.711 
24.078 24.40 
24.805 
24.313 
29.550 31.62 
33.181 
32.117 
68.204 68.47 
68.999 
68.220 
...... 
~ 
~ 
Table III - 7 
Raw data for 3050 extracts of 250 micron fraction. Concentrations are in ppm. 
Sample Sample ID As Pb Cu 
No. ID Solution Soil Ave/StDev Solution Soil Ave/StDev Solution Soil Ave/StDev 
222 Cl-I 112.94 11294 11366 120.98 12098 11976 4.11 411 403 
223 Cl-2 115.31 11531 143 ll9.94 11994 . 132 4.02 402 7 
124 Cl-3 112.73 11273 118.36 11836 3.97 397 
225 C2-l 174.56 17456 17279 149.74 14974 14847 3.53 353 351 
226 C2-2 175.37 17537 379 151.89 15189 420 3.6 360 ll 
227 C2-3 168.43 16843 143.79 14379 3.39 339 
228 C3-l 134.72 13472 13518 l 14.72 11472 11640 3.95 395 402 
229 C3-2 136.62 13662 127 118.13 11813 171 4.11 411 8 
230 C3-3 134.2 13420 116.35 I 1635 4.01 401 
231 C4-I 115.25 11525 11648 91.52 9152 9204 4.93 493 495 
232 C4-2 115.9 11590 161 91.85 9185 63 4.9 490 6 
233 C4-3 118.3 11830 92.74 9274 . 5.02 502 
234 C5-I 62.45 6245 6607 52.55 5255 5528 6.77 677 713 
235 C5-2 66.72 6672 334 56.16 5616 241 7.19 719 34 
236 C5-3 69.04 6904 57.13 5713 7.44 744 
237 Blank 0 0 0.15 0.03 
238 S 1-1 4.05 405 466 62.77 I 6277 6738 13.24 1324 1422 
239 Sl-2 4.9 490 53 69.l 6910 403 14.71 1471 85 
240 S 1-3 5.02 502 70.26 7026 14.7 1470 
241 S2-l 4.5 450 422 40.41 4041 3845 12.04 1204 1151 
242 S2-2 3.83 383 35 36.77 3677 184 10.92 1092 56 
243 S2-3 4.32 432 38.17 3817 11.57 1157 
244 S3-l 11.8 1180 1213 52.6 5260 5379 23.71 2371 2445 
245 S3-2 12.17 1217 31 54 5400 110 24.68 2468 66 
246 S3-3 12.41 1241 54.78 5478 24.96 2496 
Ni 
Solution Soil 
0.38 38 
0.25 25 
0.39 39 
0.55 55 
0.25 25 
0.29 29 
0.2 20 
0.3 30 
0.19 19 
0.6 60 
0.17 17 
0.16 16 
0.27 27 
0.27 27 
0.21 21 
0.15 
0.53 53 
0.29 29 
0.29 29 
0.23 23 
0.87 87 
0.39 39 
0.35 35 
0.64 64 
0.25 25 
Ave/StDev 
34 
8 
36 
16 
23 
6 
31 
25 
25 
3 
37 
14 
50 
33 
41 
20 
..... 
.,I::,. 
V, 
Table III - 7 
Raw data for 3050 extracts of250 micron fraction. Concentrations are in ppm. 
Sample Sample ID As Pb Cu Ni 
No. ID Solution Soil Ave/StDev Solution Soil Ave/StDev Solution Soil Ave/StDev Solution Soi.I Ave/StDev 
247 S4-l 50.22 5022 5068 210.73 21073 20412 55.22 5522 5359 0.31 31" 40 
248 S4-2 50.96 5096 40 201.37 20137 575 53.54 . 5354 160 0.47 47 8 
249 S4-3 50.87 5087 200.26 20026 52.02 5202 0.41 41 
250 S5-l 46.5 4650 4470 193.92 19392 18930 52.97 5297 5307 0.33 33 44 
251 S5-2 43.5 4350 159 187.16 18716 400 53.52 5352 41 0.53 53 10 
252 S5-3 44.11 4411 186.83 18683 52.71 5271 0.46 46 
253 Blank 0 0.2 0.07 0.12 
-. .i:,. 
°' 
Table lII-7 
Sample Sample ID Ti Zn 
No. ID Solution Soil Ave/StDev Solution Soil Ave/StDev 
222 Cl-I 1.23 123 116 19.44 1944 1942 
223 Cl-2 . 1.09 109 7 19.36 1936 6 
224 Cl-3 1.15 115 19.47 1947 
225 C2-1 1.07 107 108 20.37 2037 2065 
226 C2-2 1.07 107 2 21.3 2130 . 56 
227 C2-3 l.l l 111 .20.28 2028 
228 C3~t 1.39 139 140 18.89 1889 1893 
229 C3-2 1.38 138 2 18.89 1889 7 
230 C3-3 1.42 142 . 19;01 1901 
231 C4-I 1.8 180 171 18 .. 11 1811 1841 
232 C4-2 1.61 161 to 18.52 1852 26 
233 C4-3 l.73 173 18.6 1860 
234 C5-1 2.41 241 265 48.03 4803 5051 
235 C5-2 2.85 285 22 50.74 5074 238 
236 C5-3 2.68 268 52.77 5277 
237 Blank 0.01 () 
238 Sl-1 6.79 679 712 249.05 24905 25872 
239 Sl-2 7.01 701 40 261.87 26187 854 
240 Sl-3 7.56 756 265.23 26523 
241 S2-l 5.85 585 574 145.46 14546 13910 
242 S2-2 5.63 563 II 136.51 13651 554 
243 S2-3 5.74 574 135.32 13532 
244 S3-l 4.89 489 532 25.78 2578 2640 
245 S3-2 5.45 545 39 26.37 2637 63 
246 S3-3 5.63 563 27.04 2704 
-~ 
-....} 
Table III.- 7 
Sample Sample ID Ti Zn 
No. ID Solution Soil Ave/StDev Solution Soil Ave/StDev 
247 S4-l 3.98 398 404 50.44 5044 5166 
248 S4-2 4.II 411 7 52.27 5227 106 
249 S4-3 4.03 403 52.27 5227 
250 S5-I 3.67 367 364 45.84 4584 45 I I 
251 · S5-2 3.59 359 4 44.49 4449 68 
252 S5-3 3.66 366 45 4500 
253 Blank 0.01 0 
-..i:,.. 
~,~ 
Table III- 8 
Raw data fod050 extrac_ts of 2 mm fraction. Concentrations are mg/I in solution and mg/kg soil. 
Sample Sample As Cr Cu Ni 
No. ID mg/kg Ave mg/kg mg/kg Ave mg/kg mg/kg Ave mg/kg mg/kg Ave mg/kg 
1383 Cl-I 11309.6 11301.67 30.3 29.43 385.4 385.13 39.3 39~10 
1384 Cl-2 11251.6 27.6 373 36.6 
1385 Cl-3 11343.8 30.4 397 41.4 
1386 C2-l 16314.6 15995.53 22.I 21.60 327.6 318.87 35.3 35.93 
1387 C2-2 16005.3 21.6 318.7 36.7 
1388 C2-3 15666.7 21.1 310.3 35.8 
1389 CJ-I 14516.3 13418.53 27.4 25.83 392.8 384.13 31.8 31.40 
1390 CJ-2 12695 24.7 371.3 30.9 
1391 C3-3 13044.3 25.4 388.3 31.5 
1392 C4-l 10958.4 10918.27 25.8 25.40 541.4 524.27 30.5 32.17 
1393 C4-2 10748.1 25.2 530.7 31.1 
1394 C4-3 11048.3 25.2 500.7 34.9 
1395 CS-I 6178.8 6288.40 42.9 46.43 1021.4 996.50 36 37.40 
1396 CS-2 6146.I 53.2 1006.8 38.8 
1397 C5-3 6540.3 43.2 961.3 37.4 
1398 SI-I 664.7 647.93 200.5 198.40 1775.2 1806.93 25.1 24.47 
1399 Sl-2 632.9 198.7 1776 22.8 
1400 Sl-3 646.2 196 1869.6 25.5 
1401 S2-I 555.l 556.93 ISO.I 151.00 1568.7 1606.37 25.5 24.37 
1402 S2-2 542.5 153.4 1607.3 24.3 
1403 S2-3 573.2 149.5 1643.1 23.3 
1404 S3-1 751.6 720.60 38 35,60 2228.6 2207.53 31.8 31.87 
1405 S3-2 703.9 33.6 2204 29.1 
1406 SJ-3 706.3 35.2 2190 34.7 
-~ \0 
Sample Sample 
No. ID 
1407 S4-1 
1408 S4-2 
1409 S4-3 
1410 S5-1 
1411 S5-2 
1412 s5.3· 
1413 Blank 
Table III- 8 
Raw data for 3050 extracts of2 mm fraction. Concentrations are mg/I in solution and mg/kg soil. 
As Cr Cu Ni 
mg/kg Ave mg/kg mg/kg Ave mg/kg mg/kg Ave mg/kg mg/kg Ave mg/kg 
3033..4 3157.73 37.5 43.20 3990.4 4228.03 35.4 35.27 
3253.2 43.4 4425.1 36.1 
3186.6 48.7 4268;6 34.3 
2665.7 2711.77 43.7 48.50 3958.7 4009.17 32.l 33.97 
2706.2 46.8 4002 33,2 
2763.4 55 4066.8 36.6 
3.7 0.1 2.6 0 
..... 
Vl 
0 
Table III - 8 
Sample Sample Pb Ti Zn 
No. ID mg/kg Ave mg/kg mg/kg · Ave mg/kg - mg/kg Ave mg/kg 
1383 Cl-1 11764.3 11071.50 98.3 94.97 1649.8 1598.77 
1384 Cl-2 10436.8 91.4 1554.6 
1385 Cl-3 11013.4 95.2 1591.9 
1386 C2-l 12034.4 12105.03 90.7 92.03 1651.5 1612.63 
1387 C2-2 12385.9 95.4 1614.5 
1388 C2-3 11894.8 90 1571.9 
1389 C3-l 12139.4 10983.00 130.5 129.70 1677.7 1644.50 
1390 C3-2 10265.3 127.9 1610.9 
1391 C3-3 10544.3 130.7 1644.9 
1392 C4-l 8592.7 8430.57 162.5 163.37 1670.4 1654.53 
1393 C4-2 8235.1 167.5 1645 
1394 C4-3 8463.9 160.1 1648.2 
1395 C5-I 5879.2 5528.30 305.5 298.67 4896.6 4740.37 
1396 C5-2 5234.6 301.2 4660.6 
1397 C5-3 5471.1 289.3 4663.9 
1398 S 1-1 8636 8735.63 0 0.00 0 0.00 
1399 Sl-2 9002.6 0 0 
1400 Sl-3 8568.3 0 0 
1401 S2-I 6721.6 6834.53 0 0.00 · 0 0.00 
1402 S2-2 6912.1 0 0 
1403 S2-3 6869.9 0 0 
1404 S3-l 3655.9 3511.73 626.5 606.47 . 2593.8 2507.00 
1405 S3-2 3413.3 590 2432.4 
1406 S3-3 3466 602.9 2494.8 
...... 
V', 
...... 
Sample Sample Pb 
No. ID mg/kg Ave mg/kg 
1407 S4-1 12090.2 12611.70 
1408 S4-2 12944 
1409 S4-3 12800.9 
1410 S5-l 11414.1 11526.03 
1411 S5-2 11538.3 
1412 S5-3 11625.7 
1413 Blank 0 
. Table III - 8 
Ti 
. mg/kg Ave mg/kg 
456.4 465.73 
478.6 
462.2 
410 424.53 
419.4 
444.2 
0 
mg/kg 
4062.3 
4070.9 
3998.1 
3317.8 
3403.4 
3475.7 
0 
Zn , 
Ave mg/kg 
4043.77 
3398.97 
-Vi N 
Sample No. Soil Particle Sizf Rep No. mg/L 
l Cl < 250u 1 30.096 
2 Cl <250u 2 235.74 
3 Cl <250u 3 115.92 
4 C2 < 250u 1 41.327 
5 C2 <250u 2 129.82 
6 C2 <250 u 3 271.43 
7 CJ <250u 1 65.456 
8 CJ <250u 2 84.332 
9 CJ <250u 3 35.749 
IO C4 <250 u 1 42.398 
11 C4 <250 u 2 53.648 
12 C4 <250u 3 65.843 
13 cs <250 u 1 93.71 
14 cs <250u 2 89.173 
15 cs < 250u 3 73.727 
16 SI <250u 1 48.607 
17 SI <250 u 2 58.977 
18 SI <250u 3 33.953 
19 S2 <250u 1 60.716 
20 S2 <250u 2 65.669 
21 S2 <250u 3 49.398 
22 SJ <250u 1 78.519 
23 S3 < 250u 2 152.23 
24 S3 <250u 3 98.953 
Table III - 9 
Water Soluble Anions 
1 2 soil: 20 ml deionized 
Cl 
mg/kg Ave. mg/kg Std. Dev. 
601.920 2545.073 2065.803 
4714.840 
2318.460 
826.540 2950.473 2321.336 
2596.360 
mg/L 
7730.82 
7925.69 
8085.7 
4212.81 
4141.32 
5428.520 · 4113.73 
1309.120 1236.913 489.838 ll5l.3 
1686.640 1176.44 
714.980 1177.53 
847.960 1079.260 234.513 11278. l 
1072.960 11262.8 
1316.860 11097 
1874.200 1710.733 209.521 10992.2 
1783.460 11015.4 
1474.540 10958.8 
972.140 943.580 251.459 65.792 
1179.540 76.291 
679.060 54.093 
1214.320 1171.887 166.808 161.003 
1313.380 163.214 
987.960 168.827 
1570.380 2198.007 761.098 523.075 
3044.580 510.647 
1979.060 542.665 
S04-S 
mg/kg Ave. mg/kg 
154616.320 158281.387 
158513.760 
161714.080 
84256.220 83119.073 
82826.440 
82274.560 
23025.980 23368.440 
23528.820 
23550.520 
225562.480 224252.567 
225255.620 
221939.600 
219843.500 219775.833 
220307.440 
219176.560 
1315.840 1307.840 
1525.820 
1081.860 
3220.060 3286.960 
3264.280 
3376.540 
10461.500 i0509.247 
10212.940 
10853.300 
Std. Dev. 
3554.581 
1022.727 
296.777 
2008.955 
568.469 
222;088 
80.668 
322.839 
..... 
Ul 
w 
Sample No. Soil Particle Size Rep No. mg/L 
25 S4 <250 u 1 47.34 
26 S4 < 250 u 2 46.838 
27 S4 <250 u 3 52.262 
28 S5 < 250 u 1 55.385 
29 S5 < 250 u 2 51.577 
30 S5 <250u 3 62.397 
31 El < 250 u I 120.2 
32 El < 250 u 2 292.99 
33 El < 250 u 3 220.44 
34 E2 <250 u I 610.34 
35 E2 < 250 u 2 374.81 
36 E2 < 250 u 3 494.99 
37 E3 < 250 u I 28.083 
38 E3 < 250 u 2 35.49 
39 E3 < 250 u 3 73.287 
40 E4 < 250 u 1 94.685 
41 E4 < 250 u 2 22.694 
42 E4 << 250 u 3 249.53 
43 E5 < 250 u 1 762.39 
44 E5 <2~0 u 2 698.47 
45 E5 <250u 3 664.81 
46 C4 <2mm I 174.32 
47 C4 <2mm 2 177.04 
48 C4 <2mm 3 103.02 
Table III - 9 
Water Soluble Anions 
·1: 20 ml deionized 
Cl 
mg/kg Ave. mg/kg Std. Dev. 
946.800 976.267 59.943 
936.760 
1045.240 
1107.700 1129.060 109.770 
1031.540 
1247.940 
2404.060 4224.200 1735.229 
5859.760 
4408.780 
12206.800 9867.600 2355.434 
7496.260 
9899.740 
561.660 912.400 484.897 
709,800 
1465.740 
1893.700 2446.047 2318.228 
453.880 
4990.560 
15247.820 14171.107 991.351 
13969.340 
13296.160 
3486.380 3029.160 839.428 
3540.720 
2060.380 
mg/L 
144.122 
141.112 
149.485 
127.221 
126.954 
125.165 
10998.2 
11071.1 
11099.6 
17284.2 
16975.2 
17817 
135.847 
111.981 
124.751 
67.099 
67.708 
69.171 
470.357 
468.622 
478.384 
46.455 
50.335 
45.223 
S04-S 
mg/kg Ave. mg/kg 
2882.440 2898.127 
2822.240 
, 
2989.700 
2544.420 2528.933 
2539.080 
2503.300 
219963.560 221126.133 
221422.400 
221992.440 
345684.600 347175.853 
339503.520 
356339.440 
2716.940 2483.860 
2239.620 
2495.020 
1341.980 1359.853 
1354.160 
1383.420 
9407.140 9449.087 
9372.440 
9567.680 
929.100 946.753 
1006.700 
904.460 
Std. Dev. 
84.825 
22.359 
1046.384 
8516.450 
238.856 
21.299 
104.160 
53.357 
....... 
Vl 
.i:,.. 
Sample No. Soil Particle Sizf Rep No. mg/L 
49 S4 <2mm 1 53.878 
so S4 <2mm 2 1485.1 
51 S4 <2mm 3 40.559 
52 BG <2mm 1 43.568 
53 BG <2mm 2 44.34 
54 BG <2mm 3 40.337 
Table III - 9 
Water Soluble Anions 
I i? soil: 20 ml deionized 
Cl 
mg/kg Ave. mg/kg Std. Dev. 
1077.560 10529.913 16603.182 
29701.000 
811.180 
871.360 854.967 42.473 
886.800 
806.740 
mg/L 
11013.8 
11504.7 
11289 
111.668 
94.156 
90.852 
S04-S 
mg/kg Ave. mg/kg 
220275.160 225382.933 
230093.680 
225779.960 
2233.360 1977.840 
1883.120 
1817.040 
Std. Dev. 
4921.286 
223.740 
-Vt Vt 
Sample No. Soil Particle Size Rep No. 
49 S4 <2mm 1 
so S4 <2mm 2 
51 S4 <2mm 3 
52 BG <2mm 1 
53 BG <2mm 2 
54 BG <2mm 3 
Table III - 9 
N03-N 
mg/L mg/kg Ave. mg/kg 
12.7 254.340 290.880 
16.5 330.060 
14.4 288.240 
16.6 332.200 290.693 
11.8 235.600 
15.2 304.280 
Std. Dev. 
37.929 
49.713 
...... 
Vl 
O'I 
Sample No. Soil Particle Sizf Rep No. 
1 Cl <250u 1 
2 Cl <250u 2 
3 Cl <250u 3 
4 C2 <250u I 
s C2 <250u 2 
6 C2 <250u 3 
7 CJ <250u I 
8 CJ <250u 2 
9 CJ <250u 3 
10 C4 < 250u I 
11 C4 <250u 2 
12 C4 <250u 3 
13 cs <250 u I 
14 cs · <250u 2 
15 cs <250u 3 
16 SI <250 u I 
17 SI <250u 2 
18 SI <250u 3 
19 S2 <250u l 
20 S2 <250 u 2 
21 S2 <250u 3 
22 SJ <250 u I 
23 SJ < 250 u 2 
24 SJ <250u 3 
mg/L 
6.7 
2.48 
6.2 
0 
3.7 
20.3 
13.8 
0 
1.21 
0 
0 
7.41 
9.24 
8.02 
27.3 
8.36 
7.27 
6.4 
43.6 
46 
51.7 
22.2 
25.6 
28.3 
Table III - 9 
NOJ-N 
mg/kg Ave. mg/kg 
134.060 102.547 
49.640 
123.940 
0.000 159.860 
73.900 
405.680 
276.840 100.313 
0.000 
24.100 
0.000 49.407 
0.000 
148.220 
184.700 297.260 
160.340 
546.740 
167.280 146.947 
145.480 
128.080 
871.020 941.693 
920.600 
1033.460 
. 443.500 507.000 
512.400 
565.100 
Std. Dev. 
46.097 
216.069 
153.351 
85.575 
216.399 
19.641 
83.249 
60.980 
-VI 
.....J 
Sample No . Soil Particle Sizf Rep No. 
25 S4 <250u 1 
26 S4 <250u 2 
27 S4 ·<250 u 3 
28 SS <250u I 
29 SS <250 u 2 
30 SS <250u 3 
31 El <250u 1 
32 El <250u 2 
33 El <250u 3 
34 E2 <250u 1 
35 E2 <250u 2 
36 E2 <250u 3 
37 E3 <~50 u 1 
38 E3 <250 u 2 
39 E3 <250 u 3 
40 E4 <250u I 
41 E4 <250u 2 
42 . E4 <250u 3 
43 ES < 250u 1 
44 ES <250u 2 
45 ES < 25·0 u 3 
46 C4 <2mm 1 
47 C4 <2mm 2 
48 C4 <2mm 3 
mg/L 
18.2 
29 
35.6 
41 
26.4 
26.8 
19.4 
15.8 
13.3 
124 
131 
116 
2.29 
3.59 
2.2 
4.98 
0 
6.65 
44.3 
43.7 
43.4 
43.8 
38.4 
30.8 
Table III - 9 
N03-N 
mg/kg Ave. mg/kg 
364.300 552.213 
580.)00 
712.240 
820.580 628.227 
528.040 
536.060 
388.820 323.880 
315.980 
266.840 
2473.100 2471.267 
2617.420 
2323.280 
45.780 53.827 
71.760 
43.940 
99.580 77.520 
0.000 
132.980 
885.540 875.880 
874.940 
867.160 
875.500 753.220 
767.900 
616.260 
Std. Dev. 
175.638 
166.631 
61.373 
147.079 
15.558 
69.180 
9.226 
130.242 
..... 
VI 
00 
Sample No. Soil Particle Size Rep No. 
49 S4 <2mm 1 
50 S4 <2mm 2 
51 S4 <2mm 3 
52 BG <2mm l 
53 BG <2mm 2 
54 BG <2mm 3 
Table III - 9 
N03-N 
mg/L mg/kg Ave. mg/kg 
12.7 254.340 290.880 
16.5 330.060 
14.4 288.240 
16.6 332.200 290.693 
11.8 235.600 
15.2 304.280 
Std. Dev. 
17.929 
49.713 
...... 
V. 
\0 
160 
Table III - I 0 
Toxicity Characteristic Leaching Procedure (TCLP) 
I g:20 ml, shake rt 18 hrs 
As Average Standard Bioavailable 
Sample No. Soil Particle Size Rep No. mg/L mg/kg As, mg/kg Deviation As,% 
2853 Cl <250 u 1 3.028 2.969 60.56 59.38 1.03 0.53 
2854 Cl <250u 2 2.934 58.68 
2855 Cl <250 u 3 2.945 58.90 
2856 C2 <250 u l 3.095 3.0137 61.90 60.27 1.68 0.35 
2857 C2 <250 u 2 3.019 60.38 
2858 C2 <250u 3 2.927 58.54 
2859 C3 <250 u l 3.035 3.0267 60.70 60.53 0.16 0.45 
2860 C3 <250u 2 3.019 60.38 
2861 C3 <250u 3 3.026 60.52 
2862 C4 <250 u 1 2.98 2.941 59.60 58.82 0.68 0.51 
2863 C4 <250u 2 2.924 58.48 
2864 C4 <250 u 3 2.919 58.38 
2865 cs <250 u l 2.957 3.0007 59.14 60.01 0.77 0.96 
2866 cs <250u 2 3.016 60.32 
2867 cs <250u 3 3.029 60.58 
2868 Sl <250u I 3.082 2.961 61.64 59.22 2.28 14.62 
2869 Sl <250 u 2 2.945 58.90 
2870 SI <250u 3 2.856 57.12 
2871 S2 <250 u 1 2.788 2.7817 55.76 55.63 2.49 12.36 
2872 S2 <250 u 2 2.903 58.06 
2873 S2 <250u 3 2.654 53.08 
2874 S3 <250 u 1 2.803 2.9057 56.06 58.11 1.79 4.92 
2875 S3 <250 u 2 2.965 59.30 
2876 S3 <250 u 3 2.949 58.98 
2877 S4 <250u I 3.108 3.172 62.16 63.44 1.16 1.26 
2878 S4 <250u 2 3.221 64.42 
2879 S4 <250u 3 3.187 63.74 
2880 S5 <250 u I 2.95 2.9293 59.00 58.59 0.82 1.26 
2881 S5 <250u 2 2.882 57.64 
2882 S5 <250 u 3 2.956 59.12 
2883 El <250 u 1 2.643 2.649 52.86 52.98 0.55 16.01 
2884 El <250 u 2 2.679 53.58 
2885 El <250 u 3 2.625 52.50 
2886 E2 <250u 1 2.792 2.754 55.84 55.08 0.67 23.64 
2887 E2 <250u 2 2.741 54.82 
2888 E2 <250 u 3 2.729 54.58 
Sample No. Soil 
2889 E3 
2890 E3 
2891 E3 
2892 E4 
2893 E4 
2894 E4 
2895 ES 
2896 ES 
2897 ES 
2898 C4 
2899 C4 
2900 C4 
2901 S4 
2902 S4 
2903 S4 
2904 BG 
2905 BG 
2906 BG 
Table III - 10 
Toxicity Characteristic Leaching Procedure (TCLP) 
I g:20 ml, shake rt 18 hrs 
As Average 
Particle Size Rep No. mg/L mg/kg As, mg/kg 
<250 u 1 2.579 2.6117 51.58 52.23 
<250u 2 2.629 52.58 
<250 u 3 2.627 52.54 
<250u l 2.474 2.725 49.48 54.50 
<250 u 2 2.86 57.20 
<250 u 3 2.841 56.82 
<250 u l 3.021 2.9493 60.42 58.99 
<250 u 2 2.934 58.68 
<250u 3 2.893 57.86 
<2mm 1 2.707 2.8317 54.14 56.63 
<2mm 2 2.836 56.72 
<2mm 3 2.952 59.04 
<2mm 1 3.5 3.418 70.00 68.36 
<2mm 2 3.508 70.16 
<2mm 3 3.246 64.92 
<2mm I 2.767 2.7577 55.34 55.15 
<2mm 2 2.751 55.02 
<2mm 3 2.755 55.10 
161 
Standard Bioavailable 
Deviation As,% 
0.57 6.53 
4.35 3.73 
1.31 14.71 
1.64 
3.71 
0.06 
Very Coarse Sand Coarse Sand Medium Sand 
Sample ID 1.0-2.0 mm 0.50-1.0 mm 0.25-0.5_0 mm 
Cl 0.1 0.9 1.1 
C2 0.0 0.1 0.2 . 
C3 0.0 0.0 0.0 
C4 0.0 0.0 0.6 
cs 0.0 0.0 0.1 
SI 0.0 0.0 0.1 
S2 0.0 0.0 0.0 
S3 0.0 0.0 0.0 
S4 0.0 0.0 0.1 
ss 0.0 0.0 0.0 
BG 1.9 6.4 6.9 
Sample ID Texture <SO um 
Cl Silt Loam S 1.6 
C2 Loam 49.8 
C3 Loam 57.4 
C4 Silt Loam 45.5 
cs Loam 49.4 
SI Fine Silt Loam 30.2 
S2 Loam 59.1 
S3 Fine Silt Loam 36.S 
S4 Fine Silt Loam 45.1 
ss Fine Silt Loam 45:6 
BG Loam 55.2 
Table III - 11 
Soil Texture - Pipette Method 
Fine Sand Very Fine Sand Coarse Silt Medium Silt Fine Silt Clay 
.J0-0.25 m 0.05-0.10 mm .02-0.05 m .005-0.02 m .002-0.005 m 0.002 m 
22.8 23.S 20.8 18.1 7.0 5.7 
28.5 21.3 20.8 14.7 4.2 IO.I 
19.2 23.5 22.9 16.6 4.5 13.4 
29.2 25.0 22.2 10.9 2.6 9.8 
20.5 30.3 24.7 13.7 3.6 7.4 
49.7 19.8 14.6 7.5 1.6 6.5 
20.7 20.1 20.9 13.5 6.3 18.4 
39.6 23.4 16.6 8.9 2.6 8.4 
33.3 21.3 22.l 12.2 3.5 7.3 
34.0 20.3 21.5 12.9 3.7 1.5 
15.5 14.2 24.6 13.4 5.0 12.2 
Note: All soils above, except BG, are the 250 micron fraction. The BG sample is < 2 
I 
. 
-
°' N 
Appendix IV 
Biomethylation Data 
163 
Treatment-Rep 
OCBI 
OCB2 
OCB3 
OCB4 
OCNI 
OCN2 
OSBI 
OSB2 
OSB3 
OSB4 
OSNI 
OSN2 
ACBI 
ACB2 
ACB3 
ACB4 
ACNI 
ACN2 
ASBI 
AS82 
AS83 
AS84 
ASNl 
ASN2 
KI-I 
MMA+DMA 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
0.000 
Table IV - 1 
Biomethylation Data 
Arsenic, micrograms 
Week2 
KI-2 Total AC As KI-I 
MMA+DMA MMA+DMA TMA Total MMA+DMA 
0.000 0.000 0.000 0.000 
0.000 0.000 0.060 0.060 0.000 
0.000 0.000 0.020 0.020 0.000 
0.000 0.000 6.599 6.599 0.000 
0.000 0.000 0.074 0.074 0.000 
0.000 0.000 0.328 0.328 0.000 
0.000 0.000 105.316 105.316 0.025 
0.000 0.000 0.093 0.093 0.191 
0.000 0.000 0.068 0.068 0.022 
0.000 0.000 0.031 0.031 0.060 
0.000 0.000 0.289 0.289 0.022 
0.000 0.000 7.557 7.557 0.000 
0.000 0.000 0.082 0.082 0.000 
0.000 0.000 0.104 0.104 0.000 
0.000 0.000 0.042 0.042 0.024 
0.000 0.000 0.113 0.113 0.000 
0.000 0.000 0.000 0.000 0.000 
0.000 0.000 0.096 0.096 0.000 
0.000 0.000 0.164 0.164 0.000 
0.000 0.000 0.278 0.278 0.029 
0.000 0.000 0.120 0.120 0.091 
0.000 0.000 · 0.155 0.155 0.036 
0.000 0.000 5.773 5.773 0.129 
0.000 0.000 0,000 0.191 
Week4 
KI-2 Total AC As 
MMA+DMA .MMA+DMA TMA Total 
0.000 0.000 0.033 0.033 
0.000 0.000 3.442 3.442 
0.000 0.000 0.317 0.317 
0.000 0.000 0.377 0.377 
0.000 0.000 0.094 0.094 
0.000 0.000 0.170 0.170 · 
0.000 0.025 0.051 0.076 
0.081 0.272 0.092 0.364 
0.000 0.022 0.048 0.070 
0.000 0.060 0.080 0.140 
0.000 0.022 0.000 0.022 
0.000 0.000 0.000 0.000 
0.000 0.000. 0.000 0.000 
0.027 0.027 0.101 0.128 
0.000 0.024 0.000 0.024 
0.000 0.000 0.064 0.064 
0.000 0.000 0.248 0.248 
0.015 0.015 0.031 0.046 
0.038 0.038 0.039 0.077 
0.000 0.029 0.231 0.260 
0.060 0.151 0.385 0.536 
0.000 0.036 0.241 0.277 
0.036 0.165 0.027 0.192 
0.045 0.236 0.273 0.509 
The TMA numbers in bold (OSBI, OSN2, and ASNl) are clearly outliers. These values will be omitted on the following sheet 
-O'I 
.i:,. 
Week8 
KI-1 KI-2 Total 
Treatment-Rep MMA+DMA .MMA+DMA MMA+DMA 
OCBl 0.044 0.027. 0.071 
OCB2 0.027 0.036 0.063 
OCB3 0.023 0.030 0.053 
OCB4 0.017 0.016 0.033 
OCNl 0.019 0.024 0.043 
OCN2 0.014 0.020 0.034 
OSBl 0.029 0.010 0.039 
OSB2 0.016 0.007 0.023 
OSB3 0.016 0.023 0.039 
OSB4 0.031 0.031 
OSNl 0.010 0.012 0.022 
OSN2 0.018 0.012 0.030 
ACBl 0.013 0.009 0.022 
ACB2 0.029 0.016 0.045 
ACB3 0.001 0.000 0.001 
ACB4 0.000 0.000 0.000 
· ACNl 0.000 0.018 0.018 
ACN2 0.031 0.036 0.067 
ASBl 0.038 0.010 0.048 
ASB2 0.038 0.048 0.086 
ASB3 0.059 0.047 0.106 
ASB4 ·0.034 0.035 0.069 
ASNl 0.049 0.036 0.085 
ASN2 0.124 0.059 0.183 
Table IV - 1 
Biometh}'lation Data 
-
AC As KI-1 
TMA Total MMA+DMA 
·0.068 0.139 0.112 
0.041 0.104 0.056 
0.040 0.093 2.978 
0,041 0.074 0.390 
0.025 0.068 0.081 
0.029 0.063 0.196 
0.044 · 0.083 0.000 
0.251 0.274 0.000 
0.041 0.080 0.000 
0.079 0.110 0.021 
0.285 0.307 0.021 
0.092 0.122 0.016 
0.072 0.094 0.015 
0.050 0.095 0.033 
0.059 0.060 0.000 
0.061 0.061 0.005 
0.050 0.068 0.000 
0.058 0.125 0.000 
0.054 0.102 0.004 
0.343 0.429 0.038 
0.118 0.224 0.016 
0.118 0.187 0.008 
0.176 0.261 0.050 
0.283 0.466 0.000 
Week 12 
KI-2 Total 
MMA+DMA MMA+DMA 
0.010 0.122 
0.004 0.060 
0.079 3.057 
0.137 0.527 
0.000 0.081 
0.000 0.196 
0.000 0.000 
0.000 0.000 
0.330 0.330 
0.014 0.035 
0.016 · 0.037 
0.040 0.056 
0.018 0.033 
0.010 0.043 
0.000 0.000 
0.000 0.005 
0.000 0.000 
0.000 0.000 
0.000 0.004 
0.020 0.058 
0.000 0.016 
0.000 0.008 
0.00'1 0.051 
0.000 0.000 
AC 
TMA 
0.097 
0.086 
0.194 
0.075 
0.057 
0.143 
0.080 
0.029 
0.299 
0.030 
0.-046 
0.106 
0.026 
0.011 
0.020 
0.033 
0.041 
0.211 
0.33 
0.246 
0.215 
0.051 
As 
Total 
0.219 
0.146 
3.251 
0.602 
0.138 
0.339 
0.080 
0.029 
0.629 
0.065 
0.083 
0.162 
0.059 
0.054 
0.020 
0.038 
0.041 
0.211 
0.334 
0.304 
0.016 
0.008 
0.266 
0.051 
...... 
O'\ 
Vl 
Week 16 
Kl-I KI-2 Total 
Treatment-Rep MMA+DMA MMA+DMA MMA+DMA 
OCBI 0.014 0.057 0.071 
OCB2 1.000 0.075 1.075 
OCB3 2.412 0.059 2.471 
OCB4 0.673 0.143 0.816 
OCNl 0.148 0.069 0.217 
OCN2 0.115 0.(,)57 0.172 
OSBI 0.069 0.043 0.112 
OSB2 0.062 0.065 0.127 
OS83 0.120 0.055 0.175 
OS84 0.071 0.010 0.101 
OSNI 0.039 0:023 0.062 
OSN2 0.040 0.060 0.100 
ACBl 0.036 0.012 0.048 
ACB2 0.026 0.041 0.067 
ACB3 0.039 0.185 0.224 
ACB4 0.109 0.105 0.214 
ACNI 0.076 0.063 0.139 
ACN2 0.062 0.045 0.107 
ASBI 0.130 0.074 0.204 
AS82 0.081 0.063 0.144 
AS83 0.069 0.066 0.135 
AS84 0.070 0.077 0.147 
ASNl 0.065 0.060 0.125 
ASN2 0.085 0.062 0.147 
AC 
TMA 
0.253 
0.291 
0.200 
0.174 
0.315 
0.128 
0.101 
0.118 
0.141 
0.120 
0.122 
0.105 
0.066 
0.150 
0.109 
0.116 
0.113 
0.108 
0.152 
0.115 
0.053 
0.085 
0.071 
0.042 
Table IV - l 
Biomethylation Data 
-
As KI-I 
Total MMA+DMA 
0.324 0.038535 
1.366 0.03093 
2.671 0.04867 
. 0.990 0.13375 
0.532 0 
0.300 0.025595 
0.213 0.07785 
0.245 0.002445 
0.316 0.037545 
0.221 0.02483 
0.184 0.1334 
0.205 0.04221 
0.114 0.001455 
0.217 0 
0.333 0 
0.330 0 
0.252 0.000 
0.215 0.000 
0.356 0 
0.259 0.006375 
0.188 0.03234 
0.232 0.00370500 
0.196 0.00911500 
0.189 0.01414000 
Week.20 
KI-2 Total AC As 
MMA+DMA MMA+DMA. TMA Total 
0.003295 0.04183 0.09785 0.13968 
0 0.03093 0.00221 0.03314 
0 0.04867 0 0.04867 
0 0.13375 0.05215 0.1859 
0.007615 0.007615 . 0.00105 0.00867 
0.0079.85 0.03358 0.01213 0.04571 
0.08525 0.1631 0 0.1631 
0.001715 0.00416 0.4783 0.48246 
0.07085 0.108395 0.01508 0.12348 
0.026245 0.051075 0 0.05108 
0.07085 0.20425 0.10245 0.3067 
0 0.04221 0.00716 0.04937 
0 0.001455 0.0078 0.00925 
0.00974 0.00974 0.0163 0.02604 
0.028635 0.028635 0 0.02864 
0.003 0.002515 0.2045 0.20702 
0.037 0.03677 0 0.03677 
0.000 0.00003 0.0421 0.04213. 
0.000385 0.000385 0.01189 0.01227 
0.013315 0.01969 0.43695 0.45664 
0.01321 0.04555 0.2894 0.33495 
0.01047000 0.014175 0.4639 0.47808 
0.00616000 0.015275 0.1476 0.16288 
0.00947500 0.023615 0.1662 0.18982 
-0\ 
0\ 
As 
Sample ID ug/L 
LSI-KI 3.579 
LS2-KI 2.74 
LS3-KI 3.189 
LSI-AC 1.292 
LS2-AC 4.273 
LS3-AC 1.901 
As 
Sample ID ug/L 
LSI-KI 249.1 
LS2-KI 6.639 
LS3-KI 102.1 
LSI-AC 14.5 
LS2-AC 1.161 
LS3-AC 4.685 
Table IV - 2 
Biomethylated arsenic - lead stabilized calcine experiment 
Week2 Week2 Week8 
Total As As Total As As Total As 
ugAs ug/L ugAs ug/L ugAs 
0.119199 11.448 0.5724 27.823 2.782 
0.137 1.011 0.05055 9.27 0.927 
0.15945 1.693 0.08465 663.397 66.340 
-0.065 · 0 0.000 0 0.000 
0.214 4.768 0.238 9.069 0.453 
0.095 10.226 0.511 0 0.000 
Week 16 Week 20 
Total As As Total As 
ugAs ug/L ugAs 
24.909 21. 743 2.174 
0.664 94.306 9.431 
10.211 7.932 0.793 
0.725 4.301 0.215 
0.058 4.743 0.237 
0.234 1.885 0.094 
Week 12 
As Total As 
ug/L ugAs 
296.025 29.603 
17.674 1.767 
1263.715 126.372 
166.126 8.306 
3.981 0.199 
31.282 1.564 
-0\ 
-...J 
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Appendix V 
Quality Assurance Work Plan 
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QUALITY ASSURANCE 
Intended tJse of the Data and Acceptable Criteria for Data Quality 
Collected data will be used to evaluate the ability of proposed chemical and in-vitro 
methods to provide a better, site-specific determination of the bioavailability of metals in 
soils/solid wastes. A more reasonable, site-specific method of quantifying the bioavailable 
fractions of metals will provide a more reasonable estimation of the true risk from exposure 
to contaminated environmental media by lowering the uncertainty associated with the 
fraction of As absorbed in risk calculations. All reagents and solutions utilized for the 
proposed study will be of high purity Optima TM quality to ensure negligible As 
contamination. Criteria used to determine the acceptability of data include the evaluation ·of: 
1) precision, by determining the degree of reproducibility of data as from the analysis of 
sample replications in the laboratory and replications of swine to be exposed to each soil 
treatment; 2) accuracy, by determining spike recoveries in analytical samples and analyzing 
appropriate reference standards and blanks; 3) representativeness, in a qualitative way, by 
collecting contaminated materials representative of metals contaminated sites and choosing 
representative swine for feeding trials; 4) completeness, by providing statistically sound 
experimental designs and appropriate replications to ensure p<0.05; and 5) comparability, 
by performing statistical correlations of the in-vivo data with the chemical and in-vitro data. 
Project Requirements for Precision, Accuracy, Representativeness, Completeness, and 
Comparability (PARCS) 
Acceptability of data will be determined by following procedures described in · 
USEPA (1988). The specific PARCS parameters will be eval~ted as: 1) Precision, by 
analyzing duplicate samples and performing replicates of experimental procedures. 
Laboratory duplicates will be analyzed at the rate of 10% of the samples .. The relative 
percent difference shall not be greater than 5%. 2) Accliracy, by analysis of spiked analytical 
samples and appropriate reference materials. Spike recoveries shall be between 80 and 120% 
and reference materials shall be within 5% of the reported value. 3) Representativeness, will 
be evaluated qualitatively. 4) Completeness will be accomplished by ensuring all samples 
are analyzed and data collected. 5) Comparability will be evaluated statistically by Analysis 
of Variance (ANOV A) techniques with statistical significance level reported. Correlations 
between in-vivo, chemical, and in-vitro methods results will be determined. 
Procedures for Collection and Preparation of Samples 
Solid waste/soil materials have been collected from a mining, milling, and smelter 
site. Remedial Investigationreports·and an As-specific field test kit were used to estimate 
. the total As prior to collection. Samples were collected using decontaminated collection 
equipment. All samples were transported and stored under proper chain-of-custody 
procedures to insure maintenance of sample integrity. Soil sample preparation, including air 
drying, sieving, and homogenizing, will be performed by Oklahoma State University. 
Pr~pared soil materials will be sent to University of Missouri-Columbia under proper chain-
of-custody procedures. Urine samples will be collected, filtered, acidified by University of 
170 
Missouri-Columbia then shipped to Oklahoma State University packed in ice (cool, 4° C). 
Tissue samples will be collected, prepared by University of Missouri-Columbia and then 
shipped to Oklahoma State University packed in dry ice. 
Procedures for Sample Handling, Identification, Preservation, Transportation, and Storage 
Soil/solid waste. materials wiU be stored in air-tight containers in a locked soil 
laboratory in which only authorized personnel have access; A lettering and numerical system 
will be utilized to identify all soil samples, e.g., slag materials will be labeled with "S" and 
calcine materials will be labeled "C". Roman numerals will then be used to represent the As 
level, e.g., "I" will be used to represent the lowest level of As, "II" will represent the next 
highest level, and so forth. Numbers will be used, such as -1, 1, 3, 6~ 9, 12, and 15, to 
designate on which day of the exposure the swine urine sample was collected. Replicate 
numbers will be represented as the last number in the identification label. As an example, the 
second replication of a swine urine sample collected on day 3 following exposure to the 
lowest level of soil As would be represented as follows: "Cl33". All samples will be labeled 
with black permanent markers directly on the container. Biological samples will be collected 
and prepared by UMC and transported to OSU under chain-of-custody procedures. Urine 
samples will be stored in a dedicated refrigerator located in the Chemistry Laboratory for 
Environmental Analysis at OSU which is kept locked and only accessed by authorized 
personnel. All sample transport will be accomplished via an overnight express delivery 
company. 
Analytical Methods and Test Procedures 
Standardized analytical methods will be performed per USEPA SW-846 Method 7062 
for hydride generation and subsequent determination of As in soil extracts, in-vitro digests, 
and animal urine samples. Other te~ procedures to characterize As in contaminated materials 
will include total metals (USEPA SW-846 Method 3050) and Toxicity Characteristic 
·Leaching Procedure (USEPA SW"'."846 Method 1311). 
Standard QA/QC Control Procedures 
General Statement.oflntent to Comply with GLP (40CFR Ch. 1 Part 792; 7-1-90): 
It is the intent of the Principal Investigator, Co-Investigator, and all associated analytical 
personnel that this applied research investigation comply with good Laboratory Practice 
Procedures (GLP) as outlined in 40CFR, Chapter 1. We will follow a Quality Assurance 
Project Plan (QAPP) and the associated Standard Operating Procedures (S0Ps) developed 
according to USEP A guidance as appropriate for any work to obtain data from CERCLA 
sites (USEPA, 1988a, 1988b, and 1993). Where quality control and assurances do not 
strictly follow GLP as outlined in 40CFR, Chapter 1, the spirit of GLP will be followed in 
such a manner as to provide equivalent or comparable quality control and assessment to 
assure a defensible, scientific process. 
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